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Abstract: 
Previous research has yielded conflicting results regarding the involvement of 
mesolimbic dopamine in Pavlovian and operant tasks.  While there is abundant evidence that 
an operant lever press requires intact dopamine (DA) D1 transmission in the nucleus 
accumbens (ACB) and in the basolateral amygdala (BLA), there is conflicting evidence 
regarding the specific brain sites at which DA mediates a Pavlovian approach response.  The 
present study was designed to compare the effects of ACB and BLA D1 receptor-blockade 
on an operant and Pavlovian task, while minimizing differences in behavioral response 
topography.  Animals were trained on either a Pavlovian cued approach task or an operant 
cued nosepoke task.  In the Pavlovian approach task, a tone signaled a pellet delivery to 
which animals responded with a head entry into a food compartment.  In the operant 
nosepoke task, animals were trained to emit a nosepoke in response to the same tone, in order 
to trigger a pellet delivery.  Bilateral microinfusions of the D1 antagonist SCH 23390 (0, 1 or 
2 µg/side) into either the ACB or the BLA produced a dose-dependent disruption of the 
operant nosepoke.  In contrast, the Pavlovian cued approach response was unaffected by D1 
antagonist microinfusions into either the ACB or the BLA.  In addition, infusion of SCH 
23390 into either site suppressed general locomotion.  The results suggest a dissociation of 
the anatomical substrates mediating an operant nosepoke and a Pavlovian approach, despite 
 similar response topographies.  These findings are consistent with the notion that D1 activity 
at the ACB and BLA plays a role in the expression of operant responses, but not in the 
expression of Pavlovian approach responses.  
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I.   INTRODUCTION 
 
For the past half-century, a vast amount of research has investigated the different 
functions of the neurotransmitter dopamine (DA).  Indeed, its roles in motivated behavior 
(reviewed in Baldo & Kelley, 2007; Beninger & Miller, 1998; Berridge & Robinson, 
1998; Ikemoto & Panksepp, 1999; Stricker & Zigmond, 1985; Wise, 2006), in drug 
addictions (Di Chiara, 1995; Franken, Booij, & van den Brink, 2005; Koob & Le Moal, 
2001), but also its involvement in schizophrenia (Goldman-Rakic & Selemon, 1997; 
Laruelle, Kegeles, & Abi-Dargham, 2003; Schmidt et al., 2001; Sesack & Carr, 2002), 
depression (A. S. Brown & Gershon, 1993; Caligiuri & Ellwanger, 2000; Schmidt, et al., 
2001) and its critical implication in Parkinson’s disease (Czernecki et al., 2002; 
Hornykiewicz, 2001; Marsden, 1984; Shohamy, Myers, Grossman, Sage, & Gluck, 
2005), have fueled countless research efforts, and dopamine research now spans many 
fields. 
Within the smaller domain of animal motivation, DA is the subject of intensive 
research, particularly for its involvement in appetitive conditioning (pairing a stimulus or 
a behavior with a positive outcome such as food) (Berridge & Robinson, 1998; Ikemoto 
& Panksepp, 1999; Salamone, Correa, Mingote, & Weber, 2005; Wise, 2004), in aversive 
conditioning (pairing a stimulus or behavior with a negative outcome such as a 
footshock) (Nader & LeDoux, 1999; Pezze & Feldon, 2004; Salamone, 1994), and its 
critical role in motor functions (Beninger, 1983; Fowler & Liou, 1998; Heffner, 
Zigmond, & Stricker, 1977; Ungerstedt, 1979). 
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This doctoral project aimed at comparing the involvement of mesolimbic DA in 
the performance of Pavlovian and operant appetitive behaviors.  Therefore, key issues 
reviewed therein will include the following: First, the anatomy of the mesocorticolimbic 
system, focusing in particular on the three major forebrain targets of this dopaminergic 
system, the nucleus accumbens, the amygdala, and the prefrontal cortex.  Second, the 
associative mechanisms underlying Pavlovian and operant conditioning will be 
presented, and the distinction between Pavlovian and operant responses will be 
maintained throughout this report.  Third, the molecular mechanisms underlying learning 
(long term potentiation, LTP) as well as DA’s role in LTP will be described.  Next, the 
multiple hypotheses regarding DA’s roles in appetitive conditioning, such as reward, 
reinforcement, or motivation will be discussed.  Finally, the existing evidence regarding 
mesocorticolimbic DA participation in the acquisition and performance of Pavlovian and 
operant appetitive behaviors will be reviewed, followed by the investigations conducted 
for this thesis. 
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1.  The Mesocorticolimbic Dopamine System 
 
Since the investigations presented in this thesis were carried out on a rat model, 
the descriptions of the mesocorticolimbic system described in this section pertain to the 
rat brain. 
Based on their common neurochemical characteristic, Dahlström and Fuxe 
(Dahlstrom & Fuxe, 1964) identified three dopaminergic (DA) cells groups in the 
mesencephalon: A8 in the retrorubral field, A9 in the substantia nigra pars compacta 
(SNpc) and A10 in the ventral tegmental area (VTA).  Using more sensitive histological 
techniques, recent studies have confirmed and added to the anatomical and functional 
understanding of these cell groups.  A10 was extended to include DA cells in the 
supramammillary nucleus, dorsal raphe, periaqueductal gray, and medial habenula 
(Hasue & Shammah-Lagnado, 2002; Hökfelt, Martensson, Björklund, Kleinau, & 
Goldstein, 1984; Ikemoto, 2007).  In addition, it was discovered that the distribution and 
projections of these cell groups overlap considerably: For instance, A10 cells also project 
to the striatum (previously thought to be exclusively A9 territory), while cells in both A9 
and A8 project to limbic and cortical targets (major A10 targets) (Bjorklund & Dunnett, 
2007; Zahm, 2006).  Because the work presented here examined mesocorticolimbic 
targets, and for the sake of simplicity, the choice was made to use the traditional concept 
of A10 (i.e. limited to the VTA, not the extended definition).  Thus, a brief description of 
the VTA’s anatomy is provided, but it is important to keep in mind that cortical and 
limbic sites also receive DA inputs from cells in the A8, A9 and extended A10 groups. 
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1.1.  The Ventral Tegmental Area 
The ventral tegmental area (VTA) refers to a brain substrate located in the 
midbrain, caudal to the mammillary bodies and the hypothalamus, ventral to the red 
nucleus and medial to the substantia nigra, (SN) (Fallon & Moore, 1978; Geisler & 
Zahm, 2005; Swanson, 1982).  The delineation between the VTA and the SN (pars 
compacta) has been difficult to determine, in part due to their overlapping DA cells 
distribution (Bjorklund & Dunnett, 2007; Swanson, 1982; Zahm, 2006).  About two 
thirds of the neurons comprising the VTA are dopaminergic, most of them concentrated 
at the level of the red nucleus and interpeduncular nucleus (Nair-Roberts et al., 2008; 
Swanson, 1982).  These neurons are fuseform medium-sized neurons and exhibit 
horizontal dendrites (Moore & Bloom, 1978; Swanson, 1982).   
Dopaminergic neurons are not the only cell type in the VTA (Swanson, 1982).  
Approximately one third of VTA neurons are GABAergic (i.e., release GABA, gamma 
aminobutyric acid, an inhibitory neurotransmitter (Byrne, 2003)).  Some of these 
GABAergic neurons are local interneurons, but the majority are projections neurons, 
targeting the same areas as the DAergic projections, notably to the nucleus accumbens 
(ACB) and the prefrontal cortex (PFC) (Carr & Sesack, 2000a; Sesack & Grace, 2010; 
Van Bockstaele & Pickel, 1995).  In addition, a small population of glutamatergic (Glu) 
neurons, sometimes colocalized with DA, has recently been identified in the VTA (Nair-
Roberts, et al., 2008; Sesack & Grace, 2010; Yamaguchi, Sheen, & Morales, 2007). 
VTA Afferents:  Initial histological accounts of the VTA described a limited 
number of afferent projections, mostly coming from midbrain areas, the lateral 
hypothalamus, basal forebrain, and the nucleus accumbens (Fallon & Moore, 1978).  
5 
 
However, recent studies revealed that many more brain areas, from the prefrontal cortex 
to the brainstem, form an elongated structure projecting to the VTA (Geisler & Zahm, 
2005, p. 283).  Moving caudalward from the prefrontal cortex these inputs include the 
lateral septum, diagonal-band complex, nucleus accumbens shell, ventral pallidum, 
lateral and medial parts of the preoptic area, the lateral hypothalamus, lateral habenula, 
and finally in the brainstem, the dorsal raphe, periaqueductal gray and the reticular 
formation.  Furthermore, many of the structures projecting to the VTA also project to 
each other, hence affecting the VTA directly and indirectly (Geisler & Zahm, 2005), thus 
the activity of the VTA activity appears to be regulated by a large and interdependent 
network.  In fact, based on the dendritic and axonal characteristics of this network, the 
authors suggest that it is reminiscent of the “isodendritic core” (reticular formation), a 
structure “optimally suited for integrative functions” (Geisler & Zahm, 2005, p. 287). 
Most of the structures innervating the VTA are glutamatergic (Geisler, Derst, 
Veh, & Zahm, 2007).  In addition, the VTA also receives excitatory cholinergic inputs 
from the pedunculopontine tegmentum (PPTg) and laterodorsal tegmentum (LDT) 
(Oakman, Faris, Kerr, Cozzari, & Hartman, 1995), which may be important in 
influencing VTA activity (reviewed in (Sesack & Grace, 2010).  The VTA’s inhibitory 
(GABAergic) inputs arise mostly from the nucleus accumbens shell and the ventral 
pallidum (Heimer, Zahm, Churchill, Kalivas, & Wohltmann, 1991; Kalivas, Churchill, & 
Klitenick, 1993), but GABAergic inputs are also likely arising from numerous other 
subcortical structures, including the lateral septum, diagonal band of Brocca, bed nucleus 
of the stria terminalis, and the lateral hypothalamus; from midbrain structures such as the 
periaqueductal gray, the PPTg, LDT, the parabrachial nucleus, raphe nuclei and the 
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recently identified mesopontine rostromedial tegmental nucleus (RMTg) (Geisler & 
Zahm, 2005; Sesack & Grace, 2010); and from local GABAergic interneurons within the 
VTA itself (reviewed in Sesack & Grace, 2010). 
VTA Efferents:  The VTA sends distinct populations of neurons targeting limbic 
and cortical targets.  Most of these efferent fibers are DAergic and GABAergic, exhibit 
virtually no collateralization, and form individual projections that innervate specific 
targets with considerable terminal field overlap (Del-Fava, Hasue, Ferreira, & Shammah-
Lagnado, 2007; Fallon & Loughlin, 1982; Swanson, 1982; Van Bockstaele & Pickel, 
1995).  One of the VTA’s major outputs sends DAergic fibers to the nucleus accumbens, 
organized according to a mediolateral axis (Hasue & Shammah-Lagnado, 2002; Ikemoto, 
2007) and a reversed dorsoventral axis (Bjorklund & Dunnett, 2007; Hasue & Shammah-
Lagnado, 2002; Moore & Bloom, 1978; Swanson, 1982).  The VTA also sends DAergic 
projections to the olfactory tubercle, septal region, and caudate-putamen, to the 
prelimbic, infralimbic, cingulate and perirhinal cortices, to the central and basolateral 
nuclei of the amygdala, the entorhinal area, lateral habenula, hippocampus, and the locus 
coeruleus (Fallon & Moore, 1978; Lindvall & Bjorklund, 1978; Swanson, 1982).  Recent 
studies have also described DAergic projections to the ventral pallidum, subthalamic 
nucleus, mediodorsal thalamus, preoptic and lateral hypothalamic areas, and the dorsal 
raphe (Del-Fava, et al., 2007; Gaykema & Zaborszky, 1996; Hasue & Shammah-
Lagnado, 2002; Klitenick, Deutch, Churchill, & Kalivas, 1992; Sesack & Grace, 2010). 
Although the VTA does not receive direct sensory information, its numerous 
cortical, basal forebrain and brain stem afferents provide a comprehensive representation 
of limbic and homeostatic states.  Together, these inputs influence the activity of VTA’s 
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DAergic and GABAergic output neurons, which project to numerous areas, thus 
contributing to the elaboration of an adaptive behavioral response to environmental 
challenges (Geisler & Zahm, 2005; Hasue & Shammah-Lagnado, 2002; Ikemoto, 2007; 
Sesack & Grace, 2010; Swanson, 1982; Zahm, 2006). 
 
1.2.  The Nucleus Accumbens 
The nucleus accumbens (ACB) is comprised of three subregions: A core, a shell, 
and a rostral pole (Berendse, Galis-de Graaf, & Groenewegen, 1992; Voorn, 
Vanderschuren, Groenewegen, Robbins, & Pennartz, 2004; Zahm & Brog, 1992).  The 
subdivisions of the ACB receive afferent projections from the basolateral amygdala, the 
prefrontal cortex, the subiculum of the hippocampus and the VTA (Brog, Salyapongse, 
Deutch, & Zahm, 1993; Groenewegen, Vermeulen-Van der Zee, te Kortschot, & Witter, 
1987; Zahm & Brog, 1992).  However, some afferent projections differ between the ACB 
core and shell: The shell receives projections from the ventral prelimbic and the 
infralimbic cortices, the globus pallidus and the subthalamic nucleus (Berendse, et al., 
1992; Heimer, et al., 1991; S. M. Reynolds & Zahm, 2005; Zahm & Brog, 1992).  In 
addition to the afferents common to both the ACB core and shell, the core is specifically 
innervated by the dorsal prelimbic cortex and anterior cingulate (Berendse, et al., 1992; 
S. M. Reynolds & Zahm, 2005).  
The ACB core and shell also differ with respect to their efferent projections: The 
shell region projects principally to limbic regions, notably the lateral hypothalamus, the 
medial ventral pallidum, the bed nucleus of the stria terminalis, the preoptic area, and the 
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VTA (Heimer, et al., 1991; Zahm & Heimer, 1993).  Some have hypothesized that the 
ACB shell may be a transitional progression from the extended amygdala (Alheid & 
Heimer, 1988; Everitt et al., 1999; Heimer et al., 1997).  In contrast, the ACB core 
projections resemble more closely that of the dorsal striatum, in that they project to the 
ventral pallidum, the substantia nigra, the lateral hypothalamus and the subthalamic 
nucleus, which in turn projects back to motor cortical areas, via thalamic nuclei 
(Alexander & Crutcher, 1990; Heimer, et al., 1991; Zahm & Brog, 1992).   
The third subregion, the rostral pole is described as having both “shell-like” and 
“core-like” afferent and efferent projections (Zahm & Heimer, 1993).  In addition, it 
appears that the VTA innervation of the core and shell differ, further differentiating these 
subregions as separate units (Deutch & Cameron, 1992).  Recently, a direct connection 
has been found between the core and the shell, suggesting that these two subregions 
probably both form an interrelated network (van Dongen et al., 2005).  Like the dorsal 
striatum, the ACB is comprised of GABAergic medium spiny neurons (which make up 
most of the accumbal projections), as well as aspinous cholinergic and GABAergic 
interneurons (Groenewegen & Russchen, 1984; Voorn, Gerfen, & Groenewegen, 1989). 
In light of its anatomical position between limbic inputs and motor outputs, and 
because of its prominent DA innervation, it has been proposed that the ACB operates as a 
“limbic-motor interface” (Ikemoto & Panksepp, 1999; Mogenson, 1987; Pennartz, 
Groenewegen, & Lopes da Silva, 1994).  Because the ACB is a site of such integration, 
its DAergic innervation is in a critical position to influence behavior.  However, a matter 
of importance that is not entirely clear yet, is how DA release affects ACB cells.  Indeed, 
contradictory evidence has led to two opposite models.  One model proposes that 
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synaptic DA modulates, or “gates” glutamatergic (Glu) throughput to the ACB by 
facilitating strong Glu inputs to the accumbens and dampening weak Glu inputs, resulting 
in a sharper signal-to-noise ratio (Cepeda & Levine, 1998; Horvitz, 2002; O'Donnell, 
2003).  Indeed, striatal slice models report that DA agonists promote NMDA (N-methyl-
D-aspartate) receptors-mediated responses (Cepeda, Buchwald, & Levine, 1993; Levine, 
Li, Cepeda, Cromwell, & Altemus, 1996).  According to this view, facilitation of strong 
Glu inputs would excite ACB cells, resulting in a GABAergic inhibition of the ventral 
pallidum (VP), which based on models of a “direct” basal ganglia pathway (Alexander & 
Crutcher, 1990) is hypothesized to relieve thalamic nuclei from pallidal inhibition, thus 
permitting motor output (Nicola, 2007). 
In contrast, others have argued that DA gates the ACB reactivity to environmental 
events by suppressing ACB activity, thereby relieving the VP from ACB inhibitory 
control (Mogenson, 1987; Numan, 2006; Numan, Stolzenberg, 2009).  There is evidence 
indeed that DA inhibits excitatory inputs to the ACB (Charara & Grace, 2003; Harvey & 
Lacey, 1996; Maeda et al., 2004; Nicola & Malenka, 1997; O'Donnell & Grace, 1996).  
The ventral pallidum (VP), on the other hand, also receives Glu projections from the 
basolateral amygdala and the prefrontal cortex.  Therefore, according to this model, when 
the BLA and PFC outputs are activated jointly with DA, a) the ACB is suppressed by DA 
(hence does not inhibit the VP), and b) the VP is activated by BLA and PFC excitatory 
inputs, and thus contributes to behavioral output (Mogenson, 1987; Numan et al., 2005; 
Numan, Stolzenberg, 2009), perhaps through its glutamatergic projection to the PFC (Hur 
& Zaborszky, 2005).  In support of this view, are the findings that lesions or temporary 
inactivation of the ACB do not disrupt maternal behavior, while lesions or inactivation of 
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the VP (Numan, et al., 2005) as well as ACB D1 receptor-blockade (Numan, et al., 2005) 
do disrupt maternal behavior.  Other studies reported that ACB shell lesions do not 
suppress a Pavlovian discriminative approach response (Parkinson, Willoughby, Robbins, 
& Everitt, 2000), or a variety of operant behaviors (Ito, Robbins, & Everitt, 2004; 
Pothuizen, Feldon, & Yee, 2006).  In fact, some have even found that ACB inactivation 
increased operant responding, albeit responding to irrelevant stimuli, such as lever 
pressing on an inactive lever for exemple (Yun, Nicola, & Fields, 2004).  The 
contradictory findings supporting each model indicate that the precise relations between 
DA release and ACB response, as well as their resulting influence on behavior, remain to 
be elucidated. 
 
1.3.  The Amygdala 
The amygdala, a structure discovered by Burdach in the early 19th century has 
been the subject of intensive examination and reclassification.  The amygdala is 
comprised of three main groups of nuclei, the basolateral nuclei, the cortical-like nuclei 
and the centromedial nuclei, which are themselves divided in several subregions 
(reviewed in Sah, Faber, De Armentia, & Power, 2003).  The basolateral nuclei contain 
the lateral nucleus (LA), the basolateral nucleus (BLA), and the basomedial nucleus.  The 
cortical-like nuclei are made of the nucleus of the lateral olfactory tract, the bed nucleus 
of the accessory olfactory tract, the anterior cortical nucleus, the posterior cortical 
nucleus, and the periamygdaloid cortex.  The third group, the centromedial nuclei are 
comprised of the central amygdala (CeA) and the medial amygdala.  In addition, the 
amygdala is comprised of three more types of nuclei, which are not part of the three 
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groups mentioned: The anterior amygdala area, the amygdalo-hippocampal area, and the 
intercalated masses (Sah, et al., 2003).  This traditional classification of the amygdala has 
been debated, and some suggest that it should be extended to include portions of the bed 
nucleus of the stria terminalis and portions of the substantia inominata, thus making the 
extended amygdala (Swanson & Petrovich, 1998).  Since most of the research on learning 
and emotions has focused primarily on the central nucleus of the amygdala (CeA) and on 
the basolateral amygdala (BLA), the focus will be on these two nuclei. 
Most afferents to the amygdaloid nuclei arise from cortical sources and include a 
wide range of sensory information relayed by cortical association areas (McDonald, 
1998).  Amygdala nuclei also receive dense projections from the thalamus, the 
hippocampus, and the hypothalamus (McDonald, 1998), as well as DAergic afferent from 
the VTA and the SN, which innervate preferentially the CeA and the BLA (Brinley-Reed 
& McDonald, 1999; Loughlin & Fallon, 1983; Swanson, 1982).  Moreover, the CeA 
receives a majority of the inputs from the hypothalamus, as well as numerous brainstem 
afferents such as the midbrain periaqueductal gray and reticular formation, the pons and 
medulla (Pitkänen, 2000; Sah, et al., 2003).  The BLA, on the other hand, receives 
massive projections from the PFC (McDonald, Mascagni, & Guo, 1996), in particular 
from the infralimbic and prelimbic areas (A. Pinto & Sesack, 2000) and most of the 
inputs from the hippocampus (subiculum) (McDonald, 1998).   
Amygdala’s efferents generally project to cortical and hypothalamic areas, as well 
as brain stem nuclei (Sah, et al., 2003).  In particular, the CeA sends projections to 
several hypothalamic areas, especially the lateral hypothalamus (Petrovich, Canteras, & 
Swanson, 2001), the bed nucleus of the stria terminalis (Dong, Petrovich, & Swanson, 
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2001), the brainstem (including the VTA and the SN), and the midbrain reticular 
formation (Pitkänen, 2000; Sah, et al., 2003; Swanson & Petrovich, 1998).  The 
basolateral complex, on the other hand, sends dense projections to the PFC (McDonald, 
1991a), the thalamus, the hippocampus (Sah, et al., 2003), and importantly, to the nucleus 
accumbens (particularly the ACB shell) and the dorsal striatum (Johnson, Aylward, 
Hussain, Totterdell, 1994; Kelley, Domesick, & Nauta, 1982; McDonald, 1991b). 
In addition, amygdala nuclei are heavily interconnected (Pitkänen, 2000).  The 
input stage of the amygdala is the basolateral complex, which receives most of the 
sensory information from cortical sources.  This information then travels through 
amygdaloid nuclei on a lateral to medial axis, finishing in the output stage of the 
amygdala, the centromedial nuclei (Pitkänen, 2000; Pitkänen, Savander, & LeDoux, 
1997).  More specifically, the lateral amygdala projects heavily to the BLA (Pitkanen et 
al., 1995), which projects to the medial amygdala and the CeA (Savander, Go, Ledoux, & 
Pitkanen, 1995).  Most amygdala nuclei project back to the lateral amygdala except for 
the CeA, which only has a few sparse projections back to others amygdaloid nuclei 
(Jolkkonen & Pitkanen, 1998).   
Although the BLA and the CeA have been studied extensively for their role in 
fear conditioning (J. LeDoux, 2003; Pitkänen, et al., 1997), as will be reviewed below, 
both nuclei are also implicated in appetitive conditioning (Balleine & Killcross, 2006; 
Everitt, et al., 1999). 
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1.4.  The Prefrontal Cortex 
The prefrontal cortex (PFC) is comprised of the following subdivisions: The 
medial PFC (mPFC) containing a dorsal portion, the prelimbic cortex, and a ventral 
portion, the infralimbic cortex, the anterior cingulate, the agranular insular cortex and the 
orbitofrontal cortex (reviewed in Tzschentke, 2001).  The mPFC receives Glu projections 
from many areas, including the contralateral mPFC, the mediodorsal thalamus, the 
hippocampus, and the amygdala (Groenewegen, Berendse, Wolters, & Lohman, 1990; 
Tzschentke, 2001) and other sensory cortical areas (Ongur & Price, 2000).  It is worth 
noting that the mPFC also receives a glutamatergic (Hur & Zaborszky, 2005) as well as a 
cholinergic projection from the VP (Bigl, Woolf, & Butcher, 1982).  As mentioned 
above, the mPFC receives a dense DAergic projection from the VTA (Lindvall & 
Bjorklund, 1978; Swanson, 1982).  Swanson suggested that the mesocortical pathway 
emerges mostly from DA cell bodies in the nucleus parabrachialis pigmentosus of the 
VTA (Swanson, 1982), whereas the mesolimbic projection (to the ACB and the 
amygdala) stems from cells bodies in the nucleus paranigralis of the VTA (Swanson, 
1982). 
The mPFC sends Glu efferents to other cortical areas including the posterior 
cingulate, the entorhinal, and the orbital areas (Kolb, 1984).  The PFC also projects to 
subcortical areas including the dorsal and ventral striatum (A. Pinto & Sesack, 2000), the 
amygdala (A. O. Pinto & Sesack, 2003), the thalamus and brainstem nuclei (Kolb, 1984; 
Sesack, Deutch, Roth, & Bunney, 1989), and sends a Glu projection back to the VTA 
(Carr & Sesack, 2000b; Christie, James, & Beart, 1985).  The mPFC innervation of the 
ACB seems to be organized topographically with prelimbic area innervating principally 
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the ACB core and the infralimbic area projecting primarily to the ACB shell (Berendse, 
et al., 1992; S. M. Reynolds & Zahm, 2005).  The PFC mediates numerous complex and 
more “cognitive” functions, such as working memory, attention, decision-making, and 
behavioral flexibility (De Bruin et al., 2000), and as will be seen below, PFC DA is 
mostly implicated in operant behaviors.   
Review of the anatomical characteristics of the mesocorticolimbic system 
suggests that the ACB, the BLA, and the PFC, (as well as the hypothalamus and the 
hippocampus, but these areas are beyond the scope of this work), are part of a DA-
modulated network that underlies adaptive responding to a constantly changing 
environment (Ikemoto, 2007; Sesack & Grace, 2010; Swanson, 1982; Zahm, 2006).  
While a simplified model of these interactions will be proposed in the final chapter of this 
thesis, the individual contribution of DA in each area to the acquisition and expression of 
Pavlovian and operant appetitive behaviors will be reviewed in detail in section 5.  To 
that end, an overview of the principles of associative learning and in particular the 
principles underlying Pavlovian and operant conditioning will be presented in the 
following section. 
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2.  Associative Learning 
2.1.  Pavlovian Conditioning 
A key aspect to animals’ survival is adaptive behavior.  For a behavior to be 
adaptive, it needs to be flexible and change according to variations in the environment.  
This adaptive flexibility can only happen if an animal learns the relationships between 
environmental events and their outcomes.  This type of learning mechanism underlies 
classical conditioning, also referred to as Pavlovian conditioning, after Pavlov who first 
described this type of associative learning (Pavlov, 1927).  In this procedure, a 
biologically relevant unconditioned stimulus (US) such as food, drug, sex, or even an 
electric shock, elicits an innate, reflexive unconditioned response (UR), such as salivation 
in the case of food, or freezing in the case of a footshock.  When an initially neutral 
stimulus, the conditioned stimulus (CS) is paired contingently with such a US, the CS 
gradually becomes predictive of the US and acquires the qualities of US, as illustrated by 
the fact that it comes to elicit a conditioned response (CR) that closely resembles the UR.  
For example in Pavlov’s well-known experiment, a bell (CS) was paired with a food 
reward (US), which normally elicits salivation (UR); after several CS-US pairings, the 
bell came to elicit salivation as well (CR), even in the absence of the US.  The fact that 
the animals display a CR is evidence that learning took place, that is, an association was 
created between a representation of the US and a representation of the CS, in turn, giving 
the CS control over behavior (Mackintosh, 1974).  
The conditioning procedure used by Pavlov is termed appetitive conditioning, 
because the CS is paired with a positive (“pleasant”) outcome such as a palatable food, 
and results in an approach behavior.  On the other hand, aversive conditioning 
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(sometimes also called fear conditioning) entails pairing a CS with an aversive 
(“unpleasant”) outcome, such as an electric shock, a tail pinch, or a puff of air directed to 
the eye, which will result in an escape behavior if possible, if not in a freezing response. 
 
Modern learning theories agree that the representations of the CS and US are 
more detailed and diverse than originally understood, affording the animal a greater 
flexibility in how a CS guides behavior (Pickens & Holland, 2004).  Indeed, as discussed 
in Cardinal et al., the CS can become associated with one, or several of the US properties.  
For example, a food US can elicit several types of UR: An innate salivation specific to 
the US (consummatory response), but also an approach behavior not specific to the US 
(preparatory response), reflecting a general behavioral activation and increased arousal 
(Cardinal, Parkinson, Hall, & Everitt, 2002).  In some cases, the CS can even elicit an 
approach response to the CS source itself (i.e., location of the tone or light source – even 
though the food is not located there), a phenomenon termed “autoshaping” or “sign 
tracking” (Robbins & Everitt, 2002).  These types of approach behaviors provide useful 
measures of the strength of the CS-US association and are widely used in Pavlovian 
conditioning procedures.  Moreover, the CS-US association contains information about 
the current appetitive value of the reward.  For example, once a CS-US association has 
been established, injecting an illness-inducing compound just after food consumption 
degrades the food value, which will later result in a suppression of the approach response 
normally elicited by the CS and a rejection of the food reward (Holland & Straub, 1979).  
This illustrates the fact that the CS holds updated and rich information about the US, 
reflecting how adaptive and flexible Pavlovian conditioning can be. 
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2.2.  Operant Conditioning 
The other form of associative learning is operant conditioning (also referred to as 
instrumental conditioning).  The initial principles of operant conditioning laid out by 
Skinner, state that an instrumental contingency links a particular behavior to its 
reinforcing outcome, and that this an instrumental contingency will increase (or decrease) 
the likelihood of emitting this behavior in the future (Skinner, 1969).  More simply put in 
Thorndike’s law of effect, the probability that a response will be emitted increases when 
that response is followed by a “satisfier” (i.e., appetitive) and decreases when it is 
followed by an “annoyer” (i.e., aversive) (Thorndike, 1911). 
Modern theories of instrumental conditioning are not quite as mechanistic.  They 
recognize that reinforcers have motivational components and that operant behaviors are 
“goal-directed” (Dickinson & Balleine, 1994).  In this new perspective, the instrumental 
contingency involves an action (a more “purposive” term than behavior, (Dickinson)) and 
an outcome, or A-O contingency (Dickinson & Balleine, 1994).  The instrumental 
contingency, in this new light, requires that two conditions be met: First that animals 
“know” that their action produces the outcome, evidenced by the fact that they are able to 
learn new contingencies (Dickinson, Campos, Varga, & Balleine, 1996) – unlike the 
more reflexive behaviors in Pavlovian conditioning (Hershberger, 1986).  Second, 
animals have to actually “want” the outcome they are working to obtain.  This is 
illustrated by the fact that when the outcome is devalued with an illness-inducing 
treatment or pre-feeding, animals will stop responding (Adams & Dickinson, 1981). 
Often, operant conditioning also involves a discriminative stimulus (DS), in 
addition to the other elements of the instrumental contingency.  Presentation of the DS 
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signals the opportunity to earn a reinforcer upon the next operant response, in other 
words, the DS signals when the instrumental contingency is in effect (Skinner, 1953).  
For example, animals learn to lever press (LP) in response to a tone, when that tone 
signals a limited time window to earn a reinforcer. 
Both Pavlovian and operant conditioning can undergo extinction, another 
phenomenon described by Skinner: When the reinforcer is no longer presented after the 
Pavlovian CS or the operant response, the rate of responding gradually decreases.  
Similar to learning a new contingency, animals learn that the CS or operant behavior no 
longer produce the reinforcement (Skinner, 1933).  
Associative learning illustrates just how flexible and adaptive animal behaviors 
are – necessary qualities to ensure survival.  The conditioning techniques presented above 
have been used extensively to study animal behavior, and more recently, to examine the 
neural mechanisms underlying animal learning and behavior.  The past few decades have 
seen major advances in our understanding of the molecular mechanisms of learning, 
referred to as long term potentiation (LTP), the principles of which will now be reviewed. 
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3.  Molecular Mechanisms of Learning 
The cellular mechanisms underlying associative learning, long term potentiation 
(LTP) and long-term depression (LTD), were first studied in rabbits’ hippocampal slice 
preparations, at the CA3-CA1 synapse (Bliss & Lomo, 1973).  In invertebrates, Kandel’s 
experimentation elucidated the mechanisms of short- and long-term sensitization of 
sensory and motor neurons involved in simple withdrawal reflexes (Kandel, 2001).  
While LTD is an important contributor to synaptic plasticity, it is beyond the scope of 
this work. 
 
3.1.  Long Term Potentiation 
LTP is a synapse strengthening process, which, through a number of second-
messenger pathways, leads to several synaptic changes including an increase in the 
number of presynaptic vesicles, synaptic releasing sites, postsynaptic receptors, and an 
increase of synapses between neurons.  Research has differentiated between an early LTP 
and a late LTP, which rely on different cellular processes and differ in that only late LTP 
leads to gene activation and protein synthesis (Byrne, 2003).  
Briefly, both early and late LTP are induced by an influx of calcium into the 
postsynaptic cell.  Calcium can enter a cell through a number of ways, the best 
understood of which is through NMDA receptors1 (Bashir et al., 1993).  The calcium 
                                                
1 At baseline, NMDA receptors are obstructed by a magnesium block; therefore, calcium cannot 
flow through NMDA receptors. For this to happen, the post-synaptic neuron first needs to be depolarized 
through glutamate binding onto AMPA receptors (α-amino-3-hydroxy-5-methyl-4-isoxazole- propionic 
acid receptor), followed by additional release of glutamate, which will bind to NMDA receptors, causing 
the release of the magnesium plug. 
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influx results in adenylyl cyclase activation, which will catalyze ATP, thereby 
phosphorylating c-AMP (cyclic-adenosine-3’-5’-monphosphatase), and resulting in PKA 
(protein kinase A) activation.  Additionally, calcium will activate the enzyme calmodulin, 
which will bind to and phosphorylate calcium calmodulating kinases (CaMK II in the 
case of early LTP)(Blitzer, Wong, Nouranifar, Iyengar, & Landau, 1995).  If enough 
calcium is present, CaMK II will be persistently phosphorylated (Blitzer et al., 1998), and 
will phosphorylate AMPA receptors, improving their affinity for glutamate.  Once 
persistently phosphorylated, CaMK II can even promote the insertion of new AMPA 
receptors in the postsynaptic membrane through interaction with scaffolding proteins.  
Hence, CaMK II improves synaptic transmission while staying near the activated 
synapse. 
Late LTP is also initiated by calcium-dependent activation of the cAMP/PKA 
pathway as well as CaM Kinases activation, resulting in the phosphorylation of the 
transcription factor CREB (cAMP response element binding protein).  Phosphorylated 
CREB will bind to CRE (cAMP response element) in the promotor portion of genes, 
initiating mRNA transcription and eventually leading to new protein synthesis, such as 
new AMPA receptors (Nayak, Zastrow, Lickteig, Zahniser, & Browning, 1998).  It is not 
clear, however, how from synthesis in the cell nucleus, these new proteins are able to go 
precisely to the synapse that was just active.  Frey and Morris have hypothesized that 
synaptic activation creates a synaptic tag (such as CaMK II for example), which could 
attract new proteins, thereby strengthening only the active synapse (Frey & Morris, 
1998). 
21 
 
From this description of early and late LTP, it is apparent that both mechanisms 
rely heavily on the calcium-dependent cAMP/PKA pathway, emphasizing the importance 
of calcium in these cellular processes.  DA is often said to be important in learning, 
(Beninger, 1983; Kelley, 2004; Wise, 2004) begging the question: Is DA involved in 
LTP, and if so, how? 
 
3.2.  DA-Mediated LTP 
DA binding at D1 receptors promotes LTP by activating adenylyl cyclase, leading 
to increased cAMP levels, which will stimulate PKA, which in turn will phosphorylate 
the protein DARPP 32 (dopamine and cAMP-regulated phosphoprotein of 32 kDa) 
(Hemmings, Nairn, Aswad, & Greengard, 1984) (Nishi, Snyder, & Greengard, 1997).  In 
contrast, DA binding at D2 receptors inhibits adenylyl cyclase, resulting in 
dephosphorylation of DARPP 32 (presumably through calcineurin activation), (Nishi, et 
al., 1997).  In the striatum, D1-dependent phosphorylation of DARPP 32 facilitated 
striatal LTP, whereas D2-mediated dephosphorylation of DARPP 32 repressed LTP in 
the striatum (Calabresi et al., 2000; Centonze, Picconi, Gubellini, Bernardi, & Calabresi, 
2001).  Furthermore, D1 antagonists blocked LTP (Kerr & Wickens, 2001), whereas D2 
antagonists facilitated LTP (Calabresi, Pisani, Centonze, & Bernardi, 1997), further 
suggesting that D1 and D2 receptors play opposite roles in LTP. 
Perhaps the most compelling evidence that DA underlies reward-related learning 
via its role in LTP was provided by a recent study by Reynolds, Hyland and Wickens 
(Reynolds, Hyland, Wickens, 2001).  First, rats learned a LP response to electrically 
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stimulate their SN (intra-cerebral self stimulation, ICSS).  Subsequently, 
electrophysiological recording of cortico-striatal synapses were carried out in the same 
rats under anesthesia, before and after ICSS-like stimulation of their SN.  Essentially, 
Reynolds et al. measured the post-synaptic potentials of striatal neurons induced by 
cortical stimulation, before and after a regimen of SN stimulation that imitated the SN 
stimulation produced by each individual rat during their ICSS session (same number of 
pulses, frequency and current intensity).  The results indicate first that ICSS-like SN 
stimulation potentiated cortico-striatal synapses (i.e., cortical stimulations were more 
likely to increase post synaptic potentials in the striatal neurons they synapse onto).  
Second, that the extent of cortico-striatal potentiation produced by ICSS-like stimulation 
was highly correlated with the rate of lever-pressing acquisition.  Third, systemic 
administration of a D1 antagonist blocked the potentiation of cortico-striatal synapses by 
ICSS-like stimulation (Reynolds, 2001).  Therefore, these results suggest that DA 
facilitates cortico-striatal LTP, and that the same mechanisms take place when animals 
acquire a LP response to produce SN stimulation. 
These findings are consistent with the view that DA release onto the ACB 
“strengthens” cortico-striatal synapses, whether the actual effect of DA is to selectively 
excite (Horvitz, 2002; Nicola, 2007) or inhibit (Mogenson, 1987; Numan, 2006) medium 
spiny neurons, ultimately resulting in behavior.  In that example, DA is directly involved 
in reinforcement learning, by promoting cortico-striatal LTP and thus increasing the 
likelihood that a given set of environmental stimuli (conveyed to the striatum by cortical 
inputs) will lead to a specific behavioral output (striatal downstream motor effectors). 
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So far, the evidence reviewed implicating DA in LTP mechanisms concerned the 
striatum.  Additional evidence suggests that DA promotes LTP in the nucleus accumbens 
as well.  Indeed, a nucleus accumbens slice preparations study reports that LTP induced 
by high frequency stimulation (HFS) of glutamatergic inputs to the accumbens core 
(excitatory postsynaptic potential increase), was blocked by administration of the D1 
antagonist SCH 23390 (Schotanus & Chergui, 2008).  Moreover, another study showed 
that administration of the D1 agonist SKF81297 increased the PKA- and CaMK II- 
dependent insertion of AMPA receptors into the postsynaptic membrane of accumbens 
neurons (Sun, Milovanovic, Zhao, & Wolf, 2008).  Similarly, there is extensive evidence 
that DA underlies fear conditioning-mediated plasticity in the amygdala (Bissiere, 
Humeau, & Luthi, 2003; LeDoux, 2003; LeDoux, 2000).  Finally, slice preparation 
studies report evidence for D1-dependent LTP in the mPFC (Huang, Simpson, 
Kellendonk, & Kandel, 2004), as well as D1 (but not D2) receptor-mediated increase in 
surface expression of AMPA receptors (Sun, Zhao, & Wolf, 2005).  In vivo results in the 
anesthetized rat suggest that D1 (but not D2) receptors stimulation activates the PKA 
pathway, and induces LTP at hippocampal-PFC synapses (Gurden, Takita, & Jay, 2000). 
Having presented evidence that DA promotes synaptic plasticity, and underlies 
the acquisition of new behavioral responses (Reynolds, 2001), the next section will 
examine past and current theories about DA’ role in appetitive behaviors, with a special 
emphasis on contrasting views on motivation, reward and reinforcement. 
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4.  Dopamine’s Role: Multiple Hypotheses 
 
Research has implicated dopamine in a wide variety of appetitive conditioning 
procedures using rewards ranging from food (Joseph & Hodges, 1990; A. G. Phillips, 
Atkinson, Blackburn, & Blaha, 1993; Wise, Spindler, deWit, & Gerberg, 1978), to water 
(Gramling & Fowler, 1985; A. M. J. Young, Joseph, & Gray, 1992), drugs of abuse 
(Caine & Koob, 1994; Di Chiara & Imperato, 1986), intracranial self-stimulation 
(Fibiger, Lepiane, Jakubovic, & Phillips, 1987; Gratton, Hoffer, & Gerhardt, 1988), male 
sexual behavior (Damsma, Pfaus, Wenkstern, Phillips, & Fibiger, 1992) as well as female 
sexual behavior (Becker, Rudick, & Jenkins, 2001; Mermelstein & Becker, 1995), but 
also maternal behaviors such as pup retrieval (Numan, et al., 2005; Stolzenberg et al., 
2007).  However, DA has also been implicated in aversive conditioning procedures, such 
as a foot shock (Nader & LeDoux, 1999; Wadenberg, Ericson, Magnusson, & Ahlenius, 
1990), tail shock (Abercrombie, Keefe, DiFrischia, & Zigmond, 1989) or loud noises 
(Naudin, Canu, & Costentin, 1990), but also during an aggressive encounter with another 
male rat (Ferrari, van Erp, Tornatzky, & Miczek, 2003) and after social defeat (Anstrom, 
Miczek, & Budygin, 2009).  Thus, DA appears to be involved in wide-ranging, and 
sometimes opposite, circumstances.  The purpose of this section is to briefly review the 
most prominent theories about DA, and to distinguish between its hypothesized roles in 
reward, reinforcement and motivation.  
However, first, it is important to consider how DA’s crucial involvement in 
motoric processes has shaped and influenced much of DA research. 
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4.1.  Dopamine and Motor Processes: The Problem of Performance Deficit 
A considerable number of studies have established that DA neurotransmission 
critically mediates locomotion and motoric processes (Beninger, 1983; Fowler & Liou, 
1998; Heffner, et al., 1977; Ungerstedt, 1979).  Indeed, DA antagonists and lesions of DA 
neurons disrupt locomotion, whereas DA agonists and psychostimulants increase 
locomotor activity (Baldo, Sadeghian, Basso, & Kelley, 2002; Beninger, 1983; C. J. 
Swanson, Heath, Stratford, & Kelley, 1997; Tombaugh, Tombaugh, & Anisman, 1979).  
Therefore, the study of DA’s involvement in animal behavior has been complicated by 
DA’s critical role in motoric processes (Beninger, 1989).  Indeed, in a hypothetical 
experiment where animals have learned to approach a food compartment upon tone onset 
to obtain a food reward, and while under the influence of a DA antagonist (i.e., a drug 
interfering with DA transmission), how should one interpret animals’ failure to approach 
the food compartment upon tone onset?  One could interpret this result as evidence that 
the DA antagonist disrupted learning processes (the animal cannot make the tone-food 
association, thus does not approach the food magazine upon hearing the tone).  
Alternatively, one could interpret this result as indication that the DA antagonist 
disrupted motor processes (the animal simply cannot move toward the food 
compartment).  The same confound applies to treatment with DA agonists (i.e., drug 
increasing DA transmission) and psychostimulants such as amphetamine and cocaine: Is 
an increase in responding due to enhanced learning, or, increased excitability and 
hyperkinesia? 
The difficulty in attributing drug effects to motoric (i.e. performance) or to other 
processes under study, such as learning, motivation, memory, or attention, has been a 
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major caveat in the field of DA research.  Consequently, researchers have used 
methodological “tricks” to control that the drug’s effect on behavior is not accountable by 
a disruption of motor systems.  For example, some have used two CSs (or two response 
manipulanda in operant conditioning) to determine if drug effects are selective for the CS 
being manipulated (Beninger, 1983; Parkinson et al., 2002).  Some have used motor 
control groups (Ettenberg & Camp, 1986).  Some have administered drug treatments after 
a training session (Dalley et al., 2005; Hernandez, Andrzejewski, Sadeghian, Panksepp, 
& Kelley, 2005), while others have given the drug treatment before the training session, 
but tested animals on task performance the next day (Horvitz & Ettenberg, 1988).  
However, despite these methodological improvements, the study of DA’s role in animal 
behavior is still a challenge due to the difficulty to disentangle behavioral deficits from 
motor, or performance, deficits.  Thus, it is important to use caution when interpreting 
results from pharmacological and lesion studies. 
 
4.2.  Dopamine and Reward: The Anhedonia Hypothesis 
The notion that DA is involved, or mediates “reward” originates perhaps in the 
finding by Olds and Milner that rats rapidly acquired a LP response to stimulate and 
electrode placed in the septal area and cingulate cortex, as they would for food rewards 
(Olds & Milner, 1954).  DA was not formally implicated in reward mechanisms until a 
set of studies by Wise and colleagues where dopamine receptor-blockade produced 
within-session decreases in lever-pressing (LPing) for a food reward (Wise, et al., 1978) 
resembling extinction, which could not be attributed to motor deficits.  These findings led 
Wise and colleagues to formulate their “anhedonia hypothesis” (Wise & Rompre, 1989): 
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“Neuroleptics appear to take the pleasure out of normally (…) rewarding food” (Wise, et 
al., 1978).  This theory caught much appeal and the notion that dopamine is the “reward 
or pleasure neurotransmitter” is still widespread in popular culture (Salamone, Correa, 
Farrar, & Mingote, 2007). 
4.2.1.  Evidence against the Notion that DA Mediates “Reward” 
Several lines of research indicate that the anhedonia hypothesis of DA is highly 
unlikely.  First, as mentioned above, the fact that DA is involved in aversive conditioning 
is inconsistent with the notion that DA mediates “pleasure.”  For example, D2 receptor-
blockade in the ACB suppressed the expression of a conditioned avoidance response to a 
footshock (i.e., move to another chamber of the conditioning box to avoid the footshock) 
(Wadenberg, et al., 1990), and D1 receptor-blockade in the BLA suppressed the 
expression of a second-order fear conditioned freezing response to a footshock (Nader & 
LeDoux, 1999).  Furthermore, DA agonists accelerated the acquisition of a fear 
conditioned startle response to a CS paired with loud noises (Naudin, et al., 1990).  
Finally, DA levels increased in the ACB and the PFC in response to tail shocks 
(Abercrombie, et al., 1989), but also increased in the ACB in anticipation of, during, and 
after aggression by another male rat  (Anstrom, et al., 2009; Ferrari, et al., 2003).  
Similarly, aversive tastes such as quinine, and fearful odors such as red fox urine (a 
predator to rats) elicit DA increases in the ACB and the PFC (Bassareo, De Luca, & Di 
Chiar, 2002).  Thus, DA in the ACB, BLA, and PFC seems to be responsive to, and 
mediate, a wide range of fearful, aversive, and surely “unpleasant” situations, thus 
refuting the notion that DA mediates “pleasure” or reward (Baldo & Kelley, 2007; 
Ikemoto & Panksepp, 1999; Salamone, 1994). 
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Second, studies examining the feeding behavior indicate that while DA 
compromising treatments might decrease LPing for food, they do not decrease food 
consumption itself.  For example, during free feeding, a systemic injection of pimozide (a 
general dopamine antagonist) did not decrease total food intake (Tombaugh, et al., 1979).  
Moreover, 6-hydroxydopamine lesions (6-OHDA, a neurotoxin that selectively lesions 
DA terminals) of the ACB resulted in enhanced free food consumption (hyperphagia) 
while suppressing general locomotor activity (Koob, Riley, Smith, & Robbins, 1978).  
Similarly, infusion of D1 or D2 antagonists into the ACB core or shell did not decrease 
the amount of food consumed (in a free home cage-type setting), or the latency to initiate 
eating but increased feeding bout durations while disrupting locomotor measures (Baldo, 
et al., 2002). Therefore, disrupting DA transmission does not appear to interfere with 
food consumption itself. 
Furthermore, the finding that pre-feeding and administration of appetite 
suppressants affect feeding differently than administration of DA antagonists also argues 
against the notion that DA mediates hedonic processes.  Indeed, while pre-feeding 
(Salamone et al., 1991) and appetite suppressants such as fenfluramine (Salamone, 
Arizzi, Sandoval, Cervone, & Aberman, 2002) both decreased LPing for food and 
concurrent consumption of freely available food, DA antagonists and ACB 6-OHDA 
lesions only decreased LPing, but led to compensatory increases in free food 
consumption.  This result suggests that unlike drugs suppressing appetite or pre-feeding, 
DA manipulations do not alter general appetite for food, and do not blunt the hedonic 
properties of the food. 
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In fact, the work of Kelley and colleagues indicates that the act of feeding appears 
to be mediated by inhibition of the ACB shell (but not core), as seen by hyperphagia 
triggered in satiated rats by ACB infusion of AMPA antagonists and GABA agonists 
(Maldonado-Irizarry, Swanson, & Kelley, 1995; Stratford & Kelley, 1997), but not by 
DA transmission (Bakshi & Kelley, 1991a).  Furthermore, choice of food appears to be 
under the control of opioid transmission in the ACB (Kelley et al., 2002): ACB infusion 
of mu-opioid agonists and antagonists respectively increased and decreased intake of 
fatty and carbohydrate-rich food (Zhang, Gosnell, & Kelley, 1998; Zhang & Kelley, 
2000, 2002).  The ACB shell is presumed to control feeding through its projections to the 
lateral hypothalamus, which in turn project to brainstem pattern generators (Kelley, 
Baldo, Pratt, & Will, 2005; Stratford & Kelley, 1999). 
Taken together, the findings suggest that a) DA mediates aversive conditioning, 
b) that DA-compromising treatments do not reduce food intake, unlike appetite 
suppressants and pre-feeding and c) that opioid, glutamate and GABA transmission, but 
not DA transmission in the ACB mediate feeding.  Thus, the finding by Wise that DA 
manipulations suppress LPing needs to be reinterpreted in another light than a blunting of 
the rewarding aspect of food, or anhedonia. 
4.2.2.  Appetitive Versus Consummatory 
Wise hypothesized that the gradual decrease in LPing induced by DA receptor-
blockade indicates that the food is no longer rewarding, and concluded that DA 
antagonists blunt the rewarding qualities of food.  The problem with this interpretation is 
that the act of LPing for food is amalgamated with the act of eating.  Indeed, ethological 
observations have long noted that appetitive and consummatory phases of motivated 
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behavior are separate phases of a behavioral cycle, as described by Craig: “An appetite 
(…), is a state of agitation which continues so long as the appeted stimulus, is absent.  
When the appeted stimulus is (…) received it stimulates a consummatory reaction, after 
which the appetitive behavior ceases and is succeeded by a state of relative rest” (Craig, 
1918, p. 91).   
According to this view, LPing for food is an appetitive response, while eating is a 
consummatory response, thus the reduction in LPing observed by Wise would be 
attributed to a DA antagonist-induced disruption of an appetitive response, but not of 
consummatory processes.  This view is consistent with reports that systemic injections of 
a general DA antagonist suppressed “preparatory” approach behaviors to a food-paired 
CS, but not food consumption itself (Blackburn, Phillips, & Fibiger, 1987, 1989), or that 
ACB infusion of a DA antagonist disrupted food seeking behaviors, such as exploratory 
behaviors (Bakshi & Kelley, 1991a; Baldo, et al., 2002) and hoarding behaviors (Kelley 
& Stinus, 1985) while sparing feeding.  Similarly, ACB infusion of DA antagonists, as 
well as VTA inactivation with GABA, decreased running speeds in a runway task, but 
did not affect liquid sucrose consumption once in the goal box (Ikemoto & Panksepp, 
1996).  Conversely, ACB infusion of amphetamine (an indirect DA agonist) increased 
locomotor responses and decreased food consumption (Bakshi & Kelley, 1991b).  Thus, 
the view that dopamine mediates appetitive, or food-seeking responses but not 
consummatory responses, accounts for Wise’s finding better than the anhedonia 
hypothesis.  In this light, dopamine might still be related to reward, insofar as it mediates 
reward seeking but not reward consumption. 
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4.3.  Within-Session Decrements: A Problem of Motivation or Reinforcement? 
As discussed above, the finding that DA receptor-blockade disrupts a LP response 
was better accounted for by the view that DA mediates appetitive responses (reward 
seeking), than by Wise’s anhedonia hypothesis.  However, the notion that DA mediates 
appetitive responses still does not explain what process might be disrupted by interfering 
with DA transmission: Wise’s studies rule out a motor deficit, and the previous 
paragraphs ruled out purely hedonic processes, nevertheless, this result might still be 
interpreted in light of a motivation deficit or a reinforcement deficit. 
4.3.1.  DA Mediates Motivation or Incentive Salience 
Traditional definitions of motivation describe it as a process of arousing and 
sustaining action directed towards a goal (Young, 1959), yielding the operational 
definitions of approach (rewards) or withdrawal (punishers) (White, 1989).  Other 
theories of motivation postulate that it is driven both by homeostatic drives (e.g., thirst) 
and the hedonic qualities of a stimulus (e.g., liquid sucrose, as opposed to liquid quinine) 
(Bindra, 1974).  A more recent account of motivation describes it as incentive salience, or 
in colloquial terms “wanting,” a process postulated to depend upon mesolimbic DA, and 
that is different from purely hedonic processes, or “liking,” which depends upon opioid 
neurotransmission (Berridge, 2007; Berridge & Kringelbach, 2008; Berridge & 
Robinson, 1998; Berridge, Robinson, & Aldridge, 2009).   
Berridge and colleagues used taste reactivity measures to determine hedonic 
reactions to food rewards under different conditions of DA manipulation.  Indeed, 
stereotypical orofacial reactions to food differ according to tastes (e.g., “protrusion of the 
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tongue” for sweet tastes, vs. “grimace, gagging” for bitter tastes), therefore providing 
useful measures of affective reactions to positive/negative stimuli (Berridge, 1996).  
Berridge and colleagues found that interfering with DA transmission did not suppress 
orofacial reactions to food (Berridge, 1996; Berridge & Robinson, 1998; Berridge, 
Venier, & Robinson, 1989; Pecina, Berridge, & Parker, 1997), suggesting that hedonic 
assessment was intact even under conditions of reduced DA transmission.  Furthermore, 
DA-depleted rats subjected to conditioned taste aversion (pairing food with sickness-
inducing lithium chloride), exhibited normal orofacial reactions, suggesting that their 
hedonic assessment was intact (Berridge, 1996; Berridge and Robinson, 1998).  These 
findings further suggest that DA transmission does not mediate hedonic processes.  In 
fact, the same neural substrates underlying feeding mentioned above (Kelley, et al., 
2005), ACB opioid and GABA transmission appears to mediate hedonic processes, or 
“liking” according to Berridge (Berridge & Pecina, 1995; Doyle, Berridge, & Gosnell, 
1993; Treit & Berridge, 1990).  Furthermore, on the basis of recent findings where 
GABA infusions in rostral and caudal ACB sites elicited feeding and a fearful response, 
respectively (Reynolds & Berridge, 2001, 2002), Berridge proposed that the ACB (as 
well as the VP and brainstem nuclei) represent hedonic hotspots and coldspots, dependent 
upon opioid and benzodiazepine transmission (Berridge & Kringelbach, 2008; Berridge, 
et al., 2009).   
On the contrary, DA neurotransmission has been associated with “wanting” or 
incentive motivation, based on the finding that amphetamine infusion in the ACB 
increases Pavlovian-instrumental transfer (the ability of a Pavlovian cue to elicit 
instrumental responding) (Wyvell & Berridge, 2000), especially after animals undergo 
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amphetamine sensitization (Wyvell & Berridge, 2001).  Thus, Berridge suggests that DA 
does not mediate “liking” but rather “wanting”, or incentive salience, reflected in the 
vigor with which an animal will seek out rewarding stimuli (Berridge, 2007; Berridge & 
Robinson, 1998). 
4.3.2. DA Mediates Reinforcement - a Better Account for Wise’s Result? 
Wise formulated the anhedonia hypothesis based on the finding that DA 
compromising treatments induced a progressive decline in responding over the course of 
a session, which resembled the gradual decrease in responding observed in extinction.  If 
one postulates that DA mediates appetitive responses via motivational processes, then 
interfering with DA should suppress motivation and rats in Wise’s task should not even 
start LPing.  Instead, the fact that animals LP initially and progressively stop responding 
indicates that DA disruption must interfere with another process, perhaps reinforcement. 
Based on Skinner’s definition, reinforcement is a behavior strengthening process, 
where presentation of a stimulus such as food made contingent on a response increases 
the probability of occurrence of the response (Skinner, 1969), and reinforcers are 
“biologically important stimuli such as food, water, odor, taste, or sexual partner” 
(Bindra, 1974, p. 199).  Thus, according to this view, in Wise’s task, food is a reinforcer 
strengthening a LP response, and the DA antagonist disrupts the reinforcing process.  
Evidence from two studies comparing the effects of a DA antagonist on water 
reinforcement and on the motivation to drink indicates that DA might indeed be more 
likely to mediate reinforcement than motivation per se.   
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In one task, thirsty rats were trained to emit an operant response (traverse a 
runway) for a water reward.  Animals subsequently underwent extinction, before 
receiving a single trial of reward-reinstatement, under the influence of a DA antagonist, 
vehicle or no reward.  In a reward retention test, while the running speed of vehicle-
treated animals increased, in contrast, the running speed of animals treated with a DA 
antagonist remained low and similar to that of rats who did not receive a water reward on 
the reinstatement trial (Ettenberg & Horvitz, 1990).  While this result could be interpreted 
as a motivation deficit, another study suggests that this is not the case.  Rats subjected to 
varying degrees of water-deprivation, or to the maximum amount of water-deprivation 
and several doses of a DA antagonist exhibited different patterns of drinking behavior.  
Indeed, while latency to initiate drinking varied as a function of thirst (i.e., less thirsty 
animals had a greater latency to initiate drinking, and vice versa), the DA antagonist had 
no effect on the latency to initiate drinking (all animals exhibited a very short latency 
regardless of drug dose) (Horvitz, Richardson, & Ettenberg, 1993).  This result suggests 
that DA receptor-blockade did not decrease the motivation to drink, which contradicts the 
view that DA mediates motivation.  On the contrary, in the previous experiment, it is 
likely that the DA antagonist suppressed the ability of water reward to reinforce the 
running response.  
 
4.4.  The Cost-Benefit Alternative 
An interesting alternative to motivation and reinforcement is the suggestion by 
Salamone and colleagues that DA mediates a cost-benefit analysis where animals 
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maximize the amount of reward relative to the effort expanded on a task (Salamone & 
Correa, 2002; Salamone, et al., 2007; Salamone, Correa, et al., 2005). 
In an influential experiment, rats were given a simultaneous choice between 
LPing for palatable food pellets or consuming freely available (but less preferred) lab 
chow.  Normal (control) rats maintained a high rate of LPing and consumed little of the 
lab chow, whereas rats subjected to DA manipulations decreased their rate of LPing, and 
importantly, increased their lab chow consumption (Salamone, et al., 1991).  Previous 
tests had established that when given free access to both food pellets and lab chow, 
control and haloperidol-treated rats preferred food pellets, presumably because it is a 
more palatable food than lab chow (Salamone, et al., 1991).  This result suggests that 
even though DA disruptions suppress appetitive responding on a lever, the animals’ 
behavior is still directed at obtaining food, further supporting the view that DA 
manipulations do not interfere with motivation to eat (or drink as seen in the studies 
above).  On the basis of these results, Salamone proposed that DA-compromising 
treatments increase the perceived effort of LPing, challenge to which animals adapt by 
reallocating their behavioral resources to consuming lab chow – a less preferred reward 
but also a less effortful response – suggesting that animals analyze a situation as a 
function of its costs and benefits.  According to this view, DA manipulations reduce an 
animal’s willingness to expand energy on a given task, which Salamone refers to as 
“anergia,” (Salamone et al., 2005; Salamone & Correa, 2002; Salamone, et al., 2007; 
Salamone, Cousins, & Bucher, 1994; Salamone, Cousins, & Snyder, 1997).  This finding 
was extended to numerous reinforcement schedules as well as other tasks, such as a maze 
task, evidence that will be reviewed in more details in a later section of this thesis. 
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While the terms costly, or effortful are vague behavioral descriptors, Salamone 
defines this cost/effort, in terms of total behavioral activation, for example the difference 
between a continuous reinforcement schedule where each LP is reinforced with a food 
pellet, as opposed to a FR20 schedule, where a food pellet is delivered for every 20 LPs.  
Consistent with this view, Fowler and colleagues found that the amount of force (high 
and low) with which animals respond on a force sensitive operanda is not affected by 
haloperidol, unlike by a paralytic agent (decamethonium), indicating that DA receptor 
blockade by haloperidol does not induce muscle weakness (Fowler, Skjoldager, Liao, 
Chase, & Johnson, 1991). 
Salamone’s results suggest that DA manipulations do not interfere with primary 
motivation.  However, the results from the concurrent LP/lab chow task do not support 
the view that DA mediates reinforcement either.  Indeed, it is not clear that DA 
manipulations disrupted the ability of food pellets to maintain LPing, since animals 
remained oriented toward the goal (food) and switch to a different food-rewarded 
behavior.  Instead, these results suggest that DA mediates behavioral activation to 
biologically important stimuli, and that interfering with DA transmission will disrupt 
animals’ ability to respond to such stimuli (Baldo & Kelley, 2007; Ikemoto & Panksepp, 
1999; Kelley, et al., 2005; Nicola, 2007; Numan, 2006; Salamone, 1996; Salamone, et al., 
2007). 
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4.5.  DA Response: A Teaching Signal 
Schultz and colleagues used another approach to understand DA function: They 
measure the electrophysiological responses of dopaminergic neurons in the SN and VTA 
of monkey subjects.  Three types of DA responses have been identified: a) a burst-firing 
phasic activation, occurring between 50 and 110 ms after a reward or novel event, and 
lasting between 100 and 200 ms, b) an intermediate and sustained response, ranging on a 
scale of seconds to minutes and c) a tonic response, where continuous low levels of DA 
are released (reviewed in Schultz 1998, 2001, 2002 and 2007b).  This basal level of DA 
response appears to enable movement, cognition, and motivation (Schultz, 2001, 2002, 
2007a). 
In a series of studies, Schultz et al. examined the responses of DA to various 
appetitive Pavlovian and operant tasks and came to the following conclusions: 1) novel 
events and unexpected primary food rewards elicit a phasic activation of DA neurons; 2) 
after CS-reward training, DA neurons no longer exhibit this phasic response to the 
reward, but instead respond to the CS that predicts the reward; 3) when the reward is 
expected (predicted by a CS) but not delivered, DA neurons are depressed at the time of 
expected reward delivery (Ljungberg, Apicella, & Schultz, 1992; Romo & Schultz, 1990; 
Schultz, 1998; Schultz, Apicella, & Ljungberg, 1993).  On the basis of these findings, 
Schultz elaborated the theory that DA phasic activation is a “reward prediction error” 
signal, or a teaching signal, since DA neurons respond to unexpected rewards, but do not 
respond to rewards once they are correctly predicted by a CS, and are depressed when a 
predicted reward is omitted (Schultz, 1998, 2000, 2007a).  The view that the DA phasic 
signal acts as a teaching signal by promoting learning as a function of prediction error, is 
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consistent with learning theories such as the Rescorla-Wagner model (Schultz, 1998, 
2001).   
Recently, Schultz and colleagues have also reported that DA neurons encode the 
time of predicted reward occurrence, and that the DA response varies as a function of 
deviation from predicted reward time (Hollerman & Schultz, 1998).  Populations of DA 
neurons also appear to encode the probability of reward presentation: The more probable 
the reward, the stronger the DA response to the predictive CS and the weaker the 
response at the time of estimated reward delivery and vice versa (Fiorillo, Tobler, & 
Schultz, 2003).  Interestingly, DA neurons respond to the “unpredictability” of a reward 
(when the probability of obtaining a reward is 50%), in the form of intermediate and 
sustained population activation, different from the tonic and phasic activation (Fiorillo, et 
al., 2003).  Finally, DA neurons also appear to encode reward quantity – large quantities 
of reward elicited greater phasic activation than smaller quantities (Tobler, Fiorillo, & 
Schultz, 2005).   
However, DA neurons appear to respond to more stimuli than just primary 
rewards, thus questioning the “reward prediction error” theory (Horvitz, 2009).  Indeed, 
others report that DA neurons are phasically excited by salient events such as “loud clicks 
and bright flashes” (Horvitz, 2000; Horvitz, Stewart, & Jacobs, 1997), and some reports 
indicate that DA neurons also respond phasically to aversive events such as a shock to the 
ear (Guarraci & Kapp, 1999).  A recent study reports that DA neurons exhibit phasic 
excitations to unexpected appetitive event (apple juice) as well as unexpected aversive 
events (airpuff to the face), responses that shift to each event’s predictive CS as animals 
learn the task (Matsumoto & Hikosaka, 2009).   
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It is tempting to speculate that the teaching signal of DA neurons illustrates its 
role in learning during acquisition stages, and that after a task has been acquired, the 
responses of DA neurons to CSs predicting appetitive and aversive events might 
correspond to DA’s role in energizing behavior to promote responding to important 
environmental events.  However, these interpretations are oversimplifications and it 
might not be possible to compare single-unit results directly to pharmacological results.  
In conclusion, DA appears to mediate preparatory, or appetitive behaviors, but not 
consummatory behaviors, thus DA transmission is involved in “reward,” insofar as it 
mediates “reward-seeking,” or goal-directed behaviors.  However, DA transmission also 
mediates aversive conditioning and aversive situations such as social defeat.  
Furthermore, DA’s role in appetitive behaviors appears to be to promote behavioral 
responding to environmental events, rather than primary motivation or reinforcement.  
Finally, DA may play a direct role in learning, as suggested by electrophysiological data, 
but also by its role in LTP (reviewed in the previous section), and after a task has been 
acquired, DA may continue to promote behavioral responsiveness to environmental 
events.  In order to better characterize DA’s role in appetitive behaviors, the next section 
will examine closely whether DA transmission in the ACB, amygdala, and PFC is 
involved in the acquisition and expression of Pavlovian and operant appetitive behaviors. 
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5.  Mesocorticolimbic Dopamine Involvement in the Acquisition and 
Performance of Pavlovian and Operant Appetitive Behaviors 
 
Neuroscience research has developed specific methodologies to study whether 
DA transmission in a particular substrate such as the ACB, amygdala, or PFC is involved 
in a given process such as learning.  These include pharmacological manipulations of 
DA, either by central administration of DA agonists or antagonists, or by depletion of 
DAergic inputs to a given nucleus through 6-hydroxydopamine lesions.  However, while 
studies lesioning or inactivating a nucleus provide information about the involvement of 
that particular nucleus in a given process, they do not provide information regarding 
DA’s involvement in that process unless the exact ways in which DA influences this 
particular nucleus are known.  As discussed in the anatomy section of this paper, in the 
case of the ACB, the conditions under which DA excites and/or inhibits medium spiny 
neurons remains unclear (Horvitz, 2002; Mogenson, 1987; Nicola, Surmeier, & Malenka, 
2000; Numan, 2006).  The sections below will therefore make inferences regarding DA’s 
role in Pavlovian and operant acquisition and expression on the basis of studies that have 
directly manipulated dopamine transmission in the ACB, the amygdala, and the 
prefrontal cortex, while studies lesion or inactivating each nucleus will be reviewed 
separately. 
In addition, each of these three brain areas is comprised of several subregions.  
For example the ACB is made up of the core and shell regions; the amygdala comprises 
numerous nuclei, however this review will be limited to the CeA and the BLA; the PFC 
encompasses the prelimbic and infralimbic portions of the medial PFC, but also the 
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anterior cingulate and the orbitofrontal cortices.  Some of the studies reviewed in the 
following sections differentiate between each subarea, and this will be explicitly reflected 
in the text.  Thus, when no mention is made of which particular subregion a study 
manipulated, this should be taken to indicate that this study did not distinguish between 
subregions. 
 
5.1.  Nucleus Accumbens Dopamine 
5.1.1.  Pavlovian Behaviors 
Involvement of ACB DA in the Acquisition of Pavlovian Behaviors 
There is strong evidence that ACB DA is necessary for the acquisition of 
Pavlovian responses, particularly in the ACB core.  Robbins, Everitt, and colleagues have 
produced numerous studies investigating ACB DA in Pavlovian behaviors.  They studied 
the effects of several DA manipulations on the acquisition of an “autoshaping” task, 
where animals learn a discriminated approach between a CS+ (paired with food) and a 
CS- (no consequence).  By comparing the number of CS+ and CS- approaches, this task 
permits to examine whether DA manipulations interfere with the acquisition of the 
discriminated approach.   
In one such study, animals received 6-hydroxydopamine (6-OHDA) lesions of the 
ACB (i.e., no core/shell distinction) (Parkinson, et al., 2002).  Behavioral training began 
shortly post-lesion, at which point ACB DA levels in lesioned rats were extremely low 
relative to sham rats, as revealed by microdialysis.  6-OHDA lesions profoundly impaired 
the acquisition of the discriminated approach: Animals exhibited fewer approaches, with 
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a slower latency and did not discriminate between the CS+ and CS-, relative to controls.  
Although the decreased approaches and slowed latencies could indicate a performance 
deficit, the fact that animals did not discriminate between the CS+ and CS- when they did 
respond, indicates that the DA-depletion impaired the Pavlovian CS+/food association.  
Moreover, the fact that 1) animals collected and ate all their food pellets and 2) that sham 
and lesioned rats exhibited similar levels of spontaneous locomotion in subsequent 
locomotor tests, suggest that consummatory, hedonic and motor processes (at least those 
required for this task performance) were intact.  Therefore the failure to acquire the CS+ 
approach response appears to be attributable to learning deficits, suggesting that ACB 
DA is involved in Pavlovian learning. 
A similar 6-OHDA study extended these results (Dalley et al., 2002).  In this 
study, animals received 100 CS+/food pairings over three training sessions (whereas in 
the Parkinson 2002 study above, training consisted of 100 CS+/food pairings over the 
course of two sessions).  6-OHDA-lesioned rats were delayed in task acquisition 
(discriminating between CS+ and CS- cues by the 3rd session, compared to the 2nd session 
for shams).  Subsequent locomotor tests revealed that saline-treated lesioned and sham 
rats exhibited similar locomotor activity, indicating that the retarded acquisition was not 
attributable to motor deficits.  It is interesting to note that, while lesioned rats in the 
previous study (Parkinson, et al., 2002), who received 100 CS+/food pairings over two 
sessions, did not learn the discrimination task, lesioned rats in this study, who received 
100 pairings over three sessions, acquired the discriminated approach response by the 
third day.  The finding that DA-depleted animals needed an additional training day for 
task acquisition (but not additional CS/food pairings), suggests that compromising ACB 
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DA increases the consolidation period necessary for acquisition, a finding consistent with 
a role of ACB DA in learning.   
Alternatively, the DA lesion-induced need for an additional training day might be 
explained in terms of attentional deficits.  Indeed, studies examining the involvement of 
ACB DA in a five-choice serial reaction time task suggest that DA depletion (Cole & 
Robbins, 1989) and specifically D1 antagonism (and to a lesser extent, D2 antagonism) 
disrupted attentional performance by increasing response omission and latency (Pezze, 
Dalley, & Robbins, 2007) and decreasing response accuracy (Pezze, et al., 2007) an 
effect that appears to be mediated by the ACB core (Pattij, Janssen, Vanderschuren, 
Schoffelmeer, & van Gaalen, 2007).  In this case, ACB DA transmission might be 
indirectly involved in learning insofar as it would mediate attention to the CS or the US, 
but would therefore not be necessary for Pavlovian learning (CS-US strengthening) per 
se.   
Studies interfering with DA transmission via pharmacological DA receptor 
blockade using a general DA antagonist (Di Ciano, Cardinal, Cowell, Little, & Everitt, 
2001) or a specific D1 antagonist (Dalley, et al., 2005) found similar results of DA 
manipulation on autoshaping.  For example, infusion in the ACB core of the general 
D1/D2 antagonist α-flupenthixol just prior to each training session severely disrupted 
approach responding to both a CS+ and a CS-.  These data suggest that rats did not 
acquire the discrimination task, however, these results should be interpreted with caution: 
Since there was no locomotor control test, this apparent acquisition deficit might also be 
accounted for by motor impairments.  Still, in light of the studies above, showing that 
locomotor deficits could not account for Pavlovian learning deficits, these studies taken 
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together provide fairly strong evidence that ACB DA is involved in the acquisition of a 
conditioned Pavlovian approach. 
Dalley et al. examined the effects of immediate versus delayed post session (5-10 
min vs. 24 hours following training) ACB core infusions of a D1 (SCH 23390) or D2 
(sulpiride) antagonist or amphetamine on the acquisition of a similar CS+/CS- 
discrimination task (Dalley, et al., 2005).  Note that administration of the DA antagonists 
after the training sessions eliminates potential confounds arising from drug-induced 
performance deficits (i.e., animals are not under the influence of the drug while they are 
performing the task).  While immediate post-session infusions of the D1 antagonist in the 
ACB core impaired the acquisition of the discriminated Pavlovian approach (an equal 
number of approach responses were seen following either CS+ or CS- presentations), 
neither delayed infusions of the D1 antagonist, nor immediate or delayed infusion of the 
D2 antagonist, prevented acquisition of the discriminated approach response.  In addition, 
amphetamine ACB core infusions did not facilitate discrimination learning.  Importantly, 
because the infusions were administered after each training session, the observed 
response deficits cannot be attributed to locomotor, attentional, or motivational 
impairments.  These results suggest first, that D1 receptor activation in the ACB core is 
necessary to strengthen a Pavlovian CS-US association shortly after (and possibly while) 
an animal experiences a Pavlovian association.  Second, this D1 activation mediates 
learning processes (perhaps mediated by LTP) for a limited amount of time only (delayed 
infusions leave learning intact).  Third, ACB core D2 activation does not mediate this 
particular type of Pavlovian learning. 
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Phillips et al. (2003) found a potentiating effect of amphetamine on acquisition of 
a similar Pavlovian discriminated approach when the drug was infused into the shell of 
the ACB (Phillips, Setzu, Hitchcott, 2003).  Post session infusions of amphetamine to 
either the whole accumbens or the ACB shell accelerated acquisition of the discriminated 
approach to the CS+ and increased the number of approach responses to the CS+, relative 
to ACB core amphetamine infusions and saline infusions.  Because amphetamine 
infusions in the whole ACB and in the shell were administered after each training 
session, it is unlikely that the observed increase in CS+ responding was due to 
amphetamine-induced hyperactivity.  Instead, these results suggest that amphetamine 
infusions enhanced or accelerated the acquisition of the discrimination task, an effect 
presumably mediated by increased DA tone in the ACB shell.  Indeed, systemic 
administration of amphetamine elevates DA levels in the ACB (Carboni, Imperato, 
Perezzani, & Di Chiara, 1989) and particularly in the shell (Cadoni & Di Chiara, 1999).  
It is likely that the potentiating effect of whole ACB amphetamine infusion found in this 
study was due to the drug’s effect on the shell, since ACB core amphetamine infusions 
had no effect in either this or the previous study (Dalley, et al., 2005).  This view is 
consistent with the suggestion by others (Di Chiara et al., 1999; Everitt, et al., 1999; 
Ikemoto, 2007) that DA transmission in the ACB shell (but not in the core) mediates the 
effects of psychostimulants such as amphetamine on reward-related learning. 
Finally, consistent with the view that ACB DA participates in Pavlovian learning, 
evidence from single-unit and voltammetry studies suggest that changes in ACB DA 
responses to environmental stimuli over the course of training, correspond to changes in 
the animal’s behavioral responses to the stimuli.  Recordings from midbrain DA neurons 
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show that early during the acquisition of a CS-US Pavlovian association, DA neurons 
respond with a phasic activation to the US, however, as animals acquire the task DA 
neurons shift their response to the CS.  This phenomenon has been reported for both 
primary rewards such as fruit juice (Waelti, Dickinson, & Schultz, 2001) and aversive 
stimuli such as airpuffs to the face (Matsumoto & Hikosaka, 2009).  Similarly, a fast scan 
voltammetry study found that in a Pavlovian discriminated approach (CS+/-) task, as rats 
develop an approach response (initially to both CSs, then just to the CS+) extracellular 
ACB DA increases first in response to both CSs, and eventually just to the CS+, 
paralleling the approach response itself (Day, Roitman, Wightman, & Carelli, 2007).  
Although these electrophysiology studies suggest that the pattern of DA activity 
corresponds to behavioral performance during task acquisition, it is important to keep in 
mind that these results do not establish a causal link between DA activity and Pavlovian 
learning, and might reflect DA’s involvement in other (e.g., sensorimotor or 
motivational) processes. 
Summary 
Together, the studies reviewed in this section suggest that DA input to the 
accumbens mediates Pavlovian learning.  More specifically, acquisition of a CS+/- 
discriminated approach task depend upon intact ACB DA (Parkinson, et al., 2002), and 
specifically on D1 and not D2 transmission in the ACB core (Dalley, et al., 2005).  
Additional studies, however, are needed to rule out DA shell involvement.  Finally, 
amphetamine, an indirect DA agonist, accelerates CS discrimination learning in the shell 
(Phillips et al., 2003).  Overall, these findings are consistent with the view that ACB DA 
is involved in Pavlovian appetitive learning. 
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Involvement of ACB DA in the Performance of Pavlovian Behaviors 
Fewer studies have investigated ACB DA’s involvement in the performance of a 
previously-acquired Pavlovian behavior.  The majority of  Pavlovian performance 
experiments examined ACB DA’s role in both the acquisition of Pavlovian responses 
(reviewed above) and in performance, thus offering the opportunity to directly compare 
DA’s involvement in the acquisition and performance of a given task. 
Parkinson et al (2002) examined the effects of post training ACB DA depletion on 
the expression of a CS+/- discriminated approach response.  After a stable CS+ 
discriminated approach was established, separate animals received 6-OHDA lesions 
targeting the whole ACB.  Following recovery, lesioned animals approached the CS+ 
significantly more than the CS-, indicating that the expression of the discriminated CS+ 
approach is not vulnerable to DA depletion.  On the contrary, acquisition of this task was 
severely disrupted by 6-OHDA lesions, as seen above (Parkinson, et al., 2002).  It should 
be noted, however, that overall, lesioned rats emitted somewhat fewer CS+ approaches 
relative to sham rats, but still considerably more than CS- approaches.  This reduction in 
CS+ approaches might be attributable to lesioned-induced locomotor deficits. 
Di Ciano et al (2001) report that ACB core infusions of the general DA antagonist 
flupenthixol during a test session following several weeks of CS+/- training decreased the 
probability of CS+ approaches relative to sham, and interpret their result as evidence that 
DA receptor blockade disrupted the performance of the Pavlovian approach (Di Ciano, et 
al., 2001).  However, three points indicate that their result might be more indicative of a 
general locomotor suppression than a performance deficit: 1) Lesioned rats’ CS+ 
approach probability was largely superior to that of their CS- approach.  2) The 
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probability of CS- approach did not differ between lesioned and sham rats.  3) This study 
did not monitor any measure of general locomotion.  In light of these observations, these 
results might have to be reinterpreted as reflecting an overall locomotor deficit rather 
than a performance deficit, similar to the conclusion of Parkinson et al mentioned above.  
In this light, the findings from the Di Ciano study might indicate that performance of a 
discriminated Pavlovian approach does not depend on DA transmission in the ACB core.  
Furthermore, since whole ACB lesions in the Parkinson study above failed to disrupt task 
performance, it is likely (although not certain) that ACB shell DA is not involved in the 
performance of a CS+/- discriminated approach. 
Summary 
In conclusion, the evidence reviewed in this Pavlovian section indicates 
consistently that intact ACB DA is necessary for the acquisition but not the expression of 
Pavlovian appetitive behaviors.  More specifically, ACB core D1 transmission appeared 
to mediate the acquisition but not the expression of a CS+/- discriminated approach 
response.  These results suggest that ACB DA is only involved in Pavlovian appetitive 
learning, but not performance. 
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5.1.2.  Operant Behaviors 
Involvement of ACB DA in the Acquisition of Operant Behaviors 
A study compared the effects of 6-OHDA lesions of the whole ACB on the 
acquisition of a discriminated LP response for a pellet reward.  That is, a particular CS 
signaled to LP on lever (e.g., left lever), while another CS signaled to LP on the other 
lever (e.g., right lever).  Results indicated that 6-OHDA lesion of the ACB slowed 
acquisition of the LP discriminative response relative to sham rats (Robbins, Giardini, 
Jones, Reading, & Sahakian, 1990), suggesting that ACB DA transmission participates in 
instrumental learning. 
Kelley and colleagues examined the effects of ACB core D1 receptor-blockade on 
the acquisition of a simple LP task.  Animals received intra-ACB core infusions of either 
a D1 antagonist, an NMDA antagonist, or a combined infusion of the two prior to daily 
training sessions during the first four days.  On the subsequent days, animals experienced 
the instrumental contingency drug-free, before being tested for task performance on the 
last day, under the influence of the same drug treatment they initially received.  Results 
indicate that during the first four days the high dose of the D1 antagonist severely 
suppressed LPing.  Once animals experienced the task drug-free on subsequent days, they 
gradually acquired the LP response.  However, on the last day the final infusion of the D1 
antagonist strongly suppressed LPing again.  Animals treated with the low dose D1 or 
low dose NMDA antagonists exhibited no LP impairment.  Finally, rats treated with 
combined infusions of the low dose D1 and NMDA antagonists exhibited the same 
impairments as observed with the high dose D1 antagonist. 
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The authors interpret their findings as follows.  1) Since the low dose D1 
antagonist alone did not produce the learning/locomotor disruption seen with the high 
dose and 2) since the combined low dose treatments did not affect separate measures of 
locomotion, then 3) the LP impairments seen with the combined low dose drugs result 
from a learning (as opposed to motor) deficit (Hernandez, et al., 2005; Smith-Roe & 
Kelley, 2000).  They conclude that ACB core D1 transmission is necessary for 
instrumental learning. 
While the D1 antagonist-induced suppression of the LP response is indubitable, 
this study was unfortunately not able to entirely rule out the possibility that the observed 
disruption was due to performance deficits.  Indeed, drugged animals’ level of LPing 
while under the influence of the drug was close to zero, and this paradigm does not 
permit to dissociate locomotor from learning deficits.  It is therefore difficult to determine 
whether the initial LP disruption observed in this study was due to learning or 
performance deficits (Cardinal, Parkinson, Hall, et al., 2002; Horvitz, Choi, Morvan, 
Eyny, & Balsam, 2007; Yin, Ostlund, & Balleine, 2008). 
Indeed, the ACB’s position as a limbic/motor interface and DA’s crucial role in 
motor processes complicate the task of dissociating learning and performance deficits.  
This is especially true of operant responses, which require a complex motor response 
such as a LP (relative to the simpler and more innate Pavlovian approach).  As a result, 
current experimental paradigms have been unable to demonstrate convincingly that the 
observed disruptions are solely attributable to learning deficits (Baldo & Kelley, 2007; 
Beninger, 1989; Horvitz, et al., 2007; Salamone, et al., 2007; Wise, 2004). 
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Nevertheless, studies measuring the patterns of DA neuronal firing and ACB DA 
release can provide some information relative to ACB DA’s possible role in instrumental 
learning.  Firstly, numerous single-unit studies have indicated that the responses of 
monkeys’ midbrain DA neurons to operant reinforcers and their discriminative stimuli 
(DS) changes as a function of operant learning, similar to DA’s adaptive response in the 
context of Pavlovian learning (Ljungberg, et al., 1992; Schultz, 1998, 2007a; Schultz, et 
al., 1993).  In fact, as mentioned earlier, DA signaling has often been compared to a 
teaching signal, by virtue of its “prediction error signal” characteristic (Schultz, 2007a, 
2007b).   
Furthermore, a fast scan cyclic voltammetry study revealed that ACB shell DA 
levels change as animals acquire a cued LP response producing an electrical stimulation 
of the VTA (ICSS).  While initial DA release increased in relation to VTA stimulation, as 
animals acquired the cued LP response, DA levels gradually increased in response to the 
cue itself, and no longer to VTA stimulation or to the LP response (Owesson-White, 
Cheer, Beyene, Carelli, & Wightman, 2008).  Thus, DA release in the ACB shell appears 
to evolve as a function of task acquisition.  
Summary 
Few DA manipulations studies have examined ACB DA’s involvement in 
instrumental learning.  Review of the evidence available indicates that ACB DA is likely 
to mediate instrumental learning, although it was not possible to rule out the possibility 
that performance deficits might account for the drug-induced disruption (Hernandez, et 
al., 2005; Smith-Roe & Kelley, 2000).  In addition, DA signaling/release appears to be 
related to operant task acquisition (as it was for Pavlovian task acquisition), suggesting 
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that ACB DA transmission might be necessary for both Pavlovian and for instrumental 
learning. 
 
Involvement of ACB DA in the Performance of Operant Behaviors 
As will be evident in this section, much of the research examining the role of 
ACB DA in appetitive behavior has focused on the expression of operant responses.  The 
evidence overwhelmingly indicates that ACB DA transmission mediates the expression 
of operant responses.  Several types of task will be reviewed here, such as cued and 
uncued operant responses, effortful schedules of LP responding, and finally attentional 
performance on a five-choice serial reaction time task (5-CSRT). 
Firstly, ACB D1 transmission appears to mediate the expression of operant 
responses regardless of whether they are driven by an external cue or not.  Kelley and 
colleagues found that ACB core D1 receptor blockade suppressed the expression of an 
uncued LP response (as described in the previous section) (Smith-Roe & Kelley, 2000) 
(Hernandez, et al., 2005).  However, operant responses to cues (i.e., discriminative 
stimuli, DS) are also sensitive to ACB DA manipulations: Nicola and colleagues reported 
that infusion of a D1 (but not D2) antagonist in the ACB core/shell border region 
suppressed the expression of a LP response to a cue, and increased LP latencies (Yun, et 
al., 2004).  Furthermore, Nicola et al found that infusion of a DA reuptake blocker in the 
ACB (core/shell border) increased the expression of a cued nosepoke response to a 15% 
predictive cue but not to a 100% predictive cue.  In contrast, infusion of a D1 antagonist 
reduced responding to both the 15 % and the 100% predictive cue (Nicola, Taha, Kim, & 
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Fields, 2005).  In addition, a fast scan voltammetry study recording extracellular DA 
from the ACB core corroborates these results.  After training rats to LP in response to a 
cue for a liquid sucrose reward, Roitman and colleagues report that DA levels increased 
in response to the cue for trained animals (but not for naïve animals), and returned to 
baseline during sucrose delivery and consumption (Roitman, Stuber, Phillips, Wightman, 
& Carelli, 2004).  Together, these findings indicate that ACB DA, and in particular D1 
activity, mediates the expression of operant responses such as a LP or a nosepoke, 
regardless of reward type, and regardless of whether these responses are self-generated or 
cued by external stimuli.  As was seen in section 4 (possible roles of DA), this 
performance deficit is not likely to reflect a loss of hedonic value of the reinforcer, since 
animals still consume the food.  Alternatively, it might indicate a decrease in motivation 
to work for the reward, however, it is difficult to make this conclusion since these 
experiments did not directly test this question. 
A large body of evidence indicates that the performance deficits seen after 
disruptions in ACB DA transmission might reflect a decreased motivation to work for a 
reward.  Salamone and colleagues ingeniously tested this hypothesis, by giving rats a 
simultaneous choice between LPing for a food pellet on a fixed ratio 5 schedule (FR5, 
where each 5th LP is rewarded with a pellet), or consuming lab chow freely available on 
the cage floor.  Results showed that normal animals LPed at a high rate for food pellets 
while consuming little of the lab chow.  On the contrary, ACB DA depletion (or receptor 
blockade) led to drastic reductions in rate of LPing and to increases in consumption of lab 
chow.  However, when both lab chow and food pellets were freely available, DA-intact 
and DA-compromised rats chose to consume food pellets.  This behavioral pattern was 
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evident with ACB infusion of haloperidol as well as 6-OHDA lesion of the ACB 
(Salamone, et al., 1991), 6-OHDA lesion restricted to the ACB core, but not to the shell 
(Sokolowski & Salamone, 1998) and with D1 and D2 antagonists infused directly into 
either the ACB core or shell (Nowend, Arizzi, Carlson, & Salamone, 2001). 
This behavioral pattern indicates that despite the drug-induced LP disruption, 
animals are still aiming to obtain and consume food.  Thus, they adapt to reductions in 
DA transmission by reallocating their behavioral resources to a new strategy that is less 
effortful (Koch, Schmid, & Schnitzler, 2000; Salamone, et al., 1994; Salamone, et al., 
1997; Simmons & Neill, 2009).  On the contrary, medial and ventrolateral striatal 6-
OHDA lesions do not produce the same pattern of responding (Cousins, Sokolowski, & 
Salamone, 1993), and animals continue to LP if no lab chow is available in the cage 
(Cousins & Salamone, 1994). 
A similar behavioral reallocation paradigm used a T-maze task where animals had 
to choose between a high reward arm (4 pellets) and a low reward arm (2 pellets).  
Animals sustaining accumbal 6-OHDA lesions typically chose the high reward arm, 
except when a barrier blocked the high reward arm, requiring animals to climb over it to 
access the reward.  Control rats still chose the high reward arm and climbed the barrier, 
whereas 6-OHDA treated-animals chose the low reward arm instead (Salamone, et al., 
1994).  Interestingly, when the low reward arm did not contain any food pellets DA-
depleted rats chose to climb the barrier in the high reward arm (Cousins, Atherton, 
Turner, & Salamone, 1996), suggesting that in their “cost/benefit” analysis of a situation, 
DA-depleted animals preferred to expend some effort rather than have no reward at all. 
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The phenomenon of behavioral reallocation is particularly sensitive to schedules 
of reinforcement requiring a high work output.  Indeed, low effort schedules such as 
continuous reinforcement or variable intervals are not as sensitive to ACB 6-OHDA 
lesions (Sokolowski & Salamone, 1998), and more effortful the schedule are more 
severely disrupted (Salamone, Wisniecki, Carlson, & Correa, 2001).  This is also evident 
in progressive ratio schedules, where ratio requirements increase incrementally after each 
response: ACB 6-OHDA lesions decreased response rate as well the highest number of 
LPs animal were willing to make before obtaining a reward (i.e., highest ratio completed) 
(Aberman, Ward, & Salamone, 1998; Hamill, Trevitt, Nowend, Carlson, & Salamone, 
1999).  While one could argue that the suppression of the highest ratio completed by 
lesioned animals might be due to how distal a given LP is to the pellet reinforcer, testing 
with variable interval schedules indicate that this is not the case. 
Indeed, a variable interval 30s schedule with a one LP requirement (VI30/FR1: 
The first LP after an average interval of 30s produced a pellet) was not as vulnerable as a 
VI30/FR5 schedule (5LPs required after 30s interval to produce pellet) to ACB 6-OHDA 
lesions (Correa, Carlson, Wisniecki, & Salamone, 2002).  To thoroughly test this 
hypothesis, Salamone et al compared the effects of ACB 6-OHDA lesions on a VI60/FR1 
schedule, a VI60/FR10, and a VI120s/FR1 versus a VI120/FR10.  The results indicate 
that interval length (60s or 120) did not affect lesioned animals’ ability to respond on the 
low effort requirement (FR1).  On the contrary, higher ratio requirement (10 LPs) did 
affect lesioned animals’ responding across both interval schedules.  These results suggest 
that the amount of work output, but not the amount of time to wait between trials, is 
sensitive to ACB DA depletion (Mingote, Weber, Ishiwari, Correa, & Salamone, 2005).   
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Overall, Salamone interprets these results to indicate that ACB DA transmission 
mediates the behavioral activation necessary to perform tasks with high work outputs, 
and concludes that ACB DA-compromising treatments decrease animals’ readiness to 
expand energy on a given task (Salamone & Correa, 2002; Salamone, et al., 2007; 
Salamone, Correa, et al., 2005). 
The finding that the amount of time animals have to wait for the opportunity to 
earn a reward is not vulnerable to DA depletion is further supported by the results from a 
progressive delay task (Wakabayashi, Fields, & Nicola, 2004).  Animals were trained, 
drug-free, to respond to a cue by entering a reward receptacle and maintaining their heads 
in this receptacle for an increasing amount of time in order to obtain a liquid sucrose 
reward.  The maximum amount of time animals were willing to wait, or fail point, was 
proportional to reward size, indicating that motivational processes influenced fail point.  
In subsequent tests, the effect of ACB (core/shell border) infusions of a D1 or a D2 
antagonist on progressive delay task performance was recorded.  Results reveal that 
neither antagonist affected the amount of time animals were willing to wait for the 
reward.  However, both antagonists decreased the number of cues animals responded to 
by entering the food compartment (i.e., drugged animals did not respond to as many cues 
as saline-treated animals, however on trials where drugged animals did respond, they 
were willing to wait as long as vehicle animals).  Wakabayashi et al conclude that the 
motivation to wait for a reward does not depend upon ACB DA transmission, a result that 
furthers Salamone’s finding.   
It is surprising, however, that DA receptor-blockade decreased cued responding in 
the Wakabayashi study (a low effort head entry response), whereas Salamone et al 
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reported no effect of DA-depletion on low effort schedules such as VI30s interval, or 
continuous reinforcement (Sokolowski & Salamone, 1998).  Wakabayashi et al argue that 
the disruption of low-effort responses might be specific to cued responding (none of the 
tasks examined by Salamone et al employed a cue), however, this view is not consistent 
with the LP disruption obtained by Kelley et al, mentioned above (Smith-Roe & Kelley, 
2000).  Further research should thoroughly examine their methodological differences in 
order to understand these differences. 
Additionally, Salamone and colleagues observed that lesioned animals responding 
on the variable interval/FR task were more likely to take long pauses between responses 
(Mingote, et al., 2005).  Nicola et al made the same observation in their progressive delay 
task, and speculate that drugged animals might be more likely to become disengaged 
from a task and miss the opportunity to respond to a cue (Nicola, personal 
communication), suggesting that their responses might be affected by attentional deficits. 
Animals trained on the five-choice serial reaction time task (5-CSRT), face five 
nosepoking holes and learn to detect a brief light stimulus presented in the rear of one of 
the five holes.  Rats have a 5s period after light presentation to make a nosepoke response 
in the nosepoke hole where the light flash was presented, in order to earn a food pellet in 
a food compartment (located on the wall opposite to the nosepoke holes).  Pezze and 
colleagues found that intra-ACB (no core/shell distinction) infusion of both a D1 and D2 
antagonist disrupted 5CSRT task performance, by decreasing the accuracy of responding 
(correct nosepokes/total nosepokes), increasing the nosepoke latency, and increasing the 
numbers of omitted trials (failure to respond within 5s of stimulus presentation).  
However, while a D1 agonist (SKF38393) improved accuracy and decreased the number 
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of omissions, a D2 agonist (quinpirole) increased perseverative responding (repeated 
nosepoke after light presentation) (Pezze, et al., 2007).  These results suggest that 
attentional performance is dependent upon ACB D1 receptor activation and perhaps upon 
D2 activity as well.  However, the finding that the D2 agonist increased perseverative 
responses suggests that D2 receptor activation might be more involved in regulating 
behavioral sequence coordination (Pezze, et al., 2007) (but see, Pattij, et al., 2007). 
Furthermore, similar choice serial reaction time studies indicate that systemic 
administration of amphetamine increased the number of premature responses (during ITI 
and before light onset), decreased the number of correct responses, and decreased correct 
response latencies, but had no effect on omitted responses (Pattij, et al., 2007; van 
Gaalen, Unger, Jongen-Relo, Schoemaker, & Gross, 2009).  Each of the amphetamine-
induced effects was dose-dependently reversed by intra-core and intra-shell infusion of 
the D2 antagonist eticlopride, but not by core or shell infusions of the D1 antagonist SCH 
23390.  These results suggest that systemic amphetamine administration disrupts 
attentional performance by increasing impulsive responding (i.e., premature responses) 
and impairing response accuracy, essentially impairing inhibitory behavioral control, 
which appears to be mediated by D2 but not D1 receptor activation in the ACB core and 
shell (Pattij, et al., 2007).  
Together, these studies suggest that D2 receptor activation in the ACB mediates 
the behavioral stimulant effects of amphetamine, since D2 but not D1 receptor blockade 
reversed amphetamine-induced premature and incorrect responses (Pattij, et al., 2007).  
This effect might be related to the D2 agonist-induced increase in perseverative 
responding found in the Pezze study.  Thus, ACB D2 activity might be less involved in 
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attentional performance than in regulating behavioral inhibition and excessive D2 activity 
might increase impulsivity.  On the contrary, ACB D1 receptor activity appears to 
mediate attentional performance bidirectionally, where D1 receptor blockade worsens, 
and D1 receptor stimulation improves, attentional performance.  Furthermore, the view 
that D1 activity mediates attentional performance might explain the observation made by 
Salamone that DA-depleted animals tend to “take long pauses” or become “disengaged 
from the task,” as noted by Nicola.  
Summary 
The evidence reviewed here indicates that ACB DA activity is heavily involved in 
the performance of operant responses, whether cued (Yun, et al., 2004) or not (Smith-Roe 
& Kelley, 2000).  Furthermore, the data indicates that high effort responses are 
particularly vulnerable to ACB DA-compromising treatments (Salamone, et al., 2007; 
Salamone, Correa, Mingote, & Weber, 2003; Salamone, Correa, et al., 2005).  Moreover, 
ACB D1 activity appears to mediate attentional performance, while D2 activity might 
regulate behavioral inhibition (Pattij, et al., 2007; Pezze, et al., 2007).  These data are 
consistent with the view that DA is necessary for behavioral activation to relevant 
environmental stimuli (Ikemoto & Panksepp, 1999; Kelley, et al., 2005; Numan, 2006; 
Salamone, et al., 2007).  
In conclusion, DA transmission in the ACB seems to mediate Pavlovian and 
operant learning, as well as operant response expression.  However, ACB DA does not 
appear necessary for Pavlovian response expression.  Excluding Pavlovian performance, 
these findings are consistent with the view that ACB DA mediates behavioral activation 
to biologically important stimuli: DA-compromising treatments suppress responding 
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during Pavlovian and operant learning as well as during operant performance.  Therefore, 
DA transmission seems necessary to implement appropriate Pavlovian and operant 
responses to environmental stimuli signaling the availability of a reinforcer, except for 
learned Pavlovian responses.  The apparent invulnerability of Pavlovian performance to 
ACB DA-compromising treatments will be examined more thoroughly in the discussion.   
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5.1.3  Manipulations of the Nucleus Accumbens and Subregions 
The evidence reviewed above suggests that ACB DA mediates the acquisition but 
not the expression of Pavlovian responses, whereas it mediates both the acquisition and 
the expression of operant responses.  As was noted in the anatomy section earlier, there is 
still some debate concerning the manner in which DA influences the ACB.  Some argue 
that DA facilitates the ability of strong cortical inputs to excite medium spiny neurons 
(Cepeda & Levine, 1998; Horvitz, 2002; Nicola, 2007; O'Donnell, 2003), and that ACB 
activation results in behavioral output.  Thus, a “DA facilitatory” view predicts that 
disrupting ACB DA or the ACB itself will result in decreased behavioral output.  On the 
contrary, others argue that ACB activity suppresses behavioral output and that DA 
inhibits ACB activity, thus releasing behavior from ACB inhibitory control (Mogenson, 
1987; Nicola, 2007; Numan, 2006; Numan, Stolzenberg, 2009).  Thus, a “DA inhibitory” 
view predicts that while manipulating DA in the ACB will decrease behavioral output 
(since DA no longer releases behavior from ACB inhibition), on the contrary, lesioning 
or inactivating the ACB will result in behavioral activation (for a more in-depth 
description of each view, please refer back to pg. 9-10).  
There is evidence to suggest that treatments manipulating the ACB (i.e., lesions or 
inactivation) do no impair Pavlovian responses.  Indeed, while some report that ACB 
core treatments impaired the acquisition (Di Ciano, et al., 2001; Parkinson, Willoughby, 
et al., 2000) or the expression (Cardinal et al., 2002) of an autoshaped conditioned 
approach, the net result is really an increase in CS- responding, in addition to CS+ 
responding, thus supporting to the view that ACB lesion releases behavior from ACB’s 
inhibitory control.  While the authors’ claim that ACB core manipulations prevented the 
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acquisition of a discrimination between the CS+ and the CS- is true, this effect is due to 
increased responding to the CS-, and not an overall decrease in responding.  In addition, 
ACB shell lesions were without effects on the acquisition of autoshaping (Parkinson, 
Willoughby, et al., 2000), a finding that is still consistent with the view that DA lifts the 
ACB’s inhibition control over behavior. 
With regards to operant responses, there is mixed evidence.  Some report a mild 
to strong impairment of LP acquisition by whole ACB manipulation (de Borchgrave, 
Rawlins, Dickinson, & Balleine, 2002) or treatments restricted to the ACB core (Atallah, 
Lopez-Paniagua, Rudy, & O'Reilly, 2007; Ito, et al., 2004; Parkinson, Olmstead, Burns, 
Robbins, & Everitt, 1999).  Others however report that the acquisition of an operant 
response was unimpaired despite lesions restricted to the ACB core (Corbit, Muir, & 
Balleine, 2001; Floresco, Ghods-Sharifi, Vexelman, & Magyar, 2006; Giertler, Bohn, & 
Hauber, 2005; Pothuizen, et al., 2006) or the ACB shell (Corbit, et al., 2001; Floresco, et 
al., 2006; Parkinson, Robbins, & Everitt, 1999; Pothuizen, et al., 2006). 
In addition, while there is some data to suggest that manipulating the ACB 
impairs the expression of some operant responses (Balleine & Killcross, 1994; Giertler, 
Bohn, & Hauber, 2003; Hauber, Bohn, & Giertler, 2000; Reading & Dunnett, 1991), the 
majority of the evidence suggests that operant response expression is unimpaired (i.e., no 
effect) by manipulations of the whole ACB (V. J. Brown & Bowman, 1995; Lee, Clancy, 
& Fleming, 1999), the ACB core (Giertler, Bohn, & Hauber, 2004), or the ACB shell 
(Pothuizen, Jongen-Relo, Feldon, & Yee, 2005).  Furthermore, some studies report an 
increase in responding following inactivation or lesion of the whole ACB (Bowman & 
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Brown, 1998; Yun, et al., 2004), or the ACB core (Cardinal, Pennicott, Sugathapala, 
Robbins, & Everitt, 2001; Pothuizen, et al., 2005). 
Finally, evidence suggests that inactivation of the ACB shell along a rostrocaudal 
axis respectively, elicits feeding behavior (Reynolds & Berridge, 2001; Reynolds & 
Berridge, 2002; Stratford & Kelley, 1997) and a fearful treading behavior (S. M. 
Reynolds & Berridge, 2001, 2002).  Interestingly, these behaviors elicited by ACB shell 
inactivation were suppressed by adding a D1 and D2 antagonist to the infusion mixture, 
suggesting that intact D1 and D2 transmission in the ACB shell is necessary for ACB 
inactivating treatments to effectively suppress ACB activity and elicit behavior.   
While some of the evidence mentioned revealed a suppressive effect on behavior 
of ACB lesioning or inactivating treatments, the majority of the data suggest that these 
treatments do not impair either Pavlovian or operant acquisition or expression, thus 
supporting the view that DA inhibits the ACB.  Besides, the view that DA inhibits ACB 
activity does not conflict with the DA evidence reviewed above.  Indeed, if ACB DA 
transmission is necessary for the acquisition of Pavlovian and operant behaviors as well 
as the expressions of operant behaviors, and if one assumes that DA suppresses the ACB, 
then, ACB-compromising treatments should not impair the acquisition of Pavlovian or 
operant responses, or the expression of operant responses – consistent with some of the 
ACB lesion/inactivation evidence. 
On the contrary, adopting the view that DA facilitates excitation of the ACB, thus 
resulting in behavioral output, would make it difficult to reconcile the ACB lesion data 
with the DA-manipulation results.  Indeed, if DA manipulations disrupt behavioral 
acquisition or performance, and if one assumes that the DA-mediated excitation of the 
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ACB is necessary for behavioral output, then one would predict that ACB lesions would 
more often than not impair responding.  On the contrary, the evidence reviewed here 
indicates that ACB lesions often do not impair the acquisition or expression of Pavlovian 
and operant behaviors, thus refuting the view that DA excites the ACB.  
Future research should aim to further our understanding of how exactly DA 
suppresses ACB activity, and how releasing the ventral pallidum from ACB inhibition 
results in behavioral output.  One possibility is that the ventral pallidum (VP) through its 
glutamatergic projection to the mPFC (Hur & Zaborszky, 2005), might relay this 
disinhibition to the mPFC, which might activate downstream motor effectors and thus 
result in behavioral output. 
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5.2.  Amygdala Dopamine  
5.2.1.  Pavlovian Behaviors 
Involvement of Amygdala DA in the Acquisition and Performance of Pavlovian 
Behaviors 
The work of Phillips, Hitchcott, and colleagues suggests that D3 transmission in 
the central amygdala is necessary for the acquisition but not the expression of a Pavlovian 
discriminated approach response.  Indeed, they found that post-session infusions of a D3 
receptor agonist (7-OH-DPAT) and of amphetamines in the central nucleus of the 
amygdala (CeA) (but not in the basolateral amygdala, BLA) both enhanced the 
acquisition of a CS+ approach response.  On the contrary, infusion of a D1 agonist (SKF-
38393) and a D2 agonist (quinpirole) had no effect on task acquisition (Hitchcott, 
Bonardi, Phillips, 1997a; Hitchcott, Harmer, & Phillips, 1997; Hitchcott & Phillips, 
1998). 
In addition, while prior amphetamine sensitization enhanced the acquisition of the 
CS+ approach response for vehicle-infused animals (relative to non-sensitized animals), 
post-session intra-amygdalar infusions of the D3 receptor antagonist nafadotride 
prevented the amphetamine sensitization-induced enhancement of task acquisition 
(Phillips, Harmer, Hitchcott, 2002).  In contrast, pre-session infusions of the D3 agonist 
into the whole amygdala and the CeA (but not in the BLA) disrupted the acquisition of 
the CS+ discriminated approach (Hitchcott & Phillips, 1998; Phillips & Hitchcott, 2009).  
Finally, while pre-session amygdalar infusion of the D3 agonist 7-OH-DPAT impaired 
the acquisition of a discriminated Pavlovian approach, the same treatment had no effect 
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on the performance of this approach response, once the task had been well learned 
(Phillips & Hitchcott, 2009). 
Overall, these results suggest that intact D3 transmission in the amygdala, and in 
particular in the CeA, is necessary for the acquisition but not the performance of a 
discriminated approach response – a pattern that is similar to that found for ACB DA’s 
involvement in Pavlovian responses.  However, how to understand the different effects of 
pre- and post-session infusions of the D3 agonist (disrupting and potentiating, 
respectively)?  The authors suggest that the opposite effects of pre and post session 
infusion reflect that D3 receptor stimulation inhibits subsequent learning.  Therefore, 
when the drug is administered prior to the training session it disrupts the formation of a 
CS-US association.  However, when administered after the session, the agonist 
suppresses learning that directly follows the Pavlovian training – essentially facilitating 
task acquisition by inhibiting retroactive interference (Phillips & Hitchcott, 2009).  
According to this view, D3 receptor stimulation might be preventing memory 
consolidation of events directly succeeding its administration. 
Although Phillips et al do not mention a mechanism by which D3 receptor 
stimulation might prevent subsequent learning, one such mechanism could be the 
regulation of DA release and synthesis by D3 receptors that are located pre-synaptically 
(Levant, 1997; Sokoloff & Schwartz, 1995).  Indeed, microdialysis studies report that 
local application of 7-OH-DPAT in the ACB decreases DA efflux (Levant, 1997; Parsons 
et al., 1996; Sokoloff & Schwartz, 1995).  Thus, one can speculate that 7-OH-DPAT 
infusion in the amygdala would also decrease DA release.  In this light, it would be easier 
to understand how pre-session infusion of the D3 agonist might prevent learning: By 
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reducing DAergic tone while animals are experiencing the task.  On the contrary, post-
session infusion of 7-OH-DPAT might enhance task acquisition by decreasing DAergic 
tone while animals are experiencing other potentially interfering events, thus inhibiting 
possible retrograde interferences, as hypothesized by Phillips et al.  
Interestingly, D3 receptors distribution in the rat brain is limited to limbic sites, 
notably the nucleus accumbens, and only moderately in the rat amygdala (reviewed in 
Levant, 1997).  Furthermore, in the human amygdala, D3 receptors are concentrated in 
the central amygdala region and not in the BLA (Murray, Ryoo, Gurevich, & Joyce, 
1994).  If the same was to apply to the rat brain, this might explain why D3 receptors 
infusion had an effect in the CeA and not in the BLA.  A better knowledge of the relative 
distributions of D2 and D3 receptor in the rat amygdala will help understanding the 
results obtained by Phillips and colleagues.  In addition, the effects of 7-OHDPAT appear 
to be specific to D3 receptors, since 7-OHDPAT has a much greater affinity for D3 
relative to D2 receptors (Parsons, et al., 1996) (Missale, Nash, Robinson, Jaber, & Caron, 
1998) (Sokoloff & Schwartz, 1995). 
Moreover, while D1-like receptors activate, and D2-like receptors inhibit adenylyl 
cyclase (Missale, et al., 1998; Nishi, et al., 1997).  Although the D3 receptor belongs to 
the D2-like family, evidence indicates that it mode of action differs from that of other 
D2-like receptors, since D3 receptor activation appear to only weakly inhibits adenylyl 
cyclase (reviewed in Missale, et al., 1998).  For example, while D2 receptor stimulation 
promotes locomotion, D3 receptor stimulation inhibits locomotion (Levant, 1997; 
Missale, et al., 1998; Sokoloff & Schwartz, 1995).  Further research is needed to examine 
whether DA release in the amygdala is regulated via presynaptic inhibition by D3 
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receptors specifically, or whether D2 receptors in the amygdala serve the same function.  
Finally, although neither the D1 nor the D2 agonist used in the Hitchcott study influenced 
task acquisition (Hitchcott, Bonardi, Phillips, 1997b), it would still be interesting to 
examine whether a D1 or a D2 antagonist might disrupt task acquisition, as well as task 
performance.  Indeed, while additional stimulation of D1 or D2 receptors might not have 
measurable effects on learning, it is still possible that blocking D1 or D2 transmission 
could disrupt acquisition, or performance or both.   
Summary 
As was apparent in this section, much less research has examined the involvement 
of amygdala DA in Pavlovian appetitive conditioning than what was seen with the ACB.  
Indeed, the amygdala has mostly been implicated in aversive, or fear conditioning 
(LeDoux, 2003; LeDoux, 2000), and D1 transmission in the BLA is known to be 
necessary for the acquisition of Pavlovian fear conditioning (Nader & LeDoux, 1999; 
Pezze & Feldon, 2004).  In recent years however, the notion that the amygdala also 
participates in appetitive conditioning has gained acceptance.  Still, most research efforts 
have focused on the amygdala itself (i.e., lesion studies), and not on amygdala dopamine. 
The results from Phillips, Hitchcott, and colleagues indicate that D3 transmission 
in the amygdala (CeA in particular) regulates the acquisition but not the performance of a 
Pavlovian discriminated approach response (Hitchcott, Bonardi, et al., 1997b; Phillips & 
Hitchcott, 1998; 2009).  This is similar to what was found for ACB DA’s involvement in 
Pavlovian conditioning: DA transmission is necessary for the acquisition but not the 
expression of Pavlovian responses.  However, amygdala DA’s involvement in Pavlovian 
learning was not as straightforward as in the ACB.  Indeed, while in the ACB D1 receptor 
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blockade disrupts task acquisition (Di Ciano, et al., 2001), in the amygdala, pre-session 
stimulation of D3 receptors impairs learning, whereas post session stimulation enhances 
learning (Phillips & Hitchcott, 1998, 2009).  A possible interpretation is that D3 receptor 
activation decreases DAergic tone in the amygdala, thereby preventing Pavlovian 
learning when D3 receptors are stimulated during the training session, but facilitating 
learning by inhibiting retroactive interferences when they are stimulated after the training 
session.  This view is consistent with the notion that DA transmission in the amygdala is 
necessary for Pavlovian learning to occur, perhaps acting at other DA receptors.  Thus, it 
will be important to examine the effects of D1 and D2 receptor blockade on Pavlovian 
acquisition.   
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5.2.2.  Operant Behaviors 
Involvement of Amygdala DA in the Acquisition and Performance of Operant 
Behaviors 
Kelley and colleagues applied the same experimental protocol that was used to 
examine ACB DA’s involvement in operant LPing, to investigate whether LP acquisition 
and expression depend on DA transmission in the amygdala.  Similar to their ACB result, 
they found that infusion of a D1 antagonist (SCH 23390) in the CeA and in the BLA 
dose-dependently impaired the acquisition of LPing (Andrzejewski, Spencer, & Kelley, 
2005).  However, contrary to what was seen in the ACB, these drug infusions had no 
effect on LPing performance after animals acquired the task drug-free (Andrzejewski, et 
al., 2005). 
Similar to the ACB result, levels of LPing exhibited by drugged animals during 
the acquisition phase of this study were extremely low.  However, the finding that LPing 
expression was not impaired by D1 receptor-blockade after animals acquired the task 
makes it more likely that the initial LP disruption was due to learning deficits and not 
performance deficits.  It is still possible, nevertheless, that LP performance would be 
more vulnerable to D1 receptor-blockade early than late in training.   
Thus, the same learning versus performance deficit problem plagues the 
examination of amygdala DA’s involvement in operant learning as it did for ACB DA.  
This difficulty probably accounts for the scarcity of evidence on the topic of instrumental 
appetitive learning.  While DA in the amygdala is known to mediate fear learning, these 
studies use Pavlovian paradigms almost exclusively (reviewed in Pezze & Feldon, 2004), 
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thus it is not possible to extend these conclusions to operant conditioning.  There is 
evidence implicating ACB DA and PFC DA in the acquisition of operant LP response to 
avoid and escape (respectively) an aversive shock (McCullough, Sokolowski, & 
Salamone, 1993; Sokolowski, McCullough, & Salamone, 1994), however the same was 
not examined with amygdala DA.  It is interesting to speculate that should an operant LP 
avoidance response be subjected to DA manipulations in the amygdala, it would be found 
to depend on intact DA transmission.   
Overall, these results indicate that the acquisition but not the expression of a LP 
response is dependent upon intact amygdala D1 transmission.  This pattern is different 
from what was found for ACB DA, where both the acquisition and the performance of 
operant responses were dependent on ACB DA activity.  Furthermore, amygdala DA 
transmission appears to be necessary for the acquisition of both Pavlovian and operant 
responses, but not for the expression of either of these responses. 
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5.2.3.  Manipulations of the Amygdala and Subregions 
The sections above indicate that DA transmission in the CeA mediates the 
acquisition of Pavlovian responses, and that DA activity in both the CeA and the BLA 
mediates the acquisition of operant responses, whereas DA transmission in neither 
subregions of the amygdala is necessary for the expression of Pavlovian or operant 
responses.  Brief review of amygdala lesions and inactivation studies reveals a picture 
consistent with the amygdala DA results.  
There is data to suggest that the CeA is necessary for the acquisition of Pavlovian 
appetitive responses such as a conditioned approach (Cardinal, Parkinson, Lachenal, et 
al., 2002; Parkinson, Robbins, & Everitt, 2000) or conditioned orienting (Gallagher, 
Graham, & Holland, 1990; Groshek et al., 2005; M. McDannald, Kerfoot, Gallagher, & 
Holland, 2004), but not for their expression (Cardinal, Parkinson, Lachenal, et al., 2002; 
Gallagher, et al., 1990; Groshek, et al., 2005).  In addition, while some have shown that 
the BLA is not necessary for the acquisition of Pavlovian appetitive responses 
(Parkinson, Robbins, et al., 2000), others suggest that it is involved in the acquisition 
(Setlow, Gallagher, & Holland, 2002), or the expression (Blundell, Hall, & Killcross, 
2003; Hatfield, Han, Conley, Gallagher, & Holland, 1996; Johnson, Gallagher, Holland, 
2009) of complex aspects of Pavlovian responding such as sensitivity to outcome value 
after second-order conditioning.  Therefore, these studies implicate the BLA in some 
complex aspects of Pavlovian conditioning. 
This might be consistent with the abundant evidence implicating the BLA in 
operant conditioning.  A few studies report an involvement of the BLA in the acquisition 
of operant responses (Baldwin, Holahan, Sadeghian, & Kelley, 2000; Schoenbaum, 
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Chiba, & Gallagher, 2000; Schoenbaum, Setlow, Nugent, Saddoris, & Gallagher, 2003), 
while numerous studies implicate the BLA in the expression of various operant responses 
(Balleine, Killcross, & Dickinson, 2003; Burns, Everitt, & Robbins, 1999; Floresco & 
Ghods-Sharifi, 2007; Ghods-Sharifi, Onge, & Floresco, 2009; Lee, et al., 1999; 
Schoenbaum, et al., 2003; Winstanley, Theobald, Cardinal, & Robbins, 2004).  In 
contrast, only one study was found, which examined the effect of CeA lesion on 
instrumental performance, and it reported that the CeA does not mediate operant 
performance (Robledo, Robbins, & Everitt, 1996).  Thus, according to amygdala 
manipulation data, the CeA mediates Pavlovian acquisition, while neither amygdala 
subdivisions is involved in the expression of a simple Pavlovian response.  On the 
contrary, the BLA mediates both the acquisition and expression of operant responses and 
might mediate more complex aspects of Pavlovian conditioning.   
Comparing the evidence between studies manipulating the amygdala directly or 
studies manipulating amygdala DA reveals some degree of overlap.  Indeed, both the 
CeA and DA activity in the CeA are necessary for the acquisition of Pavlovian responses.  
Similarly, both the BLA and DA transmission in the BLA are necessary for the 
acquisition of operant responses.  Some differences between both types of evidence 
include the finding that the BLA mediates both the acquisition and the performance of 
operant responses, whereas BLA DA transmission appear to only mediate the acquisition 
but not the expression of operant responses (Andrzejewski, et al., 2005).  However, this 
was the only study that examined BLA DA involvement in operant response expression, 
and on its own, this study might not be sufficient to rule out an involvement of BLA DA 
in operant response performance, thus more research is needed to corroborate this result.   
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5.3.  Prefrontal Cortex Dopamine 
5.3.1.  Pavlovian Behaviors 
Involvement of Medial Prefrontal DA in the Acquisition and Performance of 
Pavlovian Behaviors 
Despite repeated literature searches, no evidence was found examining PFC DA 
in the acquisition of appetitive Pavlovian responses.  Instead, the most relevant evidence 
available examined PFC DA’s involvement in Pavlovian fear learning, and even so, that 
evidence suggests that PFC DA does not mediate Pavlovian responses. 
Microdialysis studies monitoring extracellular DA (16 min timeframe) in the 
medial PFC (mPFC, prelimbic-infralimbic) during CS-foot shock pairings revealed that 
increases in PFC DA were larger in response to CS-footshock pairings than in response to 
random salient stimuli (Feenstra, Vogel, Botterblom, Joosten, & de Bruin, 2001; 
Wilkinson et al., 1998).  However, these microdialysis results do not eliminate the 
possibility that the observed increase in PFC DA was due to the shock itself.  Moreover, 
mPFC DA depletion with 6-OHDA lesions did not prevent DA-depleted rats from 
normally acquiring conditioned freezing to a shock-paired CS (Morrow, Elsworth, 
Rasmusson, & Roth, 1999).  Taken together these data suggest that PFC DA is not 
necessary for aversive Pavlovian learning.  
Similarly, 6-OHDA lesions of the mPFC did not suppress the expression of 
conditioned freezing after several weeks of training (Morrow, et al., 1999).  In addition, 
extracellular DA in the mPFC, monitored every 16 min during the performance of an 
appetitive Pavlovian approach response, was found to increase both in response to paired 
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CS-food presentations and to unpaired CS and food presentation, but not to the CS 
presentation alone (Mingote, de Bruin, & Feenstra, 2004).  Again, these results do not 
rule out the possibility that mPFC DA increased in response to the food presentation 
itself, independently of its pairing with the CS.  Together, these studies suggest that 
mPFC DA is not involved in the performance of a Pavlovian appetitive approach, nor is it 
involved in the expression of Pavlovian aversive freezing. 
Summary 
Very little evidence was found addressing PFC DA’s involvement in either the 
acquisition or performance of Pavlovian responses.  In fact, no evidence was available for 
Pavlovian appetitive learning, so instead aversive conditioning studies were examined.  
The evidence presented suggests that mPFC DA is not necessary for the acquisition and 
expression of aversive Pavlovian responses (Feenstra, et al., 2001; Wilkinson, et al., 
1998) (Morrow, et al., 1999), nor is it necessary for the performance of an appetitive 
Pavlovian approach (Mingote, et al., 2004).  These negative results may help understand 
the scarcity of evidence examining PFC DA’s involvement in Pavlovian conditioning.  
However, caution should be used when generalizing results from aversive conditioning 
protocols to appetitive conditioning, as these types of conditioning might rely on different 
neural processes. 
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5.3.2.  Operant Behaviors 
Involvement of Prefrontal DA in the Acquisition of Operant Behaviors 
Applying the same training protocol as that used in the ACB and amygdala 
studies, Kelley and colleagues examined the effects of medial PFC infusions of 1) several 
doses of the D1 antagonist SCH 23390 and 2) co-administration of the low dose SCH 
23390 and a low dose of the NMDA antagonist AP5, on the acquisition of a LP response 
(Baldwin, Sadeghian, & Kelley, 2002).  The high dose D1 antagonist prevented 
acquisition of LPing, while the low dose did not.  However, combined infusion of the low 
dose D1 and NMDA antagonists (both without effects on LPing on their own) prevented 
the acquisition of LPing (Baldwin, et al., 2002).  Therefore, similar to what was seen in 
the ACB and the amygdala, these results suggest that D1 transmission in the PFC is also 
necessary for the acquisition of a LP response.  
Bubser and colleagues examined the effects of mPFC 6-OHDA lesions on the 
acquisition of a delayed alternation task (Bubser & Schmidt, 1990).  Rats running down 
the stem portion of a T-maze learned to choose the arm opposite to that which they had 
previously selected in order to obtain a pellet reward.  In between each run, rats were kept 
in a holding cage for 20 sec.  Lesioned rats made more arm selection errors than sham 
rats on the task.  They were, however, unimpaired on other maze tasks that did not 
impose a delay between each run.  Spatial navigation and long-term spatial memory of 
the maze do not appear to depend upon mPFC DA transmission, since non-delayed maze 
tasks were invulnerable to 6-OHDA lesions.   
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This result suggests that perhaps PFC DA mediation of operant response 
acquisition is due to its role in maintaining active working memory representations 
necessary for task acquisition: A working memory representation of the just-performed 
response might be necessary in order to associate the response with the outcome.  Further 
work is necessary to examine this hypothesis.  
Summary 
The evidence reviewed here suggests that mPFC DA transmission mediates the 
acquisition of operant responses, such as a LP (Baldwin, et al., 2002), and participates in 
the acquisition of complex delayed maze tasks by inhibiting interferences (Bubser & 
Schmidt, 1990).  While this PFC DA-mediated acquisition of operant response may be 
due to working memory impairments, overall, the results indicate that PFC DA is 
involved in instrumental learning, as it was in the ACB and amygdala. 
 
Involvement of Prefrontal DA in the Performance of Operant Behaviors 
In the Baldwin (2002) experiment mentioned above, the investigators also 
examined whether the expression of a LP response is vulnerable to mPFC D1 receptor-
blockade after that response has been well acquired.  Medial PFC infusion of D1 
antagonist SCH23390 did in fact suppress LPing even when administered after the 
response had been acquired (Baldwin, et al., 2002).  Thus, as was seen in the ACB 
(Smith-Roe & Kelley, 2000), both the acquisition and the expression of a LP response 
depend upon intact D1 transmission in the PFC.  In contrast, D1 activity in the amygdala 
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appears to mediate the acquisition, but not the expression of an operant LP. 
(Andrzejewski, et al., 2005) 
Sokolowski and Salamone examined whether mPFC DA mediates behavioral 
inhibition.  Rats acquired a differential reinforcement task (they had to withhold LPing 
during 30 sec in order to earn a food pellet with the next LP), before receiving mPFC 6-
OHDA lesions.  Post-lesion, DA-depleted rats were unable to withhold LPing for 30sec, 
indicating that mPFC DA depletion impaired animals’ ability to inhibit responding, or 
increased impulsivity (Sokolowski & Salamone, 1994). 
Several researchers investigated whether mPFC DA is necessary for attentional 
performance with the 5CSRT task.  Medial PFC infusion of the D1 agonist SKF38393 
improved the accuracy (% of correct responses) of animals that had low baseline 
performance, whereas the D1 antagonist SCH 23390 decreased the accuracy of animals 
that had high baseline performance, and the D2 antagonist sulpiride had no effect 
(Granon et al., 2000).  Thus, appropriate levels of D1 transmission necessary for optimal 
task performance may vary as a function of individual differences: Indeed, good baseline 
performance is not improved by the D1 agonist but worsened by the D1 antagonist, 
whereas poor baseline performance is improved by the D1 agonist but not worsened by 
the D1 antagonist.  In addition, while correct task performance depends upon intact D1 
transmission in both the mPFC and in the ACB (Pezze, et al., 2007), different results 
emerge for D2 transmission.  Indeed, while mPFC infusion of the D2 antagonist sulpiride 
had no effect in this study, infusion of the same antagonist in the ACB decreased response 
accuracy (Pezze, et al., 2007).  It is interesting to speculate that the same DA receptors 
may play different roles in the mPFC and in the ACB. 
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Furthermore, Fletcher and colleagues examined whether the effects of systemic 
amphetamine sensitization on the performance of the same 5CSRT task, and whether 
these effects are regulated by mPFC D1 transmission (Fletcher, Tenn, Sinyard, Rizos, & 
Kapur, 2007).  Their results suggest a) that attentional performance is vulnerable to 
amphetamine-sensitization, and b) that the amphetamine sensitization-induced attentional 
deficits are likely caused by a dysregulation of PFC D1 transmission, since mPFC 
infusion of a D1 agonist rescued attentional performance (but see, Pattij, et al., 2007).  
Finally, Cetin et al (2004) report that DA transmission in the orbitofrontal 
cortical (OFC) is necessary for effort expenditure in an operant task, as assessed with a 
progressive LP ratio schedule (where response requirements increase upon each earned 
pellet).  They found that intra-OFC infusion of a D1 antagonist and a D2 antagonist both 
impaired performance of the task by lowering the maximum number of unrewarded LPs 
animals are willing to make in order to earn a pellet (Cetin, Freudenberg, Fuchtemeier, & 
Koch, 2004).  This reduction in break point reflects a decreased motivation to work for a 
reinforcer, but not a disturbance of hedonic processes since drugged animals still 
preferred and consumed the food pellet reward in separate consumption tests.  Thus, OFC 
DA appears to be involved in the same cost-benefit analysis as what was seen with ACB 
DA. 
Summary 
The evidence reviewed above strongly suggests that PFC DA mediates the 
expression of operant responses.  As was the case for ACB DA’s role in operant 
performance, these studies give rise to several hypotheses regarding DA function.  
Medial PFC DA appears to be necessary to control impulsive behavior, since DA-
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depletion suppresses the ability to withhold responding (Sokolowski & Salamone, 1994).  
However, mPFC D1 transmission, but not D2 transmission, also appears necessary for 
attentional performance (Granon, et al., 2000), and to regulate attentional deficits induced 
by amphetamine sensitization (Fletcher, et al., 2007).  Finally, OFC DA activity appears 
to be important for animals’ willingness to work on effortful tasks, in a cost-benefit 
analysis similar to that seen with ACB DA manipulations (Cetin, et al., 2004).  While 
these data suggest several different functions of PFC DA activity, it is possible to 
reconcile these different hypotheses with the overarching view mentioned before: That 
DA promotes behavioral activation to relevant environmental stimuli (Ikemoto, 2007; 
Ikemoto & Panksepp, 1999; Kelley, et al., 2005; Numan, 2006; Salamone, et al., 2007).   
Overall, the evidence reviewed in this section suggests that PFC DA is necessary 
for the acquisition and expression of operant appetitive responses, but not for the 
acquisition or the expression of Pavlovian responses.  However, evidence was lacking to 
draw any firm conclusions on PFC DA’s involvement in either the acquisition or 
expression of Pavlovian responses.  Since this was not the case for operant responses, for 
which much evidence was available, this lack of Pavlovian data might reflect the fact that 
studies manipulating PFC DA in appetitive Pavlovian procedures have produced negative 
results2.  If this were to be the case, it would support the notion that the PFC does not 
mediate the acquisition or expression of Pavlovian responses. 
                                                
2 The only study that was found investigating appetitive Pavlovian conditioning was a 
microdialysis study.  Not only does this kind of evidence not permit to implicate DA in a Pavlovian 
learning, but also the study was inconclusive, as the observed increase in DA release occurred in response 
to both paired and unpaired CS-food presentations (Mingote, et al., 2004). 
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5.3.3.  Manipulations of the Prefrontal Cortex and Subregions 
The evidence reviewed above suggests that PFC DA is not involved in either the 
acquisition or the expression of Pavlovian responses, whereas it mediates both the 
acquisition and expression of operant responses.  Studies manipulating the PFC directly 
through lesions or inactivation of the PFC and subregions reveal a different picture from 
PFC DA evidence, especially with regards to Pavlovian responses.  For example, while 
PFC DA does not seem involved in either Pavlovian learning or performance, there is 
evidence implicating the anterior cingulate cortex (ACC) in the acquisition of a CS+ 
discriminated approach (Bussey, Everitt, & Robbins, 1997; Cardinal, Parkinson, 
Lachenal, et al., 2002; Cardinal et al., 2003).  The OFC, while not necessary for 
Pavlovian learning, (Gallagher, McMahan, & Schoenbaum, 1999; McDannald, Saddoris, 
Gallagher, & Holland, 2005) (Ostlund & Balleine, 2007; Pickens, Saddoris, Gallagher, & 
Holland, 2005), might mediate complex aspects of Pavlovian performance such as 
Pavlovian instrumental transfer (PIT) (McDannald, et al., 2005; Ostlund & Balleine, 
2007), and representation of an outcome’s value (Gallagher, et al., 1999; Pickens, et al., 
2005) – a role similar to that suggested for the BLA earlier. 
The pattern of results is more consistent for operant responses.  Some suggest that 
the mPFC is necessary for instrumental learning (Ostlund & Balleine, 2005), a view that 
is consistent with the notion that PFC DA mediates operant learning.  Subregions of the 
PFC and DA transmission in these subregions are both implicated in similar aspects of 
operant response expression.  Indeed, PFC lesions and inactivation evidence suggest that 
the mPFC mediates sensitivity to the outcome’s value (Coutureau & Killcross, 2003; 
Killcross & Coutureau, 2003), that the ACC mediates an animal’s willingness to expand 
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effort on a task (Walton, Bannerman, & Rushworth, 2002) (Walton, Bannerman, 
Alterescu, & Rushworth, 2003), and that the OFC is necessary to shift between foraging 
strategies (Bohn, Giertler, & Hauber, 2003a, 2003b). 
In conclusion, the evidence reviewed implicates both PFC DA transmission as 
well as the PFC itself in the acquisition and expression of operant behaviors.  In contrast, 
while there was no evidence to reliably implicate PFC DA in Pavlovian learning or 
performance, studies manipulating the PFC suggest that the acquisition of a simple 
Pavlovian response depends upon the ACC.  These opposite results seem to suggest that 
the ACC mediates Pavlovian learning regardless of its DAergic input.  Alternatively, 
these opposite results might be attributable to the different methodologies used in each 
study.  Indeed, the evidence reviewed for PFC DA employed mostly aversive 
conditioning procedures (since this was the only type of evidence available), whereas the 
evidence implicating the ACC in Pavlovian learning used appetitive Pavlovian 
conditioning.  In sum, reliable evidence examining PFC DA’s involvement in appetitive 
Pavlovian responses is lacking, and future research needs to rigorously address this 
question. 
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6.  Conclusions and Predictions 
 
The evidence reviewed in section 5 indicates that DA mediation of Pavlovian and 
operant acquisition and expression is similar across the ACB, the amygdala, and the PFC.  
Specifically, DA transmission in the ACB core and the CeA mediates Pavlovian learning, 
while DA activity at each site mediates instrumental learning.  Also consistent across the 
three DAergic target sites was the lack of involvement of DA in the expression of 
Pavlovian responses.  Finally, operant performance was dependent upon DA transmission 
in the ACB and in the mPFC and OFC, but not in the amygdala.  A summary of these 
findings is provided in table 1. 
 
 
Nucleus 
accumbens DA Amygdala DA 
Prefrontal  
cortex DA 
Pavlovian acquisition Core CeA 
 
No 
Pavlovian performance No No 
 
No 
Operant acquisition Core, shell 
 
CeA, BLA mPFC 
Operant performance Core, shell No 
 
mPFC, OFC 
 
Table 1:  Summary of DA’s involvement at each target site in the acquisition and/or 
expression of Pavlovian and operant behaviors 
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The differential involvement of DA in Pavlovian and operant conditioning, and in 
particular the opposite involvement of ACB DA in the expression of these responses, is 
presumably attributable to the Pavlovian or operant nature of each task.  Indeed, the 
Pavlovian task entails a simple CS-US association where the reward delivery is 
independent of the animal’s response, whereas the operant task entails an action-outcome 
association where the reward delivery is contingent on the animal’s response.  The 
greater complexity of the operant response might account for the sustained reliance on 
ACB DA transmission during performance, whereas the simpler Pavlovian response 
seemingly shifts from a state of ACB DA-dependent acquisition to a state of ACB DA-
independent performance. 
Alternatively, the greater motoric complexity and/or effort of an operant LP 
response (the most commonly used operant response), relative to a simpler and more 
innate approach response, might account for the different ACB DA-reliant expression of 
these responses.  Yet, a third possible explanation accounting for this different pattern of 
ACB DA-reliance lies in the numerous methodological variations between all the studies 
reviewed.  Indeed, not only are the response measures different, but also the number of 
response manipulanda, number of eliciting cues, nature and duration of these cues 
(visual, auditory…), and the type of reinforcer used (pellet, liquid sucrose, milk…). 
Therefore, this work aimed at testing rigorously the hypothesis that D1 
transmission in the ACB mediates the expression of an operant response, but not the 
expression of a Pavlovian approach response, and that the only factor accounting for this 
difference is the nature of the response contingency (i.e., operant vs. Pavlovian).  This 
will be accomplished by keeping the experimental conditions of the Pavlovian and 
85 
 
operant paradigms as similar as possible.  This will be achieved first, by employing 
response measures with an almost identical topography: The Pavlovian approach will 
entail making a head entry response into the food compartment upon CS (tone) 
presentation, while the operant task will involve making a nosepoke response into a 
nosepoke manipulandum upon DS (tone) presentation.  The operant nosepoke is 
particularly well suited because the topography of the nosepoke response is very similar 
to that of the cued approach response (recruiting related muscle groups and requiring an 
equivalent effort level), yet it differs with respect to the nature of the task (operant versus 
Pavlovian).  Second, all other aspects of the experimental setting will be kept identical: 
Auditory cue, intertrial intervals, number of trials, site of central drug infusions, drug 
type and concentration, and response measures (latency to initiate responding upon tone 
presentation, rate of non-cued responding during inter-trial intervals, see methods below).  
Under these conditions, it is predicted that D1 receptor-blockade within the ACB will 
disrupt the operant nosepoke response, but not the Pavlovian approach. 
In addition, it will be of interest to examine whether D1 transmission in the 
amygdala mediates the expression of these responses.  Indeed, a study by Kelley et al 
reports that D1 transmission in the CeA and the BLA mediates the acquisition but not the 
expression of a LP response (Andrzejewski, et al., 2005).  However, amygdala lesion 
studies reveal that the expression of operant responses requires an intact BLA (and not 
CeA).  Furthermore, the evidence reviewed above suggests that the expression of operant 
responses is mediated by ACB DA and PFC DA transmission.  Thus, it seems possible 
that a) the BLA-dependent expression of operant responses suggested by BLA lesions 
studies requires, in fact, DA transmission in the BLA; b) that DA activity in the amygdala 
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mediates the expression of operant responses, as it does in the ACB and the PFC. 
Therefore, this work tested the hypothesis that the expression of the operant 
nosepoke response is also dependent upon D1 transmission in the BLA.  The evidence 
reviewed in section 5 suggests that the performance of Pavlovian responses does not 
depend upon DA activity in the amygdala, therefore it is predicted that D1-receptor 
blockade in the amygdala should not suppress the Pavlovian approach response, as is 
predicted with ACB D1 receptor-blockade, despite a topography similar to the operant 
nosepoke response. 
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II.   GENERAL METHODS 
 
Subjects 
Fifty-nine male albino Sprague Dawley rats (Charles Rivers Laboratories, 
Wilmington, MA) weighing between 300 and 350g, were housed in an animal colony 
(21° -22°C) under a 12 hr light-dark cycle (lights on at 9 A.M.).  The rats were housed in 
pairs in Plexiglas cages (22 cm high × 22 cm wide × 46 cm deep) mounted on racks with 
water and food freely available.  Rats were handled for the first week, before being 
placed on a 22-hour food-restricted diet in order to maintain their body weight at about 
85% of their ad libitum weight.  All procedures were approved by the Boston College 
Institutional Animal Care and Use Committee, and carried out in compliance with federal 
guidelines. 
Surgery 
Animals in each experiment were anesthetized with Nembutal (50 mg/kg, Henry 
Schein, Melville, NY), placed in a stereotaxic frame (Stoelting, Wood Dale, IL) in a flat-
skull position, and implanted bilaterally with stainless steel guide cannulae (23 gauge, 
Plastics One, Roanoke, VA).  In experiments where the infusion site targeted the ACB, 
guide cannulae were lowered to the border of the shell and the core of the ACB using a 
14-degree lateral-to-medial angle, at the following coordinates relative to bregma: 
Anteroposterior +1.6, mediolateral ±3.1, and dorsoventral -5.8 (Paxinos & Watson, 
1998).  In experiments where the infusion site targeted the BLA, bilateral guide cannulae 
were implanted (without a lateral-to-medial) at the following coordinates relative to 
bregma; anteroposterior -3.1, mediolateral ±5.1, and dorsoventral -6.5 (Paxinos & 
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Watson, 1998).  In all experiments, the guide cannulae were anchored to the skull via 
dental cement (Stoelting, Wood Dale, IL) and three stainless steel screws (Plastics One, 
Roanoke, VA).  Stainless steel wire obturators (“dummy cannulae”, Plastics One, 
Roanoke, VA) flushed with the end of the guides were inserted into the guide cannulae to 
prevent occlusion.  Upon waking from the surgery, animals were injected 
(subcutaneously) with an analgesic, rimadyl (5 mg/kg; Henry Schein, Melville, NY), and 
were returned to their home cage.  Following surgery, animals were given 5 days for 
recovery.  During the first two days, animals had free access to food and water after 
which they were placed back on food deprivation.  During the recovery period, animals 
were handled and weighed daily, an antibiotic ointment (Bacitracin) was applied daily to 
the incision, and the dummy cannulae were removed and cleaned every other day to 
prevent any risk of occlusion. 
Drugs and microinfusion procedure 
In all experiments, SCH 23390 (Sigma Chemical, St. Louis, MO), a dopamine 
D1-receptor-selective antagonist (Iorio, Barnett, Leitz, Houser, & Korduba, 1983) was 
dissolved in sterile water.  Each animal received bilateral microinfusions of vehicle, and 
SCH 23390 (1μg and 2μg) in a volume of 0.5μl/side; each of these three drug treatments 
was administered in a randomized order, with a non-drug retraining day between each 
drug infusion day.  The infusions were delivered via an injector cannula (30 gauge), 
attached to a 1μl-capacity Hamilton micro-syringe (Hamilton Co., Reno, NV), through 
PE‐20 tubing (Plastics One, Roanoke VA).  Prior to testing, dummy cannulae were 
removed and the injection cannula was inserted into each guide cannula.  The drug 
treatment was delivered over approximately 50 seconds via a micro-drive pump (Razel 
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Pump, Stamford, CT), followed by a 1 min wait time to allow diffusion of the drug, after 
which the injector cannula was removed and the dummy cannulae replaced.  Immediately 
following infusions, animals were placed in the conditioning chamber and the test session 
began. 
Apparatus 
Behavioral training and test sessions were conducted in eight conditioning 
chambers (Coulbourn Instruments, Whitehall, PA), each located within a sound- and 
light-attenuating isolation box equipped with a fan for ventilation and masking noise 
(Radioshack, 273-242).  Conditioning chambers (29 cm high × 29 cm wide × 25 cm 
deep) were composed of a front and back Plexiglas wall, and two metal sidewalls.  For 
both experiments, the chamber set-up included the following: A house light (Coulbourn, 
E11-01; located at the center of the right metal wall, 2 cm below the ceiling of the 
chamber); a food compartment (Coulbourn, E14-01, 4.0 cm high × 3.0 cm wide × 2.5 cm 
deep) recessed within the bottom center of the right wall 2 cm above the chamber floor 
into which a feeder (Coulbourn, E14-24) delivered food pellets (45 mg, F0021, Bioserve, 
Frenchtown, NJ); a speaker (Coulbourn, H12-01R) mounted on the top left corner of the 
right metal wall, with the center of the speaker located 4 cm below the ceiling of the 
chamber.  Additionally, the operant nosepoke task included a nosepoke operandum, 
(Coulbourn, H21-09R) with a one-inch diameter entrance hole, located on the bottom left 
corner of the right metal wall, with its center 2.5 cm above the floor chamber. 
Each experiment included all of the following response sensors: A photocell 
sensor (Coulbourn, E20-93A) to record head entries into the food compartment, 
measured by an infrared photo-emitter-detector located on each side of the food 
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compartment (interruption of the beam indicated a head entry); an activity monitor, 
(Coulbourn, H24-61) to detect general locomotion through infrared body heat movement, 
mounted on the ceiling of the chamber.  In addition, the operant nosepoke task included 
an infrared photocell sensor on each side of the nosepoke operandum, which detected 
nosepokes into the entrance hole (Coulbourn, H21-09R).  Behavioral training and data 
collection were effectuated using the Coulbourn Graphic State data-acquisition software 
(version 3.03), running on a Cobalt computer (Cobalt 4114 LabMax Series; Cobalt, 
Whitehall, PA), which recorded the time of occurrence and duration of all behavioral and 
stimulus events throughout each session with 50 ms resolution. 
Behavioral training for the Pavlovian cued approach task 
On the first day of training, animals had access during 20 minutes to 15 food 
pellets placed at the bottom of the food compartment.  On the next day, the first of three 
drug-free conditioning sessions began.  During these sessions, rats received 28 tone/food 
trials with a variable time (VT) 70 sec inter-trial interval (ITI).  Each trial consisted of a 
brief tone (2000Hz, 68dB, 0.5 sec) followed 600 ms later by food pellet delivery into the 
food compartment (sequence of events illustrated in figure 1).  On the following (fourth) 
day, rats received an identical tone/food session following infusion of vehicle, SCH 1μg, 
or SCH 2μg.  Each animal received each drug dose on a different test day separated by a 
drug-free retraining day, and the order of drug treatment was randomized. 
Behavioral training for the operant nosepoke task 
Habituation to food pellet consumption was identical to that employed above, i.e., 
animals had a 20 min access to 15 food pellets placed at the bottom of the food 
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compartment – the nosepoke operandum was not included in the cage set up on this day.  
On the following day, the nosepoke operandum was introduced, and all nosepoke 
responses in the operandum were reinforced with a pellet on a continuous reinforcement 
schedule.  The next day, cued operant training sessions began.  Each operant session 
consisted of 28 tone presentations (0.5 sec, 2000 Hz, 68dB).  Animals had a 10 second 
period following tone presentation to emit a nosepoke in order to obtain a food pellet.  
Any nosepoke other than the first nosepoke following tone onset was not rewarded.  A 
diagram illustrating the sequence of events in the cued nosepoke task can be seen in 
figure 1.  While the ITI for these cued operant trials would eventually match the VT 70s 
ITI employed for the Pavlovian task above, rats were initially trained with a shorter ITI, 
which was gradually increased.  During the first day of cued nosepoke training, tone 
presentations were separated by a 30 sec variable time inter-trial interval (VT 30s ITI).  
Once animals responded correctly about 75% of the time on this schedule (20 correct 
nosepokes out of 28), the ITI was increased to 50 sec, and after 75% correct responding 
was established on the VT 50s ITI schedule, animals were finally trained on the VT 70s 
ITI schedule, which was considered day 1 of final cued nosepoke training.  Animals 
needed approximately one or two days of training on each the 30s and the 50s schedules 
to reach a 75% correct level of performance.  Once on the VT 70s ITI schedule, animals 
received an additional 2 days of drug-free training, and on the following (fourth) day, 
they were tested after infusion of vehicle, SCH 1μg or SCH 2μg.  Each animal received 
each drug dose on a different test day separated by a drug-free retraining day, and the 
order of drug treatment was randomized. 
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Figure 1:  Diagrams illustrating the sequence of events in the Pavlovian cued approach 
task (A) and in the operant cued nosepoke task (B). 
Tone 
Pellet 
Head entry 
VT70 sec ITI Next ITI 
10 sec post-tone to perform a 
head entry scored as a cued 
approach 
A. 
B. 
Tone 
Pellet 
Head entry 
Next ITI 
10 sec post-tone to perform a nosepoke in 
order to earn a food pellet 
VT70 sec ITI 
Nosepoke 
Possible premature 
head entries  
(non-rewarded) 
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Histology 
At the end of each experiment, animals were deeply anesthetized with Nembutal 
before being perfused transcardially with 0.9% saline followed by 10% formalin.  Brains 
were stored in formalin for a day, then transferred to a 20% sucrose and formalin mixture 
for 2 days.  Brain were cut in 40µm sections with a microtome, and stained for Nissl 
substance with cresyl violet.  Sections were examined with light microscopy to verify 
cannulae placement and infusion sites.  Reconstructions of estimated sites of infusions 
were made on Rat Brain Atlas Sections (Paxinos & Watson, 1998) with Adobe Illustrator 
(version 13.0.2).  Digital photographs of representative sections for each training protocol 
and within each brain site were captured by an RT Spot camera mounted on a Zeiss 
standard microscope, and are reproduced below.  Only data points from correctly placed 
infusion sites were included in the data analysis. 
Exclusions 
Eight animals were excluded due to death during surgery.  The following rats were 
excluded upon histological verification: Three rats in the ACB Pavlovian approach group 
(infusion sites either in the ACB core or in the ventral pallidum instead of the ACB 
core/shell border); four in the BLA Pavlovian approach group (placements in the lateral 
amygdala, or too posterior); three animals in the ACB nosepoke group (placements in the 
ACB core or in the ventral pallidum); and three in the BLA nosepoke group (placements 
too ventral and either in the basomedial amygdala or in the endopiriform cortex).  
Consequently, each experimental group comprised the following number of animals in 
the final analysis: Approach (n=9) and BLA Pavlovian approach group (n=8); ACB 
nosepoke (n=13), and BLA nosepoke (n=8), yielding a total of thirty-eight animals.
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Figure 2.  Reconstructions of the location of ACB infusion sites, drawn onto plates 
reproduced from the Paxinos and Watson Atlas (1998).  Crosses indicate approximate 
infusion sites of animals in the nosepoke group; asterisks indicate approximate infusion 
sites of animals in the Pavlovian approach group. Values indicate distance from bregma.
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Figure 3.  Reconstructions of the location of BLA infusion sites, drawn onto plates 
reproduced from the Paxinos and Watson Atlas (1998).  Crosses indicate approximate 
infusion sites of animals in the nosepoke group; asterisks indicate approximate infusion 
sites of animals in the Pavlovian approach group.  Values indicate distance from bregma. 
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Figure 4.  Histological representation of infusion sites for the ACB of a representative 
animal trained on the Pavlovian approach task. 
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Figure 5.  Histological representation of infusion sites for the ACB of a representative 
animal trained on the operant nosepoke task. 
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Figure 6.  Histological representation of the right hemisphere infusion site for the BLA 
for a representative animal trained on the Pavlovian approach task. 
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Figure 7.  Histological representation of the left hemisphere infusion site for the BLA for 
a representative animal trained on the operant nosepoke task. 
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Data Analysis 
Statistical analyses were carried out separately for animals trained on the operant 
nosepoke task and on the Pavlovian approach task.  Furthermore, within each behavioral 
task, the data from animals implanted in the ACB and the BLA were analyzed separately 
with one-way repeated measures Drug Dose (0, 1 and 2 µg) ANOVAs.  Main effects of 
Drug were further analyzed with Bonferroni post hoc tests, with alpha levels adjusted to 
p<.0167 (.05/3).  While one could have used Behavioral Task and/or Infusion Site as 
factors in a 2- or 3-way ANOVA, the 1-way ANOVAs employed here permitted a 
straightforward examination of the key questions regarding accumbens and amygdala D1 
receptor involvement in Pavlovian and operant performance.  These within-subject 
analyses minimized non-treatment-related variance in the data. 
While ANOVAs used in between-subjects designs have to meet assumptions of 
homogeneity of variance and correlation, repeated measures ANOVAs have to satisfy the 
assumption of sphericity3.  In the results section below, violations of sphericity will be 
reported, with mention of the Chi Square statistic (χ2), p level, and Greenhouse-Geisser 
epsilon value (ε) used to adjust degrees of freedom. 
                                                
3 This assumption ensures that the differences between pairs of scores have equal variance within 
a sample group (Keppel and Wickens, 2004). SPSS checks this assumption with Mauchly’s test, yielding a 
Chi Square value.  When the test is significant (p<0.05), the data violates the assumption of sphericity, and 
degrees of freedom have to be adjusted (Norusis, 2003).  The Greenhouse-Geisser correction is a 
conservative solution to violations of sphericity: it recalculates degrees of freedom according to an epsilon 
value, which measures the extent to which sphericity has been violated.  Decreasing degrees of freedom 
yields a larger critical value for the ANOVA’s F, which reduces the likelihood of falsely rejecting the null 
hypothesis (Keppel and Wickens, 2004). 
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III.   RESULTS 
 
1. Cued Response Latency 
This work aimed to determine whether D1 receptor activity in the nucleus 
accumbens and/or the basolateral amygdala mediates the performance of a Pavlovian 
and/or an operant conditioned response. 
Pavlovian cued approach: The effect of SCH 23390 (SCH) on the latency to emit 
a head entry response was assessed with separate one-way repeated-measures ANOVAs 
for each infusion site (ACB and the BLA).  When infused into the ACB, SCH did not 
significantly increase the head entry latency, F (2, 16) = .36, p=NS.  Because the BLA 
data was found to violate sphericity, χ2 (2) = 7.66, p<.05, degrees of freedom were 
adjusted with Greenhouse-Geisser’s epsilon (ε=.58).  The ANOVA run on the corrected 
BLA infusion data showed that SCH did not significantly increase the head entry latency, 
F (1.16, 8.13) = .68, p=NS.  These results, illustrated in figures 8 and 9, suggest that the 
Pavlovian approach response does not depend upon intact D1 transmission in either the 
nucleus accumbens or the BLA.  
Operant nosepoke:  In contrast to the Pavlovian approach response, performance 
of the cued nosepoke response was vulnerable to D1 receptor blockade both in the ACB 
and in the BLA (figures 10 and 11).  This is of particular interest because the motor 
topography of the nosepoke and the head entry responses, though not identical, are very 
similar.  One-way ANOVAs revealed a strong effect of SCH dose in the ACB, F (2, 24) 
= 102.36, p<.001, and in the BLA, (2, 14) = 13.03, p=.001.  Bonferroni post hoc tests 
indicated that for ACB infusions, the high dose slowed the nosepoke latency relative to  
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Figure 8.  Mean ± SEM latency to enter the food compartment upon tone onset for 
animals trained on the Pavlovian approach task and tested under the influence of SCH 
23390 (0, 1 and 2μg) infused into the ACB.  The drug treatment did not increase the 
latency to approach the food compartment relative to vehicle (p=NS). 
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Figure 9.  Mean ± SEM latency to enter the food compartment upon tone onset for 
animals trained on the Pavlovian approach task and tested under the influence of SCH 
23390 (0, 1 and 2μg) infused into the BLA.  The drug treatment did not increase the 
approach latency relative to vehicle (p=NS). 
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Figure 10.  Mean ± SEM latency to emit a nosepoke upon tone onset for animals trained 
on the operant nosepoke task and tested under the influence of SCH 23390 (0, 1 and 2μg) 
into the core/shell border region of the ACB.  The high drug dose strongly increased the 
latency to emit a nosepoke response upon presentation of the tone, relative to vehicle (**, 
p<.01). 
 
** 
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Figure 11.  Mean ± SEM latency to emit a nosepoke response upon tone onset for 
animals trained on the operant nosepoke task and tested under the influence of SCH 
23390 (0, 1 and 2μg) into the core/shell border region of the BLA.  The high drug dose 
strongly increased the latency to emit a nosepoke response upon presentation of the tone, 
relative to the vehicle treatment (**, p<.01;  *, p<.05).  
 
* ** 
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both vehicle (p<.001) and low dose of SCH (p<.001).  In the case of BLA infusions, 
Bonferroni post hoc tests showed that both the low SCH dose (p<.05) and the high dose 
(p<.01) slowed the nosepoke latency relative to the vehicle treatment.  These results 
suggest that D1 receptor transmission in both the ACB and BLA critically mediates the 
operant nosepoke response.  On the contrary, the Pavlovian approach response was 
invulnerable to D1 receptor-blockade.  Together, these findings suggest that despite 
relatively similar response topographies, the Pavlovian approach and the operant 
nosepoke may be mediated by different neural circuitry. 
 
2.  Adjusted Cued Response Latency 
In order to better understand the nature of the D1 antagonist-induced increase in 
the operant nosepoke latency, this latency measure was recalculated such that missed 
trials were excluded from the mean latency.  Recall that a missed trial consisted of a trial 
where an animal did not emit a nosepoke response within 10 seconds of tone 
presentation, and was automatically assigned a latency of 10 seconds.  Excluding these 
trials from the total latency yielded the adjusted nosepoke latency.  This recalculation 
permitted to examine the D1 antagonist’s effect on trials where animals did respond 
within 10 seconds of the tone.  With regards to the Pavlovian training group, since the D1 
antagonist did not disrupt the cued Pavlovian approach at any dose or any infusion site, 
the adjusted latency closely resembled the overall tone to head entry latency presented 
above, therefore these results are not presented here. 
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Infusion of the D1 antagonist into the ACB did not suppress the adjusted 
nosepoke latency F (2, 20) = 2.20, p=NS (figure 12), whereas infusion of the drug into 
the BLA did increase these adjusted latencies, F (2, 12) = 6.29, p<.05.  A Bonferroni 
comparison showed that, surprisingly, only the low dose of SCH increased the adjusted 
nosepoke latency, and the effect was marginal (p=.056) (figure 13).  Overall, these 
findings indicate that although D1 receptor-blockade increased the total nosepoke 
latency, the effect was not observed when ‘missed trials’ were excluded from analysis 
(i.e., the adjusted latency was unaffected).  In other words, for both ACB and BLA SCH 
infusions, on trials when animals do respond to the tone, they do so with a relatively 
normal latency.  This suggests that the D1 antagonist-induced increase in the total 
nosepoke latency should be accounted for by an increase in missed trials.   
This was confirmed by an ANOVA conducted on missed trials.  Because 
sphericity was violated [χ2 (2) = 7.66, p<.05], degrees of freedom were adjusted with 
Greenhouse-Geisser’s epsilon (ε=.58), and the corrected ANOVA revealed that SCH 
infusion into the ACB increased the number of missed trials, F (1.34, 16.06) = 96.91, 
p<.001, as well as SCH infusion in the BLA, F (2, 14) = 13.86, p<.001.  Bonferroni 
comparison showed that in the ACB, the high SCH dose increased the number of missed 
trials relative to both vehicle (p<.001) and low dose (p<.001).  For BLA infusions, both 
the high SCH dose (p<.01) and the low dose (p=.05) increased the number of missed 
trials relative to vehicle (figures not shown).  Thus, misses and adjusted latency, allow to 
better characterize the deficits induced by D1 receptor-blockade: Disrupting D1 
transmission decreases the likelihood that animals respond to the tone with a nosepoke 
response; however, when animals respond, they do so in a relatively unimpaired fashion. 
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Figure 12.  Mean ± SEM adjusted nosepoke latency (i.e. with missed trials excluded) for 
animals trained on the operant nosepoke task and tested under the influence of SCH 
23390 (0, 1 and 2μg) in the ACB.  The D1 antagonist had no effect on the adjusted 
nosepoke latency. 
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Figure 13.  Mean ± SEM adjusted nosepoke latency (i.e. with missed trials excluded) for 
animals trained on the operant nosepoke task and tested under the influence of SCH 
23390 (0, 1 and 2μg) in the BLA.  Despite a marginal increase of the adjusted nosepoke 
latency by the low SCH dose relative to vehicle and high SCH dose, overall, the D1 
antagonist did not affect the adjusted nosepoke latency.  
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3.  Frequency of Baseline Responses 
Given that SCH 23390 disrupted the cued nosepoke response but not the cued 
Pavlovian approach response, it was pertinent to examine whether the antagonist 
similarly affected other uncued nosepokes and head entries, occurring during the inter-
trial interval.  These responses were never reinforced and decreased sharply during 
training; nevertheless, animals still exhibited some residual ITI responding during test 
sessions.  A sample of these uncued responses was recorded during the 10-second period 
directly preceding the tone in each task.  These responses were referred to as baseline 
head entries in the Pavlovian task and baseline nosepokes in the operant task.  Since the 
ITI was variable in both tasks, animals could not predict the time of occurrence of the 
next tone presentation.  Therefore, this 10-second sample was fairly representative of 
overall ITI responding, and not influenced by an increase in responding due to 
anticipation of the tone. 
Pavlovian cued approach:  SCH suppressed baseline head entries both when 
infused into the ACB, F (2, 16) = 7.88, p<.01, and into the BLA, F (2, 14) = 4.08, p<.05.  
Bonferroni analyses revealed that ACB infusion of the high SCH dose suppressed 
baseline head entries (p=.01) relative to vehicle (figure 14).  For BLA SCH infusions, 
despite a main effect of drug dose and the apparent suppression of baseline head entries 
by SCH 23390 (figure 15), Bonferroni post hoc tests revealed that no individual SCH 
23390 dose suppressed baseline head entries.  This may, in part, reflect the stringent 
criteria of the Bonferroni correction (p=.05/3=.016).   
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Figure 14.  Mean ± SEM baseline head entries into the food compartment (i.e. 10 seconds 
before tone presentation) for animals trained on the Pavlovian approach task and tested 
under the influence of SCH 23390 (0, 1 and 2μg) infused into the ACB.  Both doses of 
the D1 antagonist decreased the number of baseline head entries relative to controls (**, 
p=.01). 
 
** 
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Figure 15.  Mean ± SEM baseline head entries into the food compartment (i.e. 10 seconds 
before tone presentation) for animals trained on the Pavlovian approach task and tested 
under the influence of SCH 23390 (0, 1 and 2μg) infused into the BLA.  Despite a main 
effect of SCH23390, post hoc Bonferroni tests revealed that the means of baseline head 
entries did not differ across drug treatments. 
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This analysis reveals that D1 receptor blockade, in the ACB especially, 
suppresses baseline head entries.  This result is in stark contrast with the finding reported 
above that D1 receptor blockade does not affect the cued head entry latency (Figures 8 
and 9).  Together, these results suggest that animals under the influence of a D1 
antagonist emit less baseline head entries, but exhibit intact cued head entry latency, 
relative to their performance when treated with vehicle.  Figures 16 and 17 illustrate the 
difference between the vulnerability of cued and uncued head entries to SCH 23390.  
Together these results suggest that intact D1 transmission is necessary in both the ACB 
and the BLA for the expression of uncued head entry responses, but not for head entries 
that are part of a Pavlovian contingency. 
Operant nosepoke:  Infusion of SCH into the ACB strongly suppressed baseline 
nosepokes, F (2, 24) = 13.81, p<.001, and post hoc tests revealed that the high SCH dose 
suppressed baseline nosepokes relative to vehicle (p<.01) and to the low dose (p<.05), 
and that the low SCH dose marginally suppressed baseline nosepokes (p=.058) relative to 
vehicle (figure 18).  In the case of BLA SCH infusions, the data was adjusted so as to not 
violate sphericity [χ2 (2) = 14.94, p=.001, ε=0.52].  An ANOVA conducted on these 
corrected data revealed a strong SCH 23390-induced suppression of baseline nosepokes,  
F (1.04, 7.30) = 12.98, p<.01, and post hoc tests showed that both the high SCH dose 
(p<.05) and the low dose (p<.05) suppressed baseline nosepokes relative to vehicle 
(figure 19).   
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Figure 16.  Raster plots of head entries for a representative animal trained on the 
Pavlovian task and infused in the ACB.  Head entries (horizontal lines) are represented 
from -10 sec before the tone (0 on the x axis) to 10 sec after the tone.  Successive trials 1-
28 are represented from the bottom to the top of the y-axis (center).  Top panel, A: 
Vehicle infusion, the animal exhibits some baseline head entries and reliably responds to 
the tone with a cued head entry.  Middle panel, B: Infusion of 1µg SCH23390 suppresses 
baseline head entries relative to vehicle, but not cued head entries.  Bottom panel, C: 
Infusion of 2µg SCH23390 suppresses baseline head entries relative to vehicle, but not 
cued head entries.
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Figure 17.  Raster plots of head entries for a representative animal trained on the 
Pavlovian task and infused in the BLA.  Top panel, A: Vehicle infusion, the animal 
exhibits some baseline head entries and reliably responds to the tone with a cued head 
entry.  Middle panel, B: Infusion of 1µg SCH23390 suppresses baseline head entries 
relative to vehicle, but not cued head entries.  Bottom panel, C: Infusion of 2µg 
SCH23390 suppresses baseline head entries relative to vehicle, but not cued head entries. 
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Thus, infusion of SCH 23390 into both the ACB and the BLA suppressed baseline 
nosepokes.  This suggests that intact D1 activity in the ACB and in the BLA is necessary 
to perform nosepoke responses in general, since SCH 23390 disrupts both the cued 
nosepoke (within the operant contingency) and baseline nosepokes (spontaneous).  
Figures 20 and 21 compare the effect of SCH 23390 on baseline and cued nosepokes. 
Taken together, the Pavlovian head entry and operant nosepoke results suggest 
that the mediation of baseline and cued responses by ACB and BLA D1 transmission 
differs between Pavlovian and operant behaviors.  While the expression of a baseline 
head entry requires intact ACB and BLA D1 transmission, the performance of a cued 
head entry response to a Pavlovian CS is invulnerable to D1 receptor blockade.  In 
contrast, both a cued nosepoke in response to an operant DS and a baseline nosepoke 
require intact D1 activity in the ACB and in the BLA.  It is worth noting that these results 
are remarkably consistent across both ACB and BLA infusion sites. 
 
4.  General Locomotion 
Given DA’s important role in locomotion, levels of general locomotion were 
monitored during each test session, thus providing a common measure of the D1 
antagonist’s effect across the Pavlovian and operant experimental groups. 
Locomotion in the Pavlovian task:  The ACB locomotion data was adjusted to 
satisfy sphericity requirements [χ2 (2) = 9.95, p<.01, ε=.57].  The corrected ANOVA 
revealed a strong SCH 23390-induced suppression of locomotion, F (1.14, 9.10) = 8.76, 
p=.01 (figure 22), and post hoc tests showed that relative to vehicle, the high dose (p<.05)  
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Figure 18.  Mean ± SEM baseline nosepokes (i.e. 10 seconds before tone presentation) 
for animals trained on the operant nosepoke task and tested under the influence of SCH 
23390 (0, 1 and 2μg) in the ACB.  The high SCH dose decreased the number of baseline 
nosepokes relative to controls (**, p<.01).  
 
** 
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Figure 19.  Mean ± SEM baseline nosepokes (i.e. 10 seconds before tone presentation) 
for animals trained on the operant nosepoke task and tested under the influence of SCH 
23390 (0, 1 and 2μg) in the BLA.  Both doses of the D1 antagonist decreased the number 
of baseline nosepokes relative to controls (*, p<.05).  
 
* * 
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Figure 20.  Raster plots of nosepoke responses for a representative animal trained on the 
operant nosepoke task and infused in the ACB.  Nosepokes (horizontal lines) are 
represented from -10 sec before the tone (0 on the x axis) to 10 sec after the tone.  
Successive trials 1-28 are represented from the bottom to the top of the y-axis (center).  
Top panel, A: Vehicle infusion, the animal emits many baseline nosepokes and reliably 
responds to the tone with a cued nosepoke.  Middle panel, B: Infusion of 1µg SCH23390 
somewhat suppresses baseline and cued nosepoke responses relative to vehicle.  Bottom 
panel, C: Infusion of 2µg SCH23390 strongly suppresses both baseline and cued 
nosepoke responses, relative to vehicle. 
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Figure 21.  Raster plots of nosepoke responses for a representative animal trained on the 
operant nosepoke task and infused in the BLA.  Top panel, A: Vehicle infusion, the 
animal emits many baseline nosepokes and responds to the tone with a cued nosepoke.  
Middle panel, B: Infusion of 1µg SCH23390 suppresses baseline and cued nosepoke 
responses relative to vehicle.  Bottom panel, C: Infusion of 2µg SCH23390 strongly 
suppresses both baseline and cued nosepoke responses, relative to vehicle. 
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and to a marginal extent the low dose (p=.058) treatments decreased locomotion.  The 
BLA locomotion data was adjusted to meet sphericity, [χ2 (2) = 9.62, p<.01, ε=.57], and 
the corrected ANOVA revealed that SCH 23390 suppressed locomotion, F (1.11, 7.78) = 
10.59, p=.01, and post hoc tests showed that both the high (p<.05) and the low SCH dose 
(p=.05) decreased locomotor activity relative to vehicle.  Thus, these results indicate that 
within the Pavlovian training protocol, the D1 antagonist disrupted locomotion in a 
similar, dose-dependent fashion at both infusion sites (figure 22 and 23). 
Locomotion in the operant nosepoke task:  The ACB locomotion data was 
adjusted to meet sphericity [χ2 (2) = 9.18, p=.01, ε=.64], and the corrected ANOVA 
revealed a strong SCH 23390-induced suppression of locomotion, F (1.27, 15.33) = 
18.42, p<.001.  Post hoc tests comparisons showed that a dose-dependent disruption of 
locomotion [high SCH dose relative to vehicle (p=.001) and relative to low dose (p<.01), 
and low SCH dose relative to vehicle (p=.01), figure 24].  The locomotor activity of 
animals in the BLA nosepoke group was suppressed by SCH 23390 infusion, F (2, 14) = 
7.30, p<.01.  Post hoc analyses showed that the high SCH dose suppressed locomotion 
relative to vehicle (p<.05) and relative to low SCH dose (p<.05).  The low drug dose 
effect on locomotion however did not differ (p=NS) from that of the vehicle treatment 
(figure 25). 
Together, these results indicate that overall, the D1 antagonist disrupted 
locomotion in a dose-dependent manner at both infusion sites and across both training 
protocols, suggesting that the drug infusions were efficient in each training condition. 
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Figure 22.  Mean ± SEM general locomotion for animals trained on the Pavlovian 
approach task, under the influence of intra-ACB SCH 23390 (0, 1 and 2μg).  The D1 
antagonist suppressed general locomotion (*, p<.05). 
 
* * 
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Figure 23.  Mean ± SEM general locomotion for animals trained on the Pavlovian 
approach task, under the influence of intra-BLA SCH 23390 (0, 1 and 2μg).  The D1 
antagonist suppressed general locomotion (*, p .05). 
 
* * 
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Figure 24.  Mean ± SEM general locomotion for animals trained on the nosepoke task, 
under the influence of intra-ACB SCH 23390 (0, 1 and 2μg).  The D1 antagonist strongly 
suppressed general locomotion (**, p≤.01). 
 
** 
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Figure 25.  Mean ± SEM general locomotion for animals trained on the nosepoke task, 
under the influence of intra-BLA SCH 23390 (0, 1 and 2μg).  The high drug dose 
suppressed general locomotion relative to the vehicle treatment (*, p<.05).  
 
* 
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5.  Nosepoke-To-Head-Entry Latency 
Owing to its more complex design, the operant nosepoke task offered the 
opportunity to measure additional aspects of cued nosepoke responding.  Indeed, upon 
tone presentation, animals made a nosepoke response in the nosepoking hole, which 
triggered a pellet delivery in the neighboring food compartment.  Then, to retrieve the 
food pellet, animals had to make a separate head entry response into the food 
compartment.  Given the differential effect of D1 receptor-blockade on the Pavlovian 
head entry response and the operant nosepoke response, it was of interest to examine how 
the D1 antagonist might affect this nosepoke-to-head-entry segment of the behavioral 
response sequence, recorded as the latency between the nosepoke and the head entry. 
SCH 23390 infusion did not suppress the nosepoke to head entry latency when 
infused into either the ACB, F (2, 14) = 0.29, p=NS (figure 25), or in the BLA, F (2, 12) 
= 1.68, p=NS (figure 26).  These results suggest that the nosepoke-to-head-entry segment 
of the operant response chain is invulnerable to D1 receptor blockade in the ACB and the 
BLA (figure 26 and 27).   
 
6.  Number of Nosepokes Before a Head Entry 
Another question related to the notion of a behavioral sequence entailed 
examining the number of nosepoke responses emitted between the tone and the pellet 
retrieval head entry (i.e., animals could make one or several nosepokes before retrieving 
the pellet).  Neither ACB infusion of SCH 23390, F (2, 14) = 0.32, p=NS (figure 28), nor  
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Figure 26.  Mean ± SEM nosepoke to head entry latency for animals trained on the 
nosepoke task, under the influence of intra-ACB SCH 23390 (0, 1 and 2μg).  Neither 
doses of the D1 antagonist disrupted the latency to retrieve the pellet reward after 
emitting a cued nosepoke response. 
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Figure 27.  Mean ± SEM nosepoke to head entry latency for animals trained on the 
nosepoke task, under the influence of intra-BLA SCH 23390 (0, 1 and 2μg).  Neither 
doses of the D1 antagonist disrupted the latency to retrieve the pellet reward after 
emitting a cued nosepoke response. 
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BLA infusions, F (2, 12) = 0.01, p=NS (figure 29), influenced the number of nosepokes 
emitted before the head entry response.  Inspection of figures 27 and 28 and of group 
means indicates unequivocally that in all conditions animals emit only one nosepoke 
before the pellet-retrieving head entry (ACB: 0µg, M = 1.03; 1µg, M = 1.13 and 2µg, M = 
1.12; BLA: 0µg, M = 1.07; 1µg, M = 1.08 and 2µg, M = 1.08).  Therefore, when a cued 
nosepoke response is generated, it is unaffected by the D1 antagonist. 
 
7.  Proportion of Nosepokes not Followed by a Head Entry 
The last measure monitored to understand the cued nosepoke sequence examined 
whether a cued nosepoke response is always followed by a head entry, and whether SCH 
23390 impairs this behavioral sequence such that animals emit a cued nosepoke but do 
not follow-up with a pellet-retrieving head entry.  This measure, the proportion of 
nosepokes not followed by a head entry response, was unaffected by either ACB  
SCH 23390 infusions, F (2, 14) = 0.01, p=NS, or by BLA SCH 23390 infusions, F (2, 14) 
= 0.54, p=NS.  The group means indicates that the cued nosepoke response is always 
followed by a head entry, regardless of ACB or BLA D1 transmission, since the 
proportion of nosepokes not followed by a head entry is close to zero in all conditions 
(ACB: 0µg, M = 0.00, 1 µg, M = 0.01 and 2 µg, M = 0.01; BLA: 0 µg, M = 0.01; 1 µg, M 
= 0.00 and 2 µg, M = 0.01; figures not shown). 
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Figure 28.  Mean ± SEM number of nosepokes emitted before a head entry response for 
animals trained on the nosepoke task, under the influence of intra-ACB SCH23390 (0, 1 
and 2μg).  The D1 antagonist had no effect on this response: Animals always emitted just 
one nosepoke before making a head entry to retrieve the pellet reward. 
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Figure 29.  Mean ± SEM number of nosepokes emitted before a head entry response for 
animals trained on the nosepoke task, under the influence of intra-BLA SCH23390 (0, 1 
and 2μg).  The D1 antagonist had no effect on the number of nosepokes: Animals always 
emitted just one nosepoke before making a head entry to retrieve the pellet reward. 
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8.  Baseline Head Entries in the Operant Task 
Animals in the operant nosepoke task also emitted head entry responses into the 
food compartment during the ITI, or baseline head entries, much like they emitted 
baseline nosepokes.  The measures reported above, such as the nosepoke to head entry 
latency indicate that the pellet retrieval head entry is invulnerable to SCH 23390.  
Therefore, it was of interest to examine whether SCH 23390 suppressed baseline head 
entries (sampled during 10 seconds before the tone), as was the case in the Pavlovian 
experiment above. 
The ACB baseline head entry data was adjusted to satisfy the sphericity 
assumption [χ2 (2) = 11.91, p<.01, ε=0.60], and an ANOVA conducted on the corrected 
data revealed that SCH 23390 infusion in the ACB suppressed baseline head entries, F 
(1.20, 14.45) = 13.28, p<0.01. Bonferroni comparisons showed that both the high (p<.01) 
and the low SCH dose (p<.01) decreased baseline head entries relative to vehicle (figure 
30).  Infusion of SCH 23390 into the BLA also suppressed baseline head entries, F (2, 
14) = 4.07, p<0.05, however, despite a main effect of drug and the apparent suppressive 
effect of the high SCH dose (figure 31), Bonferroni comparisons showed no effect of 
either the high or the low SCH dose relative to vehicle. 
Overall, baseline head entries are vulnerable to D1 receptor blockade in the ACB 
and to a lesser extent in the BLA, a result that mirrors the finding in the Pavlovian task.  
SCH 23390 infusions into both the ACB and BLA also suppressed baseline nosepokes, 
thus, suggesting that intact D1 transmission in the ACB and in the BLA is necessary for 
the expression of baseline responses in general. 
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Figure 30.  Mean ± SEM number of baseline head entries (emitted during the 10 seconds 
preceding the tone) for animals trained on the operant nosepoke task and tested under the 
influence of intra-ACB SCH23390 (0, 1 and 2μg).  The D1 antagonist strongly decreased 
the number of baseline head entries relative to vehicle (**, p<.01). 
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Figure 31.  Mean ± SEM number of baseline head entries (emitted during the 10 seconds 
preceding the tone) for animals trained on the operant nosepoke task and tested under the 
influence of intra-BLA SCH23390 (0, 1 and 2μg).  Despite a main effect of drug, and the 
apparent suppression of baseline head entries by the high drug dose, post hoc tests using a 
Bonferroni correction found that neither doses of the D1 antagonist suppressed baseline 
head entries relative to vehicle. 
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9.  Premature Head Entries in the Operant Task 
Animals in the cued nosepoke task could emit a head entry after the tone but 
before the cued nosepoke response.  These types of head entries were referred to as 
premature, since nosepoking upon the tone was the only reinforced response.  The 
purpose for recording potential premature head entries was to examine whether D1 
receptor-blockade caused the animals to respond to the tone with a head entry instead of a 
nosepoke as a compensatory mechanism to cope with the D1 antagonist challenge.  
Alternatively, if such premature head entries occur even in undrugged animals, it was of 
interest to determine whether these responses were vulnerable to SCH 23390 (like 
baseline head entries), or invulnerable to the D1 antagonist (like the Pavlovian pellet 
retrieval response). 
Infusions of SCH 23390 into the ACB strongly suppressed premature head 
entries, F (2, 24) = 7.56, p<.01, an effect accounted for by the high SCH dose suppression 
of premature head entries (p<.01) relative to vehicle (figure 32).  SCH 23390 infused into 
the BLA marginally suppressed premature head entries, F (2, 14) = 3.52, p<.058 (figure 
33), however neither SCH dose suppressed premature head entries relative to vehicle. 
These results indicate that premature head entries are vulnerable to D1 receptor-
blockade in the ACB and to a lesser extent in the BLA, suggesting that premature head 
entries are similar to baseline head entries (suppressed by SCH 23390) and not to pellet 
retrieval head entries (invulnerable to SCH 23390). 
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Figure 32.  Mean ± SEM number of premature head entries (occurring after the tone but 
before the cued nosepoke response necessary to obtain a pellet) tone) for animals trained 
on the operant nosepoke task and tested under the influence of intra-ACB SCH23390 (0, 
1 and 2μg).  The D1 antagonist suppressed the number of baseline head entries relative to 
vehicle (**, p<.01).  
 
 
** 
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Figure 33.  Mean ± SEM number of premature head entries (occurring after the tone but 
before the cued nosepoke response necessary to obtain a pellet) tone) for animals trained 
on the operant nosepoke task and tested under the influence of intra-BLA SCH23390 (0, 
1 and 2μg).  Despite a main effect of drug, neither drug dose was found to significantly 
suppress premature head entries, relative to vehicle. 
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10.  Relation between the vulnerability of general activity measures and missed cued 
nosepokes to SCH23390 
A final analysis was conducted to examine whether the suppression of general 
activity measures induced by SCH23390 was related to, and in fact could predict, the 
number of missed cued nosepoke trials due to SCH23390.  To that end, the relation 
between general locomotion and the number of missed cued nosepokes, as well as the 
relation between the number of baseline nosepokes and the number of missed cued 
nosepoke were examined with correlation analyses.  The data was analyzed separately for 
each infusion site (i.e. ACB vs. BLA).  Due to the within-subject nature of the data, 
correlations were carried out on the difference score for each drug dose: The locomotor 
score obtained under the 2μg dose condition was subtracted from the locomotor score 
obtained in the vehicle condition, yielding the SCH 2μg difference score.  Similarly, the 
locomotor 1μg dose was recalculated to produce the SCH 1μg difference score.  Baseline 
nosepokes and the number of missed cued nosepokes were also recalculated as difference 
scores for each drug dose, and the following correlations were carried out: Locomotion 
and missed cued nosepokes for each the SCH 1μg and the 2μg difference score; baseline 
nosepokes and missed cued nosepokes for each the SCH 1μg and 2μg difference scores.   
There was no relation between the suppressive effect of SCH23390 on locomotor 
score and missed cued nosepoke trials at either infusion site and for either the 1μg 
difference score (ACB: r = -0.05, p=NS; BLA: r = -0.34, p=NS) or the 2μg difference 
score (ACB: r = -0.25, p=NS; BLA: r = 0.29, p=NS).  Similarly, there was no relation 
between the suppressive effects of SCH23390 on baseline nosepokes and the number of 
missed trials at either infusion site and for either the 1μg difference score (ACB: r = 0.11, 
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p=NS; BLA: r = 0.51, p=NS) or the 2μg difference score (ACB: r = 0.08, p=NS; BLA:  
r = 0.51, p=NS).  These results indicate that although the D1 antagonist suppressed 
general locomotion and baseline nosepokes frequency, and increased the number of 
missed cued nosepoke trials, there was no relationship between the drug’s suppressive 
effect on locomotion or on baseline nosepokes and the number of missed cued nosepokes.  
Thus, the level of suppression of general activity measures cannot be used to predict the 
effect of SCH23390 on missed cued nosepokes. 
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IV.   DISCUSSION 
 
1.  Pavlovian Approach and Operant Nosepoke: Similar Response Topography, Different 
Neural Substrates 
The primary objective of this work was to compare the effects of D1 receptor-
blockade in the nucleus accumbens (ACB) and in the basolateral amygdala (BLA) on the 
expression of a Pavlovian cued approach and an operant cued nosepoke.  The results 
reported here suggest that performance of the operant cued nosepoke (indexed by the 
cued nosepoke latency) depends upon intact D1 activity in the ACB and in the BLA.  In 
contrast, the performance of the Pavlovian cued approach (indexed by the cued head 
entry latency) does not require D1 activity in either the ACB or the BLA.  While these 
results do not permit to infer which neural substrate(s) might underlie the performance of 
a Pavlovian approach response, they do allow the conclusion that the expression of an 
operant nosepoke is mediated by D1 receptor activity in the ACB and in the BLA, 
whereas the expression of a Pavlovian approach is not. 
Great care was taken to minimize the differences in behavioral response 
topography, training, and other methodological parameters.  Thus, despite the nearly 
identical response topography (similar effort level and muscle group activation), the 
Pavlovian approach response and the operant nosepoke response appear to be mediated 
by different neural substrates/mechanisms.  One of the key differences between each type 
of task is that in a Pavlovian task, the reward delivery is independent of the animal’s 
response, whereas in an operant task, the reward delivery is conditional on the animal’s 
response.  Indeed, in the Pavlovian approach task, rats learn that the tone (CS) predicts a 
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food pellet delivery (US), and so they respond to the tone with a food compartment 
approach response (CR).  If rats fail to approach the food compartment within 10 seconds 
of tone onset, the pellet is still delivered and available for rats to retrieve later on.  In 
contrast, in the operant task, animals learn that they can earn a food pellet (outcome) 
contingent on their making a nosepoke response (action) upon tone presentation (DS).  
However, if a rat fails to nosepoke within 10 sec of tone onset, it has lost the opportunity 
to earn a food pellet until next trial.  This difference in contingency might account for the 
different reliance of operant and Pavlovian responses on ACB and BLA D1 transmission. 
The different pattern of results could alternatively be attributed to the fact that the 
Pavlovian approach is more temporally proximal to the food pellet reinforcement 
whereas the operant nosepoke is more distal in time from reward delivery.  Indeed, 
vehicle-treated animals in the Pavlovian task are about 1.65 sec away from obtaining the 
pellet (average head entry latency), whereas rats in the operant nosepoke task are at least 
3.14 sec away from the reinforcement (combining the nosepoke latency, 2.41sec, with the 
nosepoke-to-head-entry latency, 0.73sec).  In addition, animals in the Pavlovian task only 
have to emit one response, the cued head entry, to obtain the food pellet, whereas animals 
in the operant task have to emit two responses: The cued nosepoke and the head entry. 
Nicola and colleagues examined such an operant head entry response where upon 
tone onset animals had to enter a liquid reward receptacle and maintain this head entry 
response for increasing periods of time in order to obtain the liquid reward – if they 
withdrew their head before the required amount of time the reward was not delivered.  In 
this paradigm, the operant response was directed toward the reward compartment (as it is 
in the present Pavlovian approach task), but differed from the operant and Pavlovian 
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tasks employed in the current experiments in that animals were required to emit a 
sustained as opposed to a discrete behavioral response in order to receive the reward.  D1 
receptor blockade (SCH 23390) in the ACB suppressed the number of operant head entry 
responses emitted in response to the cue (Wakabayashi, et al., 2004).  Thus, ACB D1 
receptor-blockade suppressed the expression of an operant head entry response – even 
when the operant response was directed toward the food compartment, a result consistent 
with the present findings.  While the wait requirement in the Nicola task permitted one to 
distinguish the operant head entry response from other head entries, this very prerequisite 
would have not permitted a direct comparison with our Pavlovian cued approach task, 
thus the operant nosepoke was used instead.  However together, our operant nosepoke 
result and the operant head entry result of the Nicola study, both suggest that the 
expression of operant responses, even those that closely resemble Pavlovian responses, 
depends upon intact D1 transmission in the ACB, whereas the expression of truly 
Pavlovian responses such as our Pavlovian approach are mediated by a distinct, non-DA 
dependent neural mechanism. 
 
2.  Nature of the Response Deficits Induced by the D1 Receptor Antagonist SCH 23390 
As noted above, intra-accumbens and intra-basolateral amygdala infusion of the 
D1 receptor antagonist SCH 23390 increased the latency of the cued operant nosepoke.  
The nature of the SCH 23390-induced deficit was examined more closely by separating 
missed trials (i.e., trials where animals do not nosepoke within 10 second of tone onset) 
from the overall nosepoke latency.  This recalculation yielded the adjusted latency, or the 
latency of cued nosepokes that rats successfully made within 10 seconds of tone onset.  
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This analysis revealed that at both infusion sites the D1 antagonist a) increased the 
number of missed trials and b) did not affect the adjusted latency.  Thus, D1 receptor-
blockade in the ACB and the BLA increased the likelihood that animals missed a trial 
(i.e., do not respond within 10 seconds of tone onset), but did not affect the latency of the 
cued nosepokes on trials in which rat responded to the tone.  This result suggests that D1 
transmission in the ACB and the BLA is necessary to promote behavioral activation to 
cues, rather than the speed of the movement, once initiated.  Furthermore, on trials where 
animals do respond to the tone, not only is their nosepoke latency intact, but also, the 
entire response sequence, from the cued nosepoke to the pellet retrieval, is unimpaired by 
the D1 antagonist at either infusion site.  That is, when drugged animals nosepoke within 
10 seconds of the tone, each nosepoke response systematically leads to the next 
component of the response sequence: The pellet retrieving head entry.  This is evidenced 
by a) the fact that rats emit only one nosepoke (no perseverative nosepokes) b) the 
nosepoke-to-head-entry latency is intact and c) a cued nosepoke is always followed by a 
head entry.  Therefore, once animals initiate the response sequence with a cued nosepoke, 
they perform the entire sequence unaffected by the D1 antagonist at either infusion site.  
Thus, D1 receptor-blockade appears only to suppress the likelihood that animals respond 
to a cue, but not the performance of the cued nosepoke or the rest of the response 
sequence.  In this regard, one might conceive of ACB and BLA D1 receptor transmission 
to play a role in a response-gating function.  
Similarly, in the Nicola et al study mentioned above, ACB D1 receptor-blockade 
suppressed the number of cues animals responded to, but did not reduce the amount of 
the amount of time that rats were willing to spend in the food compartment in order to 
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earn a food pellet (Wakabayashi, et al., 2004).  Consistent with the present results, ACB 
D1 receptor blockade decreased the likelihood that animals responded to the tone, but 
when they did respond, it did not disrupt parameters of the response itself (in this case, 
response duration).  Likewise, in the 5-choice serial reaction time task (5CSRT), where 
animals had to nosepoke in one of the five nosepoking holes where a brief light CS was 
presented, ACB D1 antagonist challenge increased the nosepoke latency, but did not 
affect the “magazine latency” (Pezze, et al., 2007), a measure equivalent to the nosepoke-
to-head-entry latency in the present operant nosepoke paradigm.  Together, these results 
suggest that D1 receptor-blockade in the ACB or the BLA decreases the number of cues 
animals respond to, but does not disrupt the performance of the response sequence itself 
once it is initiated, implying that performance of the response sequence is not mediated 
by ACB or BLA D1 transmission.   
Interestingly, the lack of disruption of the nosepoke-to-head-entry sequence by 
SCH 23390 is reminiscent of the invulnerability to D1 receptor-blockade of the cued 
head entry response in the Pavlovian approach task.  Both responses share not only an 
identical topography (head entry into the food compartment), but they also share the goal 
of retrieving a food pellet (the operant reinforcer or Pavlovian US, respectively.  One 
might conceptualize the nosepoke-to-head-entry response segment as a Pavlovian 
response component embedded within an operant sequence, for which the Pavlovian CS 
is not a tone but a successful nosepoke.  This view would account for the resistance of the 
nosepoke-to-head-entry latency to D1 antagonist challenge at either infusion site. 
It is interesting to note that baseline head entries (i.e., sampled during 10 sec 
before tone onset) were suppressed by ACB and BLA D1 receptor-blockade in both the 
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Pavlovian and the operant task.  While these baseline head entries have the same 
topography as the Pavlovian cued head entry, they differ from the cued head entry in two 
respects.  First, baseline head entries are internally generated, whereas the conditioned 
head entries are driven by externally cues such as a tone or a prior successful nosepoke.  
Second, baseline head entries are never reinforced, whereas cued head entries (and head 
entries following a cued operant nosepoke) are always reinforced.  Thus, head entries that 
follow of a tone or a successful nosepoke are generated with a high level of reward 
expectation, whereas internally generated head entries occur with a much lower reward 
expectation.  Since cued head entries (high reward expectation) are invulnerable to D1 
receptor-blockade, but baseline head entries (low reward expectation) are not, a possible 
interpretation is that under conditions of reduced D1 transmission in the ACB or the 
BLA, there is an increase in the threshold for reward expectation to generate an appetitive 
response.  That is to say, under these conditions, appetitive head entry responses are only 
generated by conditions of very high reward expectation such as following a Pavlovian 
CS or a successful operant nosepoke.  While this ‘reward expectation threshold’ 
explanation does not, at first glance, account for the D1-dependence of the cued operant 
nosepoke (which is always reinforced), this question is addressed below. 
The interpretation that responses with high reward expectations are not vulnerable 
to D1 receptor-blockade, but that responses with lower reward expectations are 
vulnerable, accounts for how cued and baseline head entries, which share the same 
topography, are mediated by different neural mechanisms.  In addition, this interpretation 
also explains the vulnerability of baseline nosepoke responses (occurring during the ITI, 
and never reinforced) and premature head entries (head entries emitted after the operant 
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tone but before the cued nosepoke response) to ACB and BLA D1 receptor blockade.  
Both these responses have in common the fact that the reward expectation associated 
with the response is low. 
It is possible, then, that behavioral responses that are certain to be reinforced do 
not depend upon either ACB or BLA D1 transmission.  Certainty may be important here, 
because one of the defining features of operant responses is that the reward delivery does 
not follow the CS with certainty, but rather is contingent upon the animal’s behavioral 
response.  That is, the cued nosepoke is only reinforced when the animals emit the 
behavioral response within 10 second of the tone presentation.  Thus, on trial where 
animals fail to nosepoke within the required time-period, their next nosepoke response is 
not reinforced, which might be sufficient to create a state of uncertainty about whether 
reinforcement will occur after a nosepoke response, or a state of low reward expectation.  
This reasoning might explain why the cued operant nosepoke which is normally 
reinforced, is vulnerable to D1 receptor-blockade. In fact, this difference in the certainty 
of reward delivery may be a critical feature separating Pavlovian and operant responses.  
Indeed, since Pavlovian responses are always reinforced (even after a missed trial, the 
pellet is still available in the food compartment), they are associated with a high level of 
reward expectation and therefore can be emitted even under conditions of D1 receptor-
blockade.  On the contrary, since operant responses are only reinforced when they occur 
within the required operant contingency (e.g., within a certain time frame in our task), on 
some trials, animals might miss the opportunity to earn a reinforcer.  These occasional 
missed reinforcements might be sufficient to create a lower level of reward expectation, 
and thus the expression of operant responses might always require intact D1 transmission 
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in the ACB and the BLA.  Future research should test the hypothesis that the level of 
reward expectation (high versus low) might be what determines a response’s reliance on 
D1 transmission.  For example, it would be interesting to examine whether the 
performance of a Pavlovian response to a less-than 100% (e.g., 75%, 50%) predictive CS 
is vulnerable to ACB D1 receptor-blockade  
Alternatively, one might argue that the response deficits observed in the present 
operant nosepoke task are due to attention deficits.  As described above, in a 5-choice 
serial reaction time task (5CSRT), ACB D1 receptor-blockade increases omissions 
(equivalent to our missed trials) and increases latency to nosepoke (similar to our overall 
latency), behavioral disruptions interpreted to reflect attentional deficits (Pezze, et al., 
2007) (but see, Pattij, et al., 2007).  While this interpretation might account for the 
disruption of the present cued nosepoke response, it does not account for the observation 
that the cued Pavlovian approach a behavioral response to an identical sensory elicitor 
was not disrupted by D1 receptor-blockade.  Second, it would not explain why responses 
such as baseline head entries and baseline nosepokes, which presumably do not have any 
attention requirement, are disrupted by the D1 antagonist 
Yet another explanation, to account for the difference in vulnerability to D1 
antagonist challenge of the Pavlovian and operant cued responses, is that D1 receptor 
blockade in the ACB and in the BLA suppresses all voluntary, goal-directed responses, 
but not reflexive, innate responses.  In this view, voluntary motor responses include the 
cued nosepoke response, and general exploratory behaviors (i.e. locomotion and baseline 
nosepokes) – responses that are presumably driven by the telencephalon (i.e. BLA to 
ACB to thalamus to PFC) – whereas reflexive or innate responses include the Pavlovian 
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cued approach and the nosepoke-to-head entry response – which instead could be 
mediated directly by the brainstem (i.e. BLA to CeA to brainstem).  According to this 
view, D1 receptor-blockade in the ACB and in the BLA would have suppressed the cued 
nosepoke response (or increased the number of missed trials), as it suppressed other 
general activity measures such as locomotion and baseline nosepokes, while sparring the 
cued Pavlovian approach and nosepoke-to-head entry responses.  However, as mentioned 
above, although SCH23390 increased the number of missed cued nosepokes, on some 
trials rats did nosepoke normally in response to the tone.  Therefore, according to the 
view that SCH23390 infusion into the ACB and the BLA suppresses all voluntary motor 
responses, it is possible that on missed nosepoke trials, locomotion and baseline 
nosepokes are also suppressed, whereas on trials where animals nosepoke normally to the 
tone, locomotion and baseline nosepokes are intact.  Thus, it is possible that there is a 
direct, proportional relationship between the SCH-induced increase in missed nosepoke 
trials and the level of locomotor and baseline nosepokes suppression induced by 
SCH23390. 
To examine whether there was such a relation, correlations comparing the number 
of missed nosepoke trials with the number of baseline nosepokes and general locomotion 
were carried out on each drug dose’s difference score for each measure (i.e. the 2µg score 
and 1µg score were subtracted from each vehicle score, in order to account for the 
within-subject nature of the data).  All the correlations (i.e. comparing each measure, at 
each drug dose and for each infusion site) were statistically non significant.  This means 
that although D1 receptor-blockade increased missed trials and suppressed locomotion 
and baseline nosepoke responses, there was no relation between the SCH23390-induced 
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increase in missed trials and the level of locomotor and baseline nosepokes suppression 
induced by SCH23390.  Therefore, it seems likely that ACB and BLA D1 receptor-
blockade globally suppressed locomotion and baseline nosepokes while sparring cued 
nosepoke responding on some trials.  If this were to be true, it would argue against the 
notion that such D1 receptor-blockade suppressed at once all voluntary movements while 
sparring all these responses simultaneously at other times.  A better examination of this 
question would require dividing each session into different time segments and comparing 
the level of responding for each measure at each time segment.  Nevertheless, the lack of 
relationship between the number of missed trials and the level of locomotion and baseline 
nosepoke suppression suggests that although ACB and BLA D1 receptor-blockade 
disrupts voluntary motor responses in general, it is not an all-or-nothing suppression. 
Regarding the more reflexive Pavlovian approach or nosepoke-to-head entry 
responses, it is possible that DA transmission at other brain sites such as perhaps the CeA 
(which also receives an important DAergic projection from the VTA) mediates these 
responses.  Some data suggests that D3 transmission in the CeA is not necessary for the 
performance of a Pavlovian discriminated approach (Phillips & Hitchcott, 2009).  
However, this type of discriminated Pavlovian approach is more complex than the task 
examined in the present work: In a discriminated approach task, animals approach the CS 
associated with reward, whereas in the present task animals approach the food 
compartment directly.  In addition, the involvement of other CeA DA receptors, and in 
particular D1 receptors, in the performance of a Pavlovian approach response should be 
examined as well.  As is discussed below, further research is needed to determine which 
brain sites might mediate the performance of a Pavlovian cued approach. 
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3.  Pavlovian Responses Become Invulnerable to D1 receptor-blockade After Acquisition 
The present results indicate that the expression of a Pavlovian cued approach is 
invulnerable to D1 receptor blockade in the ACB and in the BLA, a finding that is 
consistent with much of the literature reviewed in section 5.  In contrast, the literature 
suggests that the acquisition of Pavlovian responses depends upon intact D1 transmission 
in the ACB (particularly in the core) and D3 transmission in the CeA (but not in the 
BLA).  On the other hand, the view that Pavlovian responses are dependent on DA 
transmission during acquisition but not during performance is consistent with other 
reports (Bespalov, Harich, Jongen-Relo, van Gaalen, & Gross, 2007; Choi, Balsam, & 
Horvitz, 2005; Costa, 2007; Horvitz, et al., 2007; Ikemoto & Panksepp, 1999; Wickens, 
Horvitz, Costa, & Killcross, 2007).  
How might one explain a DA-dependent acquisition but DA-independent 
performance of appetitive Pavlovian behavior?  One possible mechanism underlying this 
shift might be the strengthening of cortico-striatal synapses through a DA-dependent 
mechanism during acquisition, leading to synapses that are efficient enough that cortical 
inputs can influence striatal neurons without necessitating DA’s facilitation during 
performance (Costa, 2007; Graybiel, 1998; Horvitz, 2002; O'Donnell, 2003; Wickens, et 
al., 2007). 
If D1 transmission within the ACB and BLA is not necessary for Pavlovian 
response expression, what might be the neural substrates underlying Pavlovian 
performance?  Lesion or inactivation studies indicate that the CeA does not mediate 
Pavlovian performance (Groshek, et al., 2005) (Gallagher, et al., 1990) and that the BLA 
mediates Pavlovian-instrumental-transfer, PIT, and sensitivity to outcome devaluation 
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(Blundell, et al., 2003; Hatfield, et al., 1996; Johnson et al., 2009).  ACB core lesions 
appear to increase irrelevant responding such as responding to a CS- (Cardinal, 
Parkinson, Lachenal, et al., 2002), thus this evidence does not clearly implicate the ACB 
in Pavlovian performance either – but perhaps points to its role as a filter for relevant 
responses.  In conclusion, the precise brain location(s) at which DA transmission might 
mediate a simple Pavlovian cued approach remain(s) to be elucidated (Choi, 2005). 
 
4.  An Interconnected Circuit Dependent on Dopamine 
The work presented here revealed that the performance of an operant nosepoke 
response not only depends on intact D1 transmission in the ACB, but also in the BLA.  
This result is inconsistent with the previous finding by Kelley and colleagues, that the 
acquisition but not the expression of an operant LP requires D1 activation in the BLA 
(Andrzejewski, et al., 2005).  To the best of our knowledge, this is the first report that D1 
receptor-blockade in the BLA disrupts the expression of a food-reinforced operant 
response.  There have been reports that DA transmission in the BLA mediates aversive 
conditioning (Greba & Kokkinidis, 2000; Guarraci, Frohardt, & Kapp, 1999; Nader & 
LeDoux, 1999) and drug-reinforcement (Berglind, Case, Parker, Fuchs, & See, 2006; 
Caine, Heinrichs, Coffin, & Koob, 1995; Di Ciano, 2008; Di Ciano & Everitt, 2004; 
Gremel & Cunningham, 2008).  Thus, the present finding adds to existing body of 
knowledge, that BLA D1 transmission also mediates the performance of a food-
reinforced operant response, lending support to the notion that the BLA, like the ACB, is 
part of a DA-regulated circuitry mediating a wide range of responses. 
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Although the present work did not examine the involvement of PFC D1 
transmission in the performance of the operant nosepoke response, based on the evidence 
reviewed in section 5, one would predict that D1 receptor-blockade in the mPFC should 
also impair the expression of this operant nosepoke.  In addition, the literature reviewed 
indicated that the acquisition of operant responses depends upon DA transmission in each 
area, the ACB, BLA, and PFC.  Thus, the data reviewed in section 5, together with our 
finding that BLA D1 transmission is necessary for the expression of an operant nosepoke, 
suggest that all three brain areas, the ACB, BLA, and PFC mediate both the acquisition 
and the expression of operant responses via DA-regulated mechanism(s).  As seen in the 
anatomy section, these brain areas are interconnected: The PFC projects to both the BLA 
and the ACB, and the BLA projects back to the PFC, but also has a dense projection the 
ACB.  In addition, the VTA sends DAergic efferents to each of these three areas, and 
both the ACB and the PFC project back to the VTA, thus forming an integrated network. 
A simplified neural model accounting for how this network might underlie the 
performance of operant responses follows. 
It is proposed that sensory inputs such as cues and other environmentally relevant 
stimuli excite the BLA via DA-dependent mechanisms (Kroner, Rosenkranz, Grace, & 
Barrionuevo, 2005; Rosenkranz & Grace, 1999, 2001, 2002).  Excited BLA pyramidal 
neurons projecting to the ACB act locally via glutamate release to increase DAergic tone 
in the ACB (Floresco, Yang, Phillips, & Blaha, 1998; Gracy & Pickel, 1996; Howland, 
Taepavarapruk, & Phillips, 2002), which inhibits ACB medium spiny neurons (Charara 
& Grace, 2003), thereby resulting in behavioral output (Mogenson, 1987; Nicola, 2007; 
Numan, 2006).  Simultaneously, the BLA projection to the PFC inhibits cell firing in 
153 
 
some PFC neuron populations while exciting other neuron populations (Floresco & Tse, 
2007).  PFC neuron excitation appears to result in decreased DA efflux in the ACB, 
although the exact mechanisms underlying this process are still being determined (Carr & 
Sesack, 2000b; Jackson, Frost, & Moghaddam, 2001; Jackson & Moghaddam, 2001; 
Sesack & Carr, 2002).  Thus, the BLA-mediated inhibition of some PFC neuron 
populations might prevent the PFC activation-induced decrease in ACB DA efflux (Del 
Arco & Mora, 2008; Jackson & Moghaddam, 2001), although more research is needed to 
examine how this process might take place.  In addition, DA acting at D2 receptors 
inhibits PFC neurons, resulting in increased DA efflux in the ACB (del Arco & Mora, 
2005; Del Arco & Mora, 2008; Tseng & O'Donnell, 2007).  Thus, this DA- and BLA-
mediated inhibition of the PFC might combine to maintain high DA levels in the ACB, 
which, through ACB inhibition (McGinty & Grace, 2009), results in behavioral output 
(Mogenson, 1987; Numan, 2006). 
Disconnection paradigms entail disrupting the connection between two nuclei on 
each side of the brain, by interfering with one nucleus (e.g., the BLA) on one side of the 
brain while manipulating the other nucleus (e.g., the ACB) on the other side of the brain.  
This is achieved via excitotoxic lesion, or temporary inactivation via blockade of NMDA 
or AMPA receptors, or with blockade of DA receptors.  Such behavioral evidence lends 
support to the notion that intact connections between a) the BLA and the ACB, b) the 
BLA and the PFC and c) intact DA transmission at these sites, are necessary for the 
expression of operant behaviors.  For example, unilateral inactivation of the BLA with 
contralateral ACB DA receptor-blockade suppresses the expression of a LP response 
(Simmons & Neill, 2009).  In another study, unilateral inactivation of the BLA and 
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contralateral inactivation of the dmPFC impaired responding to reward-paired cues 
(Ishikawa, Ambroggi, Nicola, & Fields, 2008).  Interestingly, a similar BLA inactivation 
with contralateral ACC inactivation resulted in animals choosing a low reward/low effort 
response (Floresco & Ghods-Sharifi, 2007).  Supporting the notion that DA’s inhibition 
of the ACB enables behavioral output, but that lesion of the ACB lifts control over 
relevant responses, unilateral ACB lesion and contralateral mPFC lesion resulted in 
increased perseverative responding on 5CSRT task (Christakou, Robbins, & Everitt, 
2004). 
 
5.  Conclusion 
In the proposed model, the initial activation of the BLA to sensory cues and other 
biologically important events is dependent on DA activation (Kroner, et al., 2005; 
Rosenkranz & Grace, 2002).  Therefore, this model suggests a mechanism by which DA 
might promote behavioral activation to important environmental stimuli (although further 
elaborations of this model should also account for the important contribution of the 
hippocampus).  While this particular model is only meant to account for the expression of 
operant responses, it is possible that the same circuitry underlies the acquisition of 
operant behaviors and perhaps that of Pavlovian behaviors as well, though the 
mechanisms mediating Pavlovian and operant acquisition might be different. 
In light of this complex circuitry, where DA appears to simultaneously promote 
excitation of BLA neurons and inhibition of PFC and ACB neurons, what might be the 
overall function of DA transmission?  Much of the evidence reviewed in this thesis 
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indicates that the deficits induced by DA manipulations revolve around reduced 
responding, especially to cues.  The simplest explanation that accounts for most findings, 
as seen in the introduction, is that the overall function of DA transmission is to energize 
behavior and promote activation to important environmental stimuli (Baldo & Kelley, 
2007; Ikemoto & Panksepp, 1999; Kelley, et al., 2005; Nicola, 2007; Numan, 2006; 
Numan, Stolzenberg, 2009; Salamone, 1996; Salamone, et al., 2007).  Although this 
general view may not account for the specific actions of DA at different neural substrates 
and via different receptors, it allows for the possibility that DA transmission mediates 
such diverse behaviors as responding to distinct cues as seen in this thesis, but also to less 
obvious stimuli, such as a lever previously associated with LPing for food (Smith-Roe & 
Kelley, 2000) or drugs (Caine & Koob, 1994), or a sexually receptive mate for males 
(Damsma, et al., 1992) and females (Becker, et al., 2001), or pups to mother rats (Numan, 
et al., 2005; Stolzenberg, et al., 2007), but also responses to aversive stimuli 
(Abercrombie, et al., 1989) (McCullough, et al., 1993) or aggressive behavior (Ferrari, et 
al., 2003) and social defeat (Anstrom, et al., 2009). 
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